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Abstract
Metals are required by a quarter of all proteins to achieve their biological function,
whether in an active site involved in catalytic chemistry or in a structural capacity. Metals
are tightly regulated at the cellular level due to their propensity to cause unwanted side
reactions and to be scavenged for use by pathogens. One of the proteins involved in this
regulation of metal homeostasis is metallothionein (MT) which is a small, cysteine rich
protein primarily involved in the regulation of zinc and copper homeostasis and heavy
metal detoxification. MT is unique in its high cysteine content (~30% of the residues), its
high capacity for metal binding and its highly dynamic structure in the absence of metals.
This fluxionality has made the structure of apo- and partially-metalated MTs difficult to
study and as a result, the binding pathway of MT for various metals remains unclear.
This thesis describes the hard-to-characterize structure of apo- and partially-metalated
MTs, their binding pathways and potential applications. Using electrospray ionization
mass spectrometry (ESI-MS) and covalent labeling, the structure of apo- and partially
metalated MTs was probed. Modeling techniques that generate simulated ESI-MS data
were used to recreate the covalent labeling spectra and aid in the interpretation of this
complicated reaction. These experiments showed that apo-MT adopts a compact, globular
conformation that is resistant to initial modification by alkylating reagents. Furthermore,
this compact conformation is essential to the fast kinetics of cadmium binding and cluster
formation. This cluster formation was found to be pH dependent and this insight was
essential in the design of an MT-based biosensor for the detection of As(III) and Hg(II).
Altogether, these results reconcile previously conflicting reports about the metal binding
mechanisms of MTs, provide evidence of compact conformations of apo-MT and its role
in binding kinetics and begin to demonstrate potential application of this fundamental
knowledge in the design and testing of an electrochemical, MT-based biosensor.
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Chapter 1

1

Introduction

Metallothioneins (MTs) are a ubiquitous family of small, cysteine-rich proteins that are
primarily involved with metal homeostasis, heavy metal detoxification and cellular redox
chemistry.1-4 Metal saturated mammalian MTs consist of two metal binding domains, the
C-terminus α-domain which contains 11 cysteine residues and the N-terminus β-domain
which contains 9 cysteines.5 These MTs bind up to seven divalent metals, for a maximum
of 4 in α- and 3 in the β-domain to form a dumbbell shape (Figure 1-1) under saturative
conditions.6 The stoichiometries and coordination geometry of divalent metals such as
zinc and cadmium are well defined and have been studied for many years.5, 7-10 However,
there still remains controversy over the specific binding mechanisms for these two
metals.11-13 MTs are also known to promiscuously bind soft metals and metalloids such
as: Uranium14, arsenic15, mercury16, copper17 and lead.18 This promiscuity is facilitated by
the lack of rigid, formal structure in the peptide backbone, keeping it flexible to
accommodate metals and metalloids of different sizes and preferred coordination
geometries.19
MTs generally lack formal secondary structural elements, especially in the absence of
metals.16 They also lack aromatic amino acids which limits the usefulness of optical
methods in the purification and isolation procedure and to probe structural changes. This
property along with the propensity for the reduced cysteine residues to oxidize forming
intra-protein covalent linkages, make MTs difficult to work with.

2

Figure 1-1: Representation of the ``dumbbell`` structure of MT. (A) Space-filling
diagram of Cd7-MT. (B) Ball-and-stick diagram of the fully metalation protein. (C) Balland-stick diagram of the isolated metal-thiolate clusters of each domain of MT.
Reproduced using data from Chan et al., 2007.20

1.1 Metals in biology
A number of transition metals are required to catalyze the reactions required for life.
Nature has selected naturally abundant metals like zinc, copper and iron for their unique
abilities to perform redox chemistry, transfer electrons and switch back and forth between
oxidation states.21-22 Redox inactive metals like zinc act more frequently as Lewis acids

3

that promote reactivity of a substrate23-24 or act in a structural role to stabilize intermolecular interactions as in the case of zinc-finger proteins.25 While essential for many
cellular processes, metals also must be strictly controlled and regulated, shuttling
electrons and changing oxidation states is not without consequences and potential
unwanted side reactions can occur causing damage to cellular machinery.26-27 In addition,
pathogens also require metals for their survival and must scavenge them from the host.28
As a result, an evolutionary arms race has ensued to develop ever more effective metal
capturing agents for pathogens while being countered by ever more strictly controlled
cellular and intra-cellular metal concentrations by the host.29-31
The strict control of metals in biological environments is achieved through binding
affinity gradients that shuttle metal ions from extra to intracellular spaces and from
intracellular chaperones to the active sites of metalloenzymes.32 The highest binding
affinities for various metals are usually found in structural enzymes that utilize those
metals to stabilize a shape to perform a specific function.33-34 Cells must also transport
metal ions across the hydrophobic cellular membrane, which requires metal transporter
proteins.35 These proteins often contain large stretches of hydrophobic residues to anchor
themselves within the lipid bilayer and provide small electrostatic channels specific for
certain ions based mostly on size and charge restrictions.36 Thus, during all stages of
transport the freedom of movement of metal ions is restricted so that side reactions and
potential thefts by pathogens are minimized.
MTs are one of the families of chaperones responsible for this strict control of free metal
concentrations, mainly of copper and zinc.1, 37 Their high capacity for binding these
metals allows them to act as a buffer, releasing zinc or copper in times of scarcity and
binding excess ions in times of over-abundance. This is the essence of homeostatic
control. MTs do not carry out any catalytic function themselves involving metals,
although reactions related to the redox state of the cell may be facilitated by the many
cysteinyl thiols of MT.38 Instead, MTs ensure a near constant supply of metals to proteins
that interact with DNA and catalyze essential reactions, while keeping concentrations of
free zinc or copper to a minimum. Free copper, in particular, can be damaging to cells
because of the Fenton and Haber-Weiss reactions it can catalyze.26
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Interactions of MTs and other metalloproteins have been investigated in vitro in order to
understand the mechanisms and kinetics involved in biological metal transfer.39 These
studies have shown potentially dangerous interactions, including the substitution of
cadmium for zinc in carbonic anhydrase, facilitated by Cd-MT.40-41 Metal swapping
between MTs has also been demonstrated, highlighting the lability required for proper
MT function in vivo.42
Many metals that are considered toxic derive their toxicity from the substitution of an
essential metal, like zinc, with a toxic metal, like cadmium, altering or inhibiting the
function of the metalloprotein.41, 43 The substitution is possible due to the electronic
similarities between the two metals, but size and reactivity differences render the
substituted metalloprotein useless.44 Two toxic metals we are particularly interested in
with relation to MT are cadmium and arsenic.

1.2

Cadmium toxicity and MT

Since its discovery by Margoshes and Vallee while investigating cadmium-bound
proteins in horse liver, MT has been known to bind strongly to this toxic metal.45 Like
many biological processes, the role MT plays in the detoxification of cadmium is
complicated.3, 46-48 Cadmium toxicity mainly targets the kidneys where significant
amounts of MTs are expressed concomitantly.48 The first evidence of the detoxifying role
of MT came from studies where MT was isolated from human kidney, having both Cd(II)
and Hg(II) bound.49 The binding affinity for these toxic metals is orders of magnitude
higher than that of Zn(II), (zinc binding range Ka 1011-12, cadmium Ka 1015-16) so native
Zn-MT is displaced when these metals are present.50 MT knockout mice, while not
immediately fatal, show greater sensitivity to toxic metal exposure.51
Occupational exposure to cadmium is the most common source of cadmium poisoning5253

, although environmental contamination has historically been a problem as well leading

to itai-itai disease in people eating foods grown in cadmium contaminated irrigation
water or drinking that contaminated water directly.54 This is exemplified in the Jinzu river
basin in Japan where industrial contamination led to the poisoning of local inhabitants,
the name of the disease “itai-itai” deriving from the expression for pain in Japanese.55
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This was the first officially recognized case of environmental induced disease in Japan
and serves as a warning for industrially developing regions.

1.3

Arsenic and MT

Arsenic is a toxic metalloid known since ancient times as a potent poison and used
historically as a pest control agent, whether those pests are rats56 or political enemies of
Pope Alexander VI or Napoleon Bonaparte.57 Today, these sinister uses are much less
prevalent and the main concern around arsenic poisoning involves naturally contaminated
well-water in poor, rural areas lacking access to centralized water treatment facilities.58-59
In areas such as South and South-East Asia, much of the surface water is highly
contaminated with bacteria and is acutely infectious.60 In the late 1980s and early 90s,
many NGOs began building wells to alleviate the problem of waterborne diseases.61 The
drilling of these wells exposed arsenic-containing rock to oxygen when the well was
depleted, solubilizing the arsenic and contaminating the well water.62 While levels even
at the most contaminated wells do not approach those that could cause acute effects, the
long term exposure to arsenic concentrations above 10-20 ppb has serious
consequences.63 Arsenicosis is characterized by skin lesions, cancers and multi-system
disease that currently lacks effective treatment options.64
Drinking water is the main source of hazardous exposure to arsenic, although an
increasing amount of evidence points to contaminated irrigation water and uptake by rice
crops as another potential exposure route.65 Arsenic is thought to interfere with proper
DNA methylation through its interaction with S-adenosylmethionine (SAM).66 SAM is
the source of the methyl group which attaches to DNA via enzymatic coupling by DNA
methyltransferase and which detoxifies arsenicals to mono-, di- and tri-methyl arsenic.6768

DNA methylation controls transcription and either hypo- or hyper-methylation can

alter transcription patterns and rates, leading to cancer.69 Arsenic also acts as a
phosphorous mimic, as they are in the same group in the periodic table sharing many
chemical properties.70 Arsenic may take the place of phosphorous in ATP molecules, the
DNA backbone or even in bone structure.71 This replacement of long-lived structures in
biological systems may contribute to the many effects of chronic arsenic poisoning. In
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acute poisoning, replacement of phosphate in ATP and inhibition of proteins essential for
energy metabolism essential starves the cell of energy causing death.72-73
Arsenical binding to MTs has been studied since the early 2000s,15, 74 with seminal work
in the determination of kinetic parameters using ESI-MS due to the slow reaction rate of
MT with As(III).39 Toxicological studies have shown upregulation of MT genes in
response to acute arsenic exposure, indicating in vivo interaction with at least the metal
responsive elements that regulate MT expression.75-76 Questions remain about the extent
to which MTs play a role in defense against arsenicals in vivo as isolation of As-MT from
biological samples remains elusive.77 Despite lack of clear evidence for As-MT formation
in biological samples, the interactions in vitro have allowed us to gain more
understanding of the metal binding pathways of MT, structural determinants and have
produced unique binding modes under unusual conditions where MT does not typically
coordinate metals.
Arsenical binding to MT is curious in that it binds strongly, albeit slowly, at very low pH,
less than 3.0, where most metals do not bind as they are out-competed for thiolates by the
wealth of H+ ions.74 Only Cu(I) and Ag(I) can are able to bind at such a low pH, as Cdand Zn-MTs demetalate starting at pH 5.0.78 This is advantageous for manipulation in
vitro due to the protective effect of low pH on the inadvertent oxidation of MT thiols
during experimental procedures. Low pH also facilitates the complete dissolution of
As2O3 used for the experiments, and As(OH)3 tends to precipitate out of solution at
physiological pH, confounding stoichiometric calculations.42
The slow binding of As3+ to MT requires a long equilibration time for steady-state
studies, however this sluggish binding allowed the determination of specific constants
from ESI-MS relative abundance data that was both time and temperature resolved. The
detailed investigations of Ngu and coworkers revealed important kinetic properties of the
MT-1a isoform and its isolated domain fragments.39 The kinetic data show a “kink” in the
reaction rate, where the first rate constant is lower than second, followed by a linear
decrease in the subsequent rate constants. This phenomenon was observed in the isolated
α-domain as well but was absent in the β-domain. These investigations also showed that
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transfer of As(III) between MT peptides could not be a dissociative mechanism since at
physiological pH stoichiometric transfer would not occur due to precipitation of arsenic
species once dissociated from the protein.42 These studies were among the first to
demonstrate reliably that kinetic parameters can be resolved via ESI-MS. The strengths
and limitation of this method will be discussed further in section 1.6.4.

1.4

Structural characterization of MT

The MT family consists of many isoforms and sub-isoforms that can vary in sequence but
generally all share Cys-Cys, Cys-X-Cys and Cys-X-X-Cys motifs.79 For the purpose of
this thesis the discussion will be limited to more generally mammalian MTs and more
specifically human isoforms. In humans there are four major MT isoforms: MT-1 which
is constitutively expressed, MT-2 which is also constitutively expressed, MT-3 which is
expressed in cells of the nervous system including brain cells, and MT-4 which is
expressed mainly in epithelial cells.80 While differences in sequence of the isoforms exist
(Figure 1-2), only minor differences in binding properties occur and MT-1 and MT-2
have been considered to behave in near identical fashion.81

Figure 1-2: Clustal Omega sequence alignment of the major human metallothionein
isoforms with conserved amino acids highlighted in black. Generated with ESPript
3.0.
Mammalian MTs consist of 60-70 residues, 20 of them being cysteine which facilitate the
coordination of up to seven divalent metals, and twenty monovalent metals such as
Cu(I).82 The N-terminal β-domain contains 9 cysteine residues that can accommodate up
to 3 divalent metals, the C-terminal α-domain contains 11 cysteine residues that can
coordinate up to 4 divalent metals.83 In conditions where there is a vast excess of
cadmium, these isolated domain fragments and the full-length protein have been shown
to super-metalate and coordinate an extra Cd(II) ion.84-85 The β-domain M3S9 cluster
forms a six member ring like structure of alternating metal (M)-sulfur (S) bonds where all
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the sulfurs in the ring are bridging ligands. The remaining coordination sites on the metal
are filled by terminal cysteinyl sulfurs. The α-domain forms an adamantine like structure,
an M4S11 cluster, with 5 bridging and 6 terminal sulfurs. Taken together, the full protein
forms a “dumbbell” shaped structure when both clusters are formed.8 The differences in
Cys:metal ratios of these domains are thought to give rise to domain specify observed in
some MTs.
While a countless number of MTs exist due to their ubiquitous nature and variety of
metal available for coordination, only two x-ray structures have been solved to date. MTs
are notoriously difficult to crystallize due to their small size and inherent fluxionality.
This high fluxionality has also precluded NMR analysis of many partially metalated
species with the possible exception of cooperatively formed Cd4-clusters in the α-domain,
but these are not complete structures of the full protein.86 Full metalation of MT tends to
limit the conformational freedom which the peptide can explore, allowing a limited
number of fully-metalated structures to be solved by X-ray and NMR analysis.7, 83, 86
These structures were determined for divalent species, the only monovalent solved
structure being the Cu8-MT species from yeast.87 The structure of yeast MT is very
different from mammalian MTs, and ESI-MS, CD spectroscopy and emission studies
have suggested that the Cu8-cluster is not formed in mammalian MTs.88-91 No X-ray
diffraction or NMR structures exist for metal-free MT.
The absence of metals in apo-MT eliminates the ability of researches to use metal-based
probes of its structure and greatly complicates structural determination. Techniques like
molecular dynamics (MD) simulations92-93 and fluorescence resonance energy transfer
(FRET) have indicated that apo-MT exists as a random coil structure with no welldefined secondary structural elements like alpha helices or beta sheets.94-95 The lack of
intrinsic optical probes in the peptide adds further complication to studies of apo-MT.
Recently, ion-mobility mass spectrometry (IM-MS) has been used to investigate the
conformation of apo-MT in the gas phase.96 These results show apo-MT adopts both
compact and extended conformers depending on the charge state and the variety of
conformations converges as metalation occurs.96-97 As the starting point in the metalation

9

pathway(s) of MT, the determination of apo-MT structure is important in order to fully
understand the complicated metalation mechanism.

1.5
Metalation pathways of MT and structural
intermediates
To form a metal saturated MT, apo-MT passes through many intermediate metalation
states, each adopting distinct structure to facilitate the coordination of an additional
metal. Since metal saturation of MTs is unlikely given normal cellular metal
concentrations and competition for metals from the binding sites of other
metallochaperones and enzymes, these metalation intermediates are among the most
biologically relevant MT species.98
The flexibility of the peptide backbone allows it to adopt many possible coordination
geometries and structures of many metalation intermediates remain ambiguous. For
example, Zn4-MT could exist as a Zn4S11 cluster in the α-domain or 4 separate ZnS4
coordinated metal structures spread throughout the protein. Zinc being spectroscopically
silent, makes further structural investigation difficult. The proposed ZnS4 structures are
termed “beads” as they would be spread across the protein causing local wrapping of the
peptide backbone to orient the cysteine residues in a way amenable for tetrahedral
coordination.99
There has been significant controversy over the mechanism of metal binding and as a
result, the pathway which apo-MT takes to form the fully metalated species. Significant
evidence exists for both cooperative and anti- or non-cooperative metal binding.11-12, 91, 99100

In addition to the slight differences in pathway preference between MT isoforms, the

identity of the metal being bound also has a substantial effect. Even electronically similar
metals like Zn(II) and Cd(II) have radically different pathway preferences as will be
demontrated in Chapter 2 of this thesis.

1.5.1

Cooperative vs. non-cooperative metal binding

When describing the binding properties of proteins and other ligands with multiple
binding sites the terms “cooperative” and “non-cooperative” are often used but not
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frequently defined. A cooperative binding mechanism is one where there is an effector, a
conformation change, for example, which promotes subsequent binding events after the
first substrate has bound.101 The manifestations of a cooperative mechanism include an
increasing set of equilibrium binding constants and physical presence of mainly the apoligand and the saturated ligand simultaneously with little contribution from any
intermediate species.102 A non-cooperative mechanism can be thought of as the “default”
mechanism where no effector is present and each subsequent binding after the first is less
favoured due to statistical loss of binding sites as the reaction proceeds. This manifests as
a series of sequentially decreasing equilibrium constants, significant presence of
intermediate species and often the final substrate being bound less tightly to the ligand.102
For MTs both types of binding have been observed. Calculations that involved finetuning equilibrium constants to simulate mass spectra have shown that these alone can
determine the type of reaction mechanism and can be compared with experimental
evidence, as seen in Figure 1-3.102 Experimentally, ESI-MS is the most reliable method
for determining binding mechanisms for MTs because of the lack of unique optical
signatures for each intermediately metalated species. All species in solution are observed
via ESI-MS, whereas in optical spectroscopy an average signal of all species in solution
is observed. Metal titrations of apo-MT monitored solely by optical methods result in a
steadily increasing peak for the optical spectra with little information about the
distribution of species in solution.
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Figure 1-3: ESI-mass spectral data for the metalation of apo-βαMT 1a with Zn2+.
(A) Experimental ESI-mass spectral data for βαMT 1a at the 0.9 and 5.9 equivalentsadded steps of the Zn2+ metalation reaction. (B) Simulated ESI-mass spectral data based
upon a noncooperative mechanism (C) Simulated ESI-mass spectral data based upon a
weakly cooperative mechanism. (D) Simulated ESI-mass spectral data based upon a
cooperative mechanism. Reproduced with permission from Sutherland et al., 2012.102
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Results from ESI-MS show that both types of binding are possible and that a mixed
mechanism is also possible where certain intermediate species are more abundant than
others and clusters still form with a slight preference.34

1.6

Methods for structural characterization of MT

Due to its unique properties, a number of methods are required for proper investigations
of MT, each with their own specific strengths and weaknesses. Relying on one method
alone gives a limited picture of the complicated processes of metal binding, protein
folding and protein-protein interaction that occurs for MTs. The most commonly used
techniques to study MTs are: ultraviolet (UV) and X-ray absorption, circular dichroism
(CD) spectroscopy, electrospray ionization mass spectrometry (ESI-MS) and nuclear
magnetic resonance (111/113Cd and 1H NMR). The strengths and limitations of these
methods will be discussed in this section with emphasis on those used in this thesis.

1.6.1

Ultraviolet (UV) absorption spectroscopy

Ultraviolet spectroscopy is useful for quick characterization of characteristic ligand-tometal charge transfer (LMCT) bands for metals such as cadmium and copper in MT.
Only the far UV-region contains relevant absorption bands. For zinc binding to MT, the
LMCT band overlaps with the absorption from the protein backbone and is not
particularly useful for analysis. The 250 nm cysteine-cadmium charge transfer band is
frequently used to confirm molar equivalents of metal bound to MTs and also for MT
concentration determination using the molar absorptivity constant. The use of this
technique primarily occurs during the preparation and purification of recombinant MTs
due to the speed and simplicity needed for detecting molecules following
chromatographic separation. In addition to its use in purification protocols, absorption
spectroscopy is useful in monitoring the fast kinetics of a reaction where measurements
must be taken on the order of milliseconds. Other techniques cannot achieve this type of
speed.
However, absorption spectroscopy suffers from lack of specific information; only the
average metal loading in solution can be probed. MT also lacks aromatic amino acids that
typically absorb around the 280 nm region and are frequently used to determine the

13

presence and concentration of proteins. This renders absorption spectroscopy less useful
than for other proteins. As mentioned previously, if optical absorptions overlap there is
no way to distinguish between the two using absorption spectroscopy alone. While often
considered a crude analytical method, this method finds a niche in providing cheap,
quick, easy and non-specific information in situations where time is important and
extreme detail is not required.

1.6.2

Circular dichroism spectroscopy

Circular dichroism spectroscopy is a technique often used to probe secondary structural
elements of proteins due to their natural chirality. Given the lack of these features in
MTs, this is not the primary tool for the measurement of folding but rather to probe the
chirality of the environment surrounding metal centers. Like UV absorption, CD
spectroscopy has fast time resolution so it is able to monitor events that happen on the ms
time scale, like the folding of more typical peptides to form alpha helices and beta sheets.
The basis of CD spectroscopy is the measurement of differences between the absorption
of left and right-handed circularly polarized light. Optically active molecules absorb one
of the two types of polarized light and a difference spectra is generated. Amino acids,
with the exceptions of glycine and proline, are naturally chiral and have a CD signal in
the UV region that is sensitive to shifts in the conformation of the protein. The folding of
these chiral residues into secondary structural elements gives signature spectral features
that can be identified as α-helices, β-sheets or random coils typically in the far UV
region, 190-220 nm. In this region, apo-MTs give a strongly negative difference spectra,
indicative of random coil structure.

1.6.3

Emission spectroscopy

For emissive MT species, such as Cu(I) MTs, emission spectroscopy can be used to
determine and quantify species present in solution. It is known that Cu-thiolate clusters
that are exposed to the solvent have reduced emission intensity compared to a counterpart
buried within the interior of the protein. Therefore, by measuring the intensity of
emission bands, the structure of the Cu-MTs can be determined. Like other optical
techniques, emission spectroscopy gives an average of all species in solution, so it is
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difficult to assign spectra to specific species when multiple species are present. ESI-MS
can confirm the presence of multiple species in solution.

1.7

Mass spectrometry

Mass spectrometry (MS) is a technique that relies on the ionization of chemical entities
and subsequent sorting of ions based on their mass-to-charge ratio. Many methods exist
for ionization of molecules for analysis by MS, many of which are harsh and cause
fragmentation of the analyte in the process of ionization. This is useful in structural
determination of small, organic molecules but not for analysis of larger bio-molecules
such as proteins when extensive fragmentation occurs. Less harsh fragmentation
techniques, however, have proven to be useful in the field of proteomics and structural
biology.
Electrospray is a soft ionization technique that is especially well suited for the study of
metalation of metallothioneins. A schematic diagram of a typical ESI mass spectrometer
is shown in Figure 1-4A. All mass spectrometers contain a sample inlet source that
converts analytes into ions in the gas phase (a). The ions are then focused with ion optics
and directed into the mass spectrometer (b). Then they are detected by the ion detector (c)
and with an analyzer displaying the counts and masses of the detected ions.
The mechanism of ion formation in electrospray is still being investigated. From what we
know, a sample solution that is infused through a charged capillary exits as a fine mist of
tiny, charged droplets. These droplets quickly evaporate increasing the charge density
until the Rayleigh limit is reached where the electrostatic repulsion overcomes the surface
tension of the droplet and fission occurs. This process continues until only the gas phase
analyte remains, and is known as the charged residue model (CRM). The specific
mechanism of this process depends on the nature of the analyte.
In the CRM (Figure 1-4B) a distribution of charges per analyte molecule is possible and
is dependent on solution composition, instrumental conditions and the size of the analyte.
This results in the formation of a number of "charge states" which have different numbers
of adducted protons which form [M + nH]n+ species. These proton adducts form more
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readily with unfolded proteins, due to increased surface area and exposure of
protonatable sites. This phenomenon results in useful information about conformational
preferences and folded states to be gained by charge state analysis.

Figure 1-4: Schematic of an electrospray ionization mass spectrometer. (A)
Schematic of an ESI- mass spectrometer ionization and ion focusing set-up. (a) ion
source, (b) ion focuser and (c) mass analyzer. (B) Simplified diagram of the charged
residue model (CRM) of the electrospray ionization mechanism
Since the development of soft ionization techniques like electrospray, the use of mass
spectrometry in the field of protein structure and dynamics has grown exponentially.103
Unlike optical techniques, which examine global properties and observe an average
response of all species present, MS techniques can simultaneously delineate many
parameters including: species distribution, relative abundance, protein surface area and
conformational changes via charge states and information about specific regions within
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the protein and their solvent exposure via hydrogen/deuterium exchange (HDX).104-105 In
addition, protein-ligand interactions or site specific covalent modifications can be
measured.106-107 HDX is suited for larger proteins, with an extensive H-bonding network
between backbone amide hydrogens which limits the rate of association/dissociation
resulting in a smaller mass change compared with disordered regions and those that are
more solvent exposed. These exchange techniques are reviewed in detail elsewhere.108

1.7.1

ESI-MS for analysis of MT structure and metalation

ESI-MS is particularly well suited for the study of metalation reactions of MTs due to the
ease in which metal binding can be detected even for spectroscopically silent ions like
zinc. The mass increase upon binding of metals is easily distinguished and metals with
similar masses can be identified via isotopic pattern analysis. In addition, ESI-MS offers
the ability to: identify individual or many species in solution with unique m/z ratios, use
dilute samples of small volumes with direct solution injection, monitor structural changes
via charge state analysis and obtain time and temperature resolved metalation data.
A potential limitation, especially for semi-quantitative analysis using ESI-MS, lies in the
ionization efficiencies of the protein analytes. Quantitative analysis of relative
abundances of species in solution relies on the assumption that all species have the same
ionization efficiency; meaning that all species in solution have the same likelihood of
successful ionization into the gas phase and detection by the MS. It is known that
different isoforms of MT have varying ionization efficiencies and concentrations of
domain fragments and the full-length protein must be externally quantified in competition
experiments. However, Fenselau and co-workers showed in 1993 that concentrations of
Mn-MT species determined via ESI-MS are reliable.109 Further studies used ESI-MS
semi-quantitatively to determine parameters such as binding and kinetic constants.34, 39, 97,
110

The equal ionization assumption appears to be valid as long as the analysis only

considers one isoform or construct of MT at a time.
Charge state analysis has been applied to MTs in a limited scope due to the small changes
observed for the unfolding of such a small protein.111 Charge state distributions do not
change drastically for MTs unless demetalation is being monitored or apo-MT is
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subjected to extreme conditions (pH 1.8) which may introduce signal masking.20, 112For
apo-MT, where a multitude of conformers exist, the charge distributions carried by
individual conformers likely do not vary enough to be distinguished by ESI-MS.113 This
type of analysis is better suited to larger proteins with more distinct structural features
that include tertiary strucural elements and dramatic surface area changes when
unfolding.114-115

1.7.2

Covalent modification coupled with ESI-MS

A common criticism of the use of ESI-MS for the analysis of protein structure and
conformation lies in the radically different surroundings the protein finds itself in when
being analyzed compared to its native state.116 The native state is one in solution,
buffered around neutral pH with an appropriate salt concentration, approximately 37oC
and in the absence of chemical denaturants. The conditions of the electrospray process
introduce high voltages, evaporating solvents causing a hyper-accumulation of salt ions
and finally ionization of the protein itself and transition into a gas phase ion.117 The
assumption that the conformations adopted in solution and under ESI conditions may be a
tenuous one.
An advantage of covalent modification is that it probes the conformation in solution and
changes thereafter during analysis and measurement of the gas phase ions have no effect
on the modifications that occur prior to ionization. This is especially important for
proteins whose structure is unstable and whose solution stabilized conformation may not
reflect those conformers adopted during the electrospray process.
Cysteine is an important amino acid with high reactivity118, an ability to coordinate a
variety of soft metals119 and form Cys-Cys covalent linkages that add stability to folded
proteins.120 Cysteine is also used to attach therapeutic and imaging moieties to proteins in
vivo.121 Covalent modification coupled with mass spectrometry can easily identify free
cysteinyl thiols vs those that are oxidized to form crosslinks. New proteomic strategies
also make use of specific covalent modifiers coupled with LC-MS and tandem MS to
identify S-sulfenylation of cysteines and identify the most solvent exposed residues.122
The redox chemistry inherent in quinones has been used for on-line tagging of free
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cysteines in ESI-MS analysis via a 1,4-Michael addition.123 With the incorporation of a
photo-active quinone, the protein backbone can be selectively fragmented with ultraviolet
light for analysis of solution structural properties or to monitor biological quinone posttranslational modifications.124 This technique can also be applied to other amino acids by
leveraging thiol chemistry to selectively modify phosphorylated serine or threonine
residues.125
In the case of MTs, determining the number of free thiols under an assortment of
different metal coordination numbers and geometries can help in structural determination.
The number of free thiols can be a good indicator of metal-cysteine cluster formation, as
clusters involve bridging thiolates and, as a result, more metal ions can be coordinated
with a smaller number of cysteine residues. Terminally coordinated metals require more
cysteinyl thiols in MT and are theorized to be more labile and primed for donation to
other metalloenzymes.126 Also when probing potentially new structures formed by
coordination of unusual metals and metalloids where the stoichiometry is not defined, the
quantification of free thiols by cysteine modification and ESI-MS can established defined
Cys:Metal ratios.127 The reaction profile of alkylation reagents with the many cysteines of
MT may also be useful in determination of solution structural conformation. Examples of
three major types of reaction profiles are given in Figure 1-5.
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Figure 1-5: Possible reaction profiles of a cysteine alkyating reagent with a peptide
containing 9 reaction sites. (A) Normal distribution of modified species. (B) Semicooperative pattern with significant amount of all possible modified species. (C)
Cooperative pattern with little contribution from intermediate species, unmodified and
fully modified species dominate.
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1.8

Scope of the thesis

Much of what is known about MTs is based on models and experiments investigating
fully metalated and well-defined structures. Apo- and partially metalated MTs pose a
unique challenge to investigators but are critical to the biological function. Key to a
complete description of MT chemistry and function in vivo is structural information about
the starting point of the metalation reaction, apo-MT, and the many possible intermediate
structures the protein can adopt in the metalation pathway before saturation. The research
presented in this thesis primarily concerns the elucidation of the many structures adopted
by metal-free and partially metalated MTs along the metalation pathway and their
implications for binding kinetics and biological function.
This thesis contains eight Chapters and an Appendix. The first Chapter includes a brief
introduction of techniques relevant to MT research and what is known about the structure
and metalation mechanisms of MT. The biological context of MTs is also discussed with
detailed background information pertaining to the toxicity of arsenic and cadmium and
the essentiality of zinc. Chapter 2 describes the pH dependence of the cadmium and zinc
binding pathways of βαMT using ESI-MS and CD spectroscopy. Chapter 3 investigates
the isolated domains of MT to determine their individual properties and compare them to
that of the full-length protein. These two chapters reconcile previously conflicting reports
on the nature of the metalation mechanism.
Chapter 4 details our use of covalent cysteine modification to determine the
stoichiometry of As3+ binding to the α- and βMT fragments and the structures adopted
during metalation. Furthermore, we probe the configuration of apo- and partially
metalation species under denaturing conditions to investigate the role of metal-induced
folding and protein-protein interaction of As-MT species.
Chapter 5 further investigates the use of cysteine alkylating reagents to probe the
conformations adopted by apo-MTs in a systematic way testing three different reagents
with the full-length protein and its isolated domains. Chapter 6 builds on the
conformational investigations of chapter five by testing the Cd2+ metalation kinetics of
MT under native and denaturing conditions.
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Chapter 7 chronicles progress in building on knowledge gained by the fundamental
research into MT binding affinities and the pH dependence of metal binding through the
design and testing of an MT-based biosensor for the electrochemical detection of arsenic
and mercury.
Chapter 8 attempts to bring together the results from the previous seven chapters in order
to paint a clearer picture of MT structure, metalation mechanisms and possible
applications of MTs in biosensors. The results are also discussed in a biological context
to connect the in vitro studies to MT function in vivo.

1.9
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Chapter 2

2

Defining the metal binding pathways of human
metallothionein 1a: balancing zinc availability and
cadmium exclusion1

2.1 Introduction
Mammalian metallothioneins (MTs) are a family of small, cysteine rich metal-binding
proteins that are involved in zinc and copper homeostasis,1-8 heavy metal detoxification916

and cellular redox chemistry.17-21 When saturated with seven divalent metals,

mammalian MTs consist of an N-terminal β-domain and a C-terminal α-domain
connected by a flexible linker region.22 The α-domain can accommodate up to 4 divalent
metals and the β-domain 3 metals by forming MII4Scys11 and MII3Scys9 clusters,
respectively. This domain description is only relevant in the fully metalated structure as
there are no true binding domains in the partially-metalated and apo-structures under
most conditions.23-27 The more biologically relevant structures of the apo- and partially
metalated MTs are considered to be poorly defined.23,27-28 Currently, these apo- and
partially metalated MT species are thought to adopt a fluxional, globular structure.29-30
Metalation of the 20 Cys apo-peptide can take place in a number of different ways.24, 31
As there is no pre-existing domain structure in the absence of bound metals, the
thermodynamics and kinetics associated with metal binding control the structures adopted
at each metalation step.27 For each species (ie. M1-βαMT, M2-βαMT, etc) numerous
structures are possible and complex rearrangement of the bound metals can occur.32-33
The mechanism of divalent metal binding to MTs, specifically that of Zn(II) and Cd(II),
has been a topic of great interest but the results have generated conflicting reports

1
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concerning the identity and description of the intermediate structures formed before the
complete complement of seven metals has been bound.2, 34-38 Because of the
spectroscopic accessibility of Cd(II), much of what is currently known about Zn(II) and
Cd(II) binding to MT has been based largely on the chemistry of Cd(II) or other
spectroscopically active metals, such as Co(II).25, 39 Indeed, 113Cd is often used to probe
structural properties of Zn(II) binding sites in proteins other than MTs.40

Figure 2-1: Cartoon ribbon representation of proposed MT1a metalation
intermediates. The "beaded" intermediate and a ball-and-stick representation of the
terminal coordination of the metals with up to 5 MII(SCys)4 “beads” (left; 4 beads shown).
The cluster structure M4SCYS11 is shown in the α-domain of the ribbon structure and as a
ball-and-stick model of the bridged and terminal Cys that make up the cluster (right).
When discussing metal binding mechanisms of MTs, the terms cooperative and
noncooperative are often used. In a fully cooperative mechanism, only the apo-MT and
end-product should be detected at any point during the reaction. In a non-cooperative
mechanism, intermediates can be measured and become the most abundant species during
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the early to mid-stages of the metal titration. The kinetic data for As(III) binding to MT1a clearly follow this noncooperative, stochastic model.31

Metalation details from early studies of cadmium binding relied on 113Cd NMR26 or
protein modification41 and reported the formation of cluster dominated products. With the
development of new technologies, most notably electrospray ionization mass
spectrometry (ESI-MS), the description of a purely cluster dominated mechanism became
less convincing. Some groups have reported a cluster dominated mechanism with ESIMS37 and reported that the Cd-thiolate cluster formation occurs first in the α-domain.30
However, reports by our group and others have shown that the binding pathway involves
non-clustered intermediates.35-36, 38, 42 It should be noted that these studies used different
solution conditions and often different isoforms of human MT, which possess different
metalation properties.43 It has also been suggested that differing ESI-MS settings may
cause the discrepancy in mechanistic details.30
In this chapter, we report definitive evidence for two parallel, competing pathways that
are dependent on metal identity, Zn(II) or Cd(II), and the pH. We have examined the pH
dependence of the Zn(II) and Cd(II) metalation pathways of human MT1a using ESI-MS
and circular dichroism spectroscopy at the important early stages of metalation where the
largest number of conformations are possible. The presence of these two distinct
metalation pathways was determined by monitoring the formation of the partially
metalated intermediates during the Zn(II) and Cd(II) metalation reactions of the apo-MT1a. We discuss how significant differences in the intermediates formed during metalation
for each metal may explain how MT-1a functions as a multi-purpose protein: regulating
zinc levels, providing zinc to other apo-enzymes,44 and sequestering toxic heavy
metals.45-46 From the data presented here it is clear that metalation can occur via one of
two major pathways: a cooperative, α-cluster driven pathway or a non-cooperative,
terminally-bound, beaded pathway (Figure 2-1).
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2.2
2.2.1

Methods
Protein preparation

Recombinant human metallothionein 1a (MGKAAAACSC ATGGSCTCTG
SCKCKECKCN SCKKCC SCCPMSCAKC AQGCVCKGAS EKCSCCK KAA AA)
was expressed with an S-tag in BL21 E. coli cells which has been described in detail
elsewhere.47 In brief, cells containing the plasmid for the full protein (βα-MT1a) were
plated on to growth media containing kanamycin from a stock culture stored at -80oC and
grown for 16 hours at 37oC. The grown cells were then inoculated into 4x1L LB broth
cultures enriched with 50 μL of 1 M cadmium and incubated in a shaker for 4 hours until
OD600 absorbance was 0.8. An aliquot of 0.7 mL of 1 M Isopropyl β-D-1thiogalactopyranoside (IPTG) was then added to induce expression of MT and 30
minutes later 150 uL of 1 M cadmium sulfate solution was added to the broth. The cells
were collected 3.5 hours after induction, centrifuged and stored at -80oC.
The recombinant cells were lysed using a cell disruptor (Constant Systems, UK) shot at
20K psi. From there, the cell lysate was centrifuged for 1h to pellet out cellular debris.
The supernatant was filtered and loaded on to a GE healthcare SP ion exchange columns
with a total volume of 10 mL. The columns were washed with pH 7.4 10 mM Tris(trishydroxymethyl-aminomethane) buffer for approximately 2h to remove loosely bound
proteins and other organic compounds. MT was eluted using an increasing gradient of 1
M NaCl + 10 mM Tris buffer at pH 7.4. The eluted MT was concentrated down to <20
mL and the S-tag cleaved using a Thrombin Clean-Cleave kit as per the manufacturers’
instructions (Sigma-Aldrich). The mixture was then diluted, desalted and placed on
another SP ion exchange column. The S-tag does not bind as strongly as MT and thus
elutes at low salt concentrations. The protein and S-tag were separated in this fashion.
The eluted MT was concentrated to approximately 120 µM and stored at -20oC.
To prepare MT for the pH titration experiments, aliquots were first demetalated and
desalted using centrifugal filter tubes with a 3 kDa membrane (Millipore) and a 10 mM
pH 2.8 ammonium formate buffer. The low pH solutions contained 1 mM Dithiothreitol
(DTT) to prevent oxidation of the free thiols in MT. The pH was raised by buffer
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exchange with argon saturated, pH 7.0 10 mM ammonium formate solutions that did not
contain reductant. The protein solutions were checked for final concentration by
remetalation of a small aliquot with cadmium using the metal-to-ligand charge transfer
band at 250 nm (ε250 = 89,000 Lmol-1 cm-1). The solutions were also monitored for
oxidation using UV-visible absorption spectroscopy to monitor absorption corresponding
to 280 nm from oxidized disulfide. Once demetalated and desalted, the MT concentration
was determined, all concentrations were between 40-90 µM to ensure good signal to
noise ratios In the ESI-MS experiment. We note that this was a concern because the
titration introduced salt into the solution which suppresses the MT signal at high
concentrations.
In addition to demetalating MT in the presence of DTT, the solutions were vacuum
degassed and bubbled with Argon to displace any dissolved oxygen. This was done for
the 10 mM Cd2+ and Zn2+ and the 0.5% NH3 and 0.5% formic acid solutions as well to
ensure no oxygen was introduced into the system during the titration. Great care was
taken to reduce the possibility of oxidation pf the protein at neutral pH.

2.2.2

ESI-MS and circular dichroism pH titrations

Mass spectra were collected on a micrOTOF II electrospray-ionization time-of-flight
mass spectrometer (Bruker Daltonics) in the positive ion mode. NaI was used as the mass
calibrant. The scan conditions for the spectrometer were: end plate offset, −500 V;
capillary, +4200 V; nebulizer, 2.0 bar; dry gas flow, 8.0 L min−1; dry temperature, 30 °C;
capillary exit, 180 V; skimmer 1, 22.0 V; hexapole 1, 22.5 V; hexapole RF, 600 Vpp;
skimmer 2, 22 V; lens 1 transfer, 88 μs; lens 1 pre-pulse storage, 23 μs. The mass range
was 500.0–3000.0 m/z. Spectra were assembled and deconvoluted using the Bruker
Compass data analysis software package. ESI-mass spectrometry was used to monitor all
stages of the pH titration of Cd-MT and Zn-MT. First, approximately 2.5 molar
equivalents of Cd(II) acetate and Zn(II) acetate were added to the MT solution at pH 5.5.
This caused a drop in pH due to the displacement of H+ from the thiol groups. After the
metal solution was added, the ESI-MS spectra were recorded and averaged over 2
minutes. Then aliquots of 0.5% NH3 were added to raise the pH and the spectra recorded.
The pH was confirmed using a micro-pH probe (Accumet). This was repeated in steps
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until the salt peaks became more intense than the peaks corresponding to MT species. No
change of the M2+/MT ratio was observed meaning no precipitation of Cd(OH)2 or
Zn(OH)2 occurred.
The pH titrations of the partially metalated Cd-MT and Zn-MT were performed at least 6
separate times with different protein preparations and starting at slightly different pH
values in the region of 4.5-5.5. Thus separate data points were obtained for each pH
reported increasing in increments of 0.1 pH units and serve as a statistical check. The
separate preparations were run under the same solution and ESI-MS conditions. The error
associated with these ESI-MS measurements is estimated to be about ±10%.
For the circular dichroism (CD) spectra, 2.5 molar equivalents of cadmium acetate were
added to apo-MT in a pH 7.0 10 mM ammonium formate solution in the manner
described above for the ESI-MS data. The CD spectra (Jasco J810) were measured over
the range of 200-300 nm at various stages in the pH titration. Below 220 nm, the CD
spectrum is skewed due to the absorbance of the ammonium formate buffer and is not
shown. The significant Cd-dependent CD spectral bands lie in the 240-280 nm region.
The CD spectra obtained were compared to spectra of apo-MT and Cd4-MT that were
obtained previously by our group and have been extensively discussed in other works.4849

We note that the Zn-S charge transfer band lies at 220-230 nm under the protein bands.

To determine the degree of cluster formation vs terminally bound metal, the ratios of the
abundances of the intermediates (Cd1-3-βαMT) to the initial apo-MT and final product
(Cd4-βαMT) were determined and normalized for each ESI mass spectrum in the pH
titration. The most clustered spectra (at lower pH) had only a minimal fraction of
intermediates compared to the spectra recorded at more basic pH. The sigmoidal fit of the
set of ratios was generated using a least squares method. The lack of saturation of the
sigmoidal fit is likely due to the 100% terminal coordination binding mechanism
occurring at the highest pH range of the titration and spectra were not measured above
pH 8.2.
The simulated ESI-MS data were calculated using a set of 4 equilibrium constants that
correspond to each of the bimolecular metalation reactions up to Cd4-MT (Scheme 1).
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Each sequential bimolecular reaction was controlled by an individual Kf. The values of
the log(Kf) of the formation constants all average to 14.4 which is within the range
reported in the literature for Cd(II) binding to MT.50 It should be noted that the binding
constants presented in this work and those referenced are conditional binding constants
that amongst other parameters, are dependent on pH.

2.3
2.3.1

Results
pH depedence of cadmium binding to apo-MT1a

Figure 2-2 shows a series of deconvoluted ESI mass spectra recorded for a single sample
of apo-MT1a metalated with 2.5 equivalents of Cd(II) at increasing pH (A-E). This metal
loading of 2.5 molar equivalents (mol. eq.) was chosen to challenge the formation of the
abiguous Cd4 intermediate. This is the point at which the spectra corresponding to the
cooperative and non-cooperative mechanisms appear in stark contrast to each other. Each
species present in solution can be identified and the change in its relative abundance
monitored. At more acidic pH (<6.0) the relative abundance of the intermediates, Cd1-3MT1a, is very low and the dominant species is Cd4-MT1a. With increasing pH, the
appearance of Cd1-3-MT1a can be seen with their relative intensities increasing as the pH
is raised. At pH 7.9 the distribution of species present is narrower, now completely
dominated by the terminally-bound Cd1-3-MT1a species, which we describe as being
comprised of the “beaded” Cd(SCYS )4 structures. Our assignment of these species being
terminally-bound is supported by the loss of the specific spectral envelope motif in the
circular dichroism spectral data seen in Figure 2-3. The change in metalation pathway is
apparent from the complete loss of both the initial apo- and Cd4-MT1a masses in the ESImass spectrum (Figure 2-2A). These two species are replaced by higher intensities of
Cd1-3-MT1a species (Figure 2-2E). Figure 2-2 B-D show a blending of these two
pathways leading to a mixture of all species.
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Figure 2-2: Representative ESI-MS data showing the relative abundances of
CdxMT species (x=0-4) as a function of pH. These are representative spectra from pH
titrations after an aliquot of approx. 2.5 molar equivalents of Cd(II) was added to the
apoMT solution. The species distribution at pH 5.0 (A) and 6.0 (B) represent a mostly
cluster-dominated pathway for metal binding. The spectra at pH 6.7 (C) shows a blend of
the pathways, and at pH 7.1 (D) and 7.9 (E) a terminal binding pathway dominates.
Adduct peaks with a mass of +60 Da were present for each species and were removed for
clarity.
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Figure 2-3: Circular dichroism spectra of apoMT1a with 2.5 mol. eq. of Cd(II)
added as a function of increasing pH. The derivative envelope with a cross-over near
240 nm is characteristic of the Cd4-cluster whereas the maximum dichroic intensity near
242 nm is characteristic of partially-metalated species with terminal thiolate coordination
or supermetallated species.
The switch from cluster bound Cd(II) to terminally bound Cd(II) was observed in the
circular dichroism (CD) spectra, Figure 2-3.54-57 When the Cd(II) are bound only as
Cd4-clusters the spectra show a characteristic derivative envelope with a crossover point
near 240 nm and a maximum near 260 nm. The shape of this CD envelope has been
assigned previously as arising from exciton coupling of Cd(II) from the ligand to metal
charge transfer band.51-54 The spectrum shown here is a combination of contributions
from apo-MT1a and the clustered intermediate, Cd4-MT1a. As the pH is raised, the
terminally bound contribution increases and the envelope from the clustered species
disappears. This neutral pH spectra matches that of previous work where 1-3 mol. eq.
Cd(II) had been added to mouse apo-MT1.51 When the cluster structure is disrupted by
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either excess or insufficient Cd(II), the spectra is blue shifted, which can be observed in
Figure 2-3. The CD spectral data correlate closely with the species measured in the ESImass spectra. The Cd4 cluster, dominant at low pH in the ESI-MS data (Figure 2-2) is
associated with the derivative envelope in Figure 2-3. The terminally bound Cd(II) at
neutral pH exhibit a CD envelope centered on the absorption band of Cd-MT (240-250
nm). The CD data confirm that the gas phase, ESI-MS data are reporting the solution
species accurately.

Figure 2-4: Change in cadmium binding pathway as a function of pH. The
"%Terminal Pathway" was calculated from the ESI-MS data shown in Figure 2-2. The
cluster formation pathway dominates below pH 6.5 (red box), between pH 6.5-7.2 (green)
the two pathways compete and the terminal pathway based on “beads” dominates above
pH 7.2 (blue).
The pH dependence of the Cd-metalation pathway is plotted in Figure 2-4. The trend is
similar to a standard pH titration with a sharp change just before pH 7.0. Between pH
5.0-6.4 the change from cluster to terminal pathway is gradual, then the terminally-bound

39

fraction increases sharply between 6.5-7.2. The binding mechanism is mostly terminal
above pH 7.2, the non-cooperative metalation pathway.

2.3.2

pH dependence of zinc binding to apo-MT1a

MT1a speciation during Zn(II) binding differs drastically from that of Cd(II) at all pH
values, Figure 2-5. This is a very significant result when Cd(II) is considered as a model
for Zn(II). Clustering does not become dominant to the extent that it does with the Cd(II)
metalation at any pH tested here. Only at very low pH, less than 5.0, does some cluster
formation (Zn4SCYS11) become evident. Even at this low pH, the Zn(II) spectra are
comparable to the blended pathway shown in Figure 2-2B or C for Cd(II). Such a low pH
(≤5.0) is not physiologically relevant except for in low pH cellular compartments such as
the lysosome.55-56 Therefore, we can conclude that the Zn(II) binding pathway is
dominated by the formation of terminally-bound Zn(II) intermediates (Figure 2-5B, C)
over a physiologically relevant pH range, in sharp contrast to Cd(II) binding.
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Figure 2-5: Representative deconvoluted ESI-MS spectra recorded during the pH
titration of ZnxMT (x=0-5) after approximately 2.5 equivalents of Zn(II) had been
added. The spectra at pH 4.5 (A) shows a mixed binding mechanism whereas by pH 5.2
(B) it is largely distributive and terminally bound remaining unchanged to pH 7.4 (C).
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2.4

Discussion

The metalation mechanism of MT1a is critical to our understanding of its in vivo function
and to the fundamental description of protein based metal-thiolate chemistry. MT1a
provides a unique example of a highly flexible metal-binding protein that can coordinate
many metals in a number of conformations. This flexibility makes defining a specific
binding mechanism difficult as there may be many possible mechanisms and
conformations that can be adopted. Adding to this difficulty, metallothioneins lack
spectroscopic features common in other proteins like aromatic amino acids or welldefined secondary structural elements.57 Thus, spectroscopically active metals like Cd(II)
have been used as a model for Zn(II) binding which is more difficult to monitor. From
the experiments presented here, we show that MT1a metalation can begin via two main
pathways and that Zn(II) and Cd(II) show divergence in their pathway preference and pH
sensitivity. The presence of a pH dependent equilibrium between structures of the
partially metalated species has fundamental importance in the assessment of the role of
MT1a in vivo.

2.4.1

The pH dependency of cadmium binding

The data shown in Figures 2-2 and 2-3 demonstrate the pH dependence of the Cd(II)
binding pathway. The distributed pattern of the Cd1-3-MT1a species at pH 7.9, and
reported for more basic pH,38 shows a stochastic distribution of metals over 7 possible
binding sites. Scheme 1 shows the equilibria for the binding of the first four metals to
MT with different Ks to indicate that the values of these constants change, depending on
conditions, and control pathway selection.
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Scheme 2-1: The possible metalation pathways for the first four metals bound to
human MT1a. These pathways follow a clustered (cooperative mechanism) or beaded
(terminally-bound, noncooperative) structure.
The declining stoichiometric binding constants (K1>K2>K3>K4), calculated to fit the noncooperative data are shown in Figure 2-6C. From the binding constants, simulated ESIMS spectra were generated which closely match the experimental data. At pH 5.0, the
data do not show a distributed pattern and we sought to replicate the experimental data by
modifying the binding constants in the simulation. Figure 2-6A shows that an increasing
series of binding constants (K1<K2<K3<K4) generates a close fit to the low pH data. In
Figure 2-6B the intermediate or mixed pathway is replicated by binding constants that are
approximately equal. These simulations confirm the presence of two major, pH
dependent metalation pathways: one leading to a clustered Cd4-MT1a and the other a
series of terminally-bound Cdx-MT1a (x=1-5) species. The analysis shows that the pH
controls pathway selection based on modification of the relative magnitude of the
apparent binding constants associated with formation of bead or cluster structures. The
important feature is the relative magnitude of the constants and the trend that they follow,
not the absolute magnitude, as concentrations of each species were not directly measured
through calibration with internal standards.
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Figure 2-6: Simulated (hatched) and experimental (solid) ESI-MS data for binding
of 2.5 mol. equivalent of Cd(II) to apo-MT1a at pH 5.0. (A), 6.7 (B) and 7.9(C). The
experimental ESI-MS data are shown by the solid black bars and the simulated data by
the hatched bars (left). The simulated data were calculated based on the relative log(K)
values for 4 consecutive bimolecular reactions assuming 2.5 mol. eq. Cd(II) had been
added. The log(K) values average to 14.4 in A-C, a value similar to that previously
reported for the MT Cd-binding affinity.50 The trend in the relative log(K) values are
shown on the right. K1K4 are the equilibrium constants for the addition of 1 to 4
Cd(II) to MT1a. It should be noted that these values are relatively correct but not absolute
and decrease at lower pH.
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2.4.2

pH dependency of the zinc binding pathway

The MT1a-Zn(II) binding pathway always proceeds via terminally-bound, beaded species
near physiological pH. The pH sensitivity over a physiologically relevant range, as
shown for the Cd(II) data, was not observed for Zn(II). The ESI-MS spectra for Zn(II)binding (Figure 2-5) are essentially unchanged between pH 5.2 and 7.4. This means that
the declining series of formation constants associated with the sequential Zn(II)
metalation reactions are much less sensitive to pH and only begin to change below pH 5.2
which is not physiologically relevant. The pathway selection for the Zn(II) metalation is
dominated by the non-cooperative, terminally-bound beaded structure. Figure 2-7,
specific to Zn(II) binding, was generated in the same way as Figure 2-6 and gives an
accurate description of the changes in Kf that are involved in pathway selection. Unlike
for the Cd(II) data, the Kf values do not steadily increase for the lowest pH tested, but
instead slightly increase then fall. This matches previous work that showed the last Zn(II)
atoms are bound weakly by MT1a and are available for donation.44
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Figure 2-7: Simulated (hatched) and experimental (solid) ESI-MS data for MT
metalation with 2.5 mol. equivalents of Zn(II) at pH 4.5 (A) and 7.4 (B). The
simulated data were calculated using the relative log(K) values for 5 consecutive
bimolecular reactions with relative log(K) values similar to those reported in the
literature.44

2.4.3

The divergent metalation pathway preferences for zinc and
cadmium binding

Critical to the biological functions of MTs are the structures adopted when coordinating
various metal ions. The proposed in vivo functions of MTs require this family of
structurally homogenous proteins to bind essential and toxic metals for different
purposes; namely to act as a metallochaperone for Zn(II) and Cu(I) while aiding in the
detoxification of heavy metals like Hg(II) and Cd(II). On the surface, this appears to be a
difficult task for a protein that lacks defined binding sites and formal secondary structure
in the absence of bound metals. This is especially true for Zn(II) and Cd(II) since they
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both preferentially adopt tetrahedral coordination geometries and both form M4-Cys11 and
M3-Cys9 clusters in the α and β domains of MTs. Critical to the use of Cd(II) as a model
for Zn(II) is that the two metals follow the same metalation pathway, form the same
intermediates and exhibit similar structural properties. However, our results show that the
assumption that the binding pathway is the same for both Zn(II) and Cd(II) is flawed.
Figure 2-8 shows the two competing pathways that account for the metalation of apoMT1a to the fully metalated species. At slightly basic pH, Cd(II) passes through
intermediates to form species similar to those shown in 2-8A and 2-8B before all Cys are
involved in coordination and clustering must occur to accommodate further metal
binding. At slightly acidic pH, Cd(II) metalation proceeds through the pathway shown by
red arrows where the reaction is dominated by the formation of the Cd4-cluster structure.
The metalation step leading to D may be part of a cooperative pathway that only features
a clustered intermediate (2-8C) and a fully metalated, two-domain end-product (2-8E).
The pathway selection for Zn(II) is strongly biased towards the beaded pathway shown
by the blue arrows in Figure 2-8. At very low pH, a mixture of the two pathways is seen
with some clustering occurring but with a large fraction of Zn5-MT1a being formed,
compared to the low pH Cd(II) titration where no Cd5-MT1a was observed. This suggests
the presence of both clustered (2-8C) and terminally-bound species (2-8B) in equilibrium
at low pH for Zn(II) metalation. The Zn4-MT1a cluster does not have a stability
advantage over terminally bound Zn1-5-MT1a. This supports our previous model where
we suggested that Zn(II) binding to apo-MT1a results in a beaded structure with 5
terminally bound zinc.58
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Figure 2-8: Representation of two possible pathways for MT1a metalation with
Zn(II) or Cd(II). The cooperative cluster driven pathway (red arrows) and the
noncooperative beaded pathway (blue arrows). The terminally-bound, beaded structure
(A) is able to coordinate an additional metal terminally, forming (B), which utilizes all
twenty Cys residues, after which clusters are formed to accommodate the last two metals
and form the stable two-cluster M7MT (E). The cooperatively formed cluster (C) must
coordinate additional metals in the β-domain (D).
Figure 2-9 summarizes the experimental data and compares the pH dependence of the
Zn(II) and Cd(II) metalation pathways. Significantly, at neutral pH there is a considerable
contribution from the clustered pathway of Cd(II). This suggests that, in vivo, MT1a can
sequester Cd(II) into clusters with relatively higher binding constants, making it less
available for transfer to zinc-dependent enzymes which mostly involve terminal
coordination.59
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Figure 2-9: Change in Zn(II) metalation pathway as a function of pH (grey line)
compared to Cd (orange line). Demetalation begins to occur at pH <4.5 so the curve
was extrapolated to pH 3 based on the Cd metalation data. At the lowest physiologically
relevant pH around 5.5 the binding pathway is greater than 80% terminal (blue box) and
only forms clusters below pH 4.5 (red box).
Cadmium completely switches pathway preference between pH 6.5 and 7.2, where
cluster formation is favored at lower pH and terminal coordination at higher pH. At lower
pH, H+ ions effectively compete with incoming metals for thiolates and the stability
associated with the Cd4-thiolate cluster becomes the driving force behind cadmium
binding. At higher pH, cadmium is bound terminally as the competition between metal
and protons for thiolates is less intense.
In light of the results presented here, the use of exogenous metals as models for zinc and
copper binding with respect to cluster formation need to be carried out with caution. Due
to its spectroscopic properties, many studies on cluster formation in MT used Co(II) as a
spectroscopic probe.25, 39, 60 Although Zn(II) and Cd(II) are both d10 metals, their Lewis
acidities differ, resulting in chemistries that change the mechanism in which they are
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bound by thiolates. It is likely that the differences between Zn(II) and Co(II) are even
greater.

2.4.4

The origin of proton sensitivity of the beaded and clustered
binding constants

The ESI-MS data show that the [Cd4(Cys)11]3- cluster dominates as the primary
metalation intermediate below pH 6.5 in the metalation of MT1a. DFT calculations of
Ohanessian et al.61 on the proton affinities of thiolates in a wide range of zinc-thiolate
compounds, have shown the terminal thiolates in [Zn(Cys)4]2- are significantly more
basic than in the clustered [Zn4(Cys)11]3-. In our context, this suggests that the terminallycoordinated, beaded structures will be less stable under acidic conditions. We show the
points at which the terminal structures become less stable in MT are approximately pH
5.0 for Zn(II) and 7.0 for Cd(II). The increased nephelauxetic effect or propensity for
covalency of Cd(II) compared with Zn(II) supports the stability of the [Cd4(Cys)11clusters] over terminally bound Cd(II) below neutral pH and the different speciation
observed here by ESI-MS between Zn(II) and Cd(II) for partially metalated MT1a. (The
nephelauxetic effect refers to the increased propensity for covalency going down the ZnCd-Hg triad.)

2.4.5

Understanding the multitude of biological functions of MT1a

The fact that Zn(II) does not cluster as readily as Cd(II) is relevant to its in vivo function.
MT1a acts as a zinc-chaperone by delivering Zn(II) to newly synthesized
metalloenzymes which requires a constant shuffling of metal ions.44, 62 This function is
facilitated by terminally bound Zn(II), increasing accessibility for donation compared to
the clustered form. On the other hand, the donation of Cd(II) often causes Znmetalloenzymes to partially or completely lose function.63-65 By locking most of the
Cd(II) in a cluster structure, donation may be discouraged. Only a small change in pH
would induce clustering and many biological compartments have a pH well below 7.2
where clustering begins to take over as the preferred Cd-binding pathway.55-56, 66 This is
especially true in the medulla and proximal tubules of the kidneys which are known to be
at low pH.67-68 Cd(II) has also been shown to accumulate in those areas69-71 and the
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clustered MT1a may promote this accumulation. Wolff et al. have also demonstrated that
Cd-MT is localized to lysosomes in proximal tubule cells, which is typically in the pH
range that favors cluster formation.72 The clustered Cd-MT is also known to be more
resistant to proteolysis than apo- or partially metalated MT.73-75 This resistance to
degradation, especially in low pH compartment to which MT1a is localized, may provide
a mechanism by which cadmium persists in the kidneys for long periods of time, with a
half-life of 10-30 years.76 Contrary to the concept of detoxification of heavy metals, this
tendency to cluster and persist in the kidneys may cause more damage. It is for this
reason that mammalian MTs are not thought of as being "real" cadmium detoxifiers, but
bind cadmium as a secondary, intrinsic property which exacerbates the toxicity in
mammalian systems.
In addition to specialized cells that are typically found at slightly acidic pH, organelles
responsible for protein maturation, such as the golgi, are also slightly acidic (pH 6.47.0).77 With Zn-MTs being less prone to clustering under acidic conditions, they would
still be able to effectively donate zinc ions to maturing metalloproteins. The clustering of
Cd-MTs at these pH ranges may provide a mechanism of protection by which the
maturing metalloproteins are not improperly metalated with cadmium.
In addition to metal sequestration, MTs plays a role in cellular redox chemistry due to its
abundance of thiols.78 For these thiols to be active they need to be exposed, so only apoand partially metalated proteins in the MT pool are redox active.79 The higher propensity
to cluster in slightly acidic environments exposes more thiols which may affect cellular
redox balance. This role as a redox active species is not necessarily separate from its
main function as a zinc chaperone, and many reports have shown that these functions are
intrinsically linked.21, 80

2.4.6

Importance of pH control during experimental measurements

Figures 2-4 and 2-7 highlight the potential complication when determining the metal
speciation of MT, particularly when partially metalated, due to the pH effect on
intermediate formation. For example, during Cd(II) metalation, a slight change in pH
from 7.2 to 7.0 results in a large increase in the cluster pathway contribution.
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Experimentally, this small pH change could be caused by the displacement of cysteinyl
protons during metalation so it is essential to monitor pH before and after each metal
addition. It is also clear that this is much less of a problem during Zn(II) metalation
because of the decreased pH sensitivity at physiological pH. MT also binds a number of
exogenous heavy metals involved in chemotherapeutics81-83 and water contamination84
and the pH considerations raised in this chapter likely apply to other MT-metal binding
systems. Similar metalation experiments with human MT2a show a mixed mechanism at
pH 7.430 and rabbit liver MT2a has been shown by NMR to cluster at pH 7.2, with the
signal disappearing at higher pH.26 The pH dependence curve can likely be modestly
shifted for different isoforms of MT. Indeed small differences in binding properties were
found between human MT2 and MT3 isoforms, although the overall trend remained the
same.85

2.5

Conclusions

The considerable debate in the literature over the mechanisms behind MT metalation can
be reconciled by the results presented in this chapter. MT1a can bind Cd(II) and, to a
lesser degree, Zn(II) via two distinct pathways that feature either a cooperative
(clustered) or non-cooperative (beaded) mechanism. Thus, the discrepancy between
experimental results was likely due to small changes in pH conditions and the specific pH
at which the cluster pathway dominates for each MT isoform.
Of the two metalation pathways presented here, Zn(II) has a clear preference for the noncooperative, terminally-coordinated pathway under most pH conditions. The trend in Kf
values associated with Zn(II) metalation of MT is largely unchanged over the range of
physiologically relevant pH where most experiments are carried out. In contrast, Cd(II)
showed a change in pathway preference between pH 6.8-7.2 where clustering became
dominant at slightly acidic pH. This highlights the potential pitfalls in using Cd(II) as a
model for Zn(II) binding.
The pH dependence of metal binding pathway and the structures adopted in those
pathways provide insight into how MT functions as a metallochaperone (for Zn(II)) and
sequesters toxic Cd(II). The cluster binds Cd(II) with a high affinity preventing the
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donation to lower affinity, terminal sites for Cd(II) coordination. This structure, resistant
to degradation, may provide the mechanism by which Cd(II) persists in lower pH
compartments in renal cells for many years. For Zn(II), these results strengthen our
previously proposed model, where the terminally-coordinated beaded structure in
dominant and the Zn5-MT species is more stable compared to the clustered structures.
The last two Zn(II) are bound weakly and can easily be donated to other metalloenzymes.

2.6
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Chapter 3

3

Cadmium binding mechanisms of the isolated domains
of human MT1a: non-cooperative terminal sites and
cooperative clusters2

3.1 Introductions
Mammalian metallothioneins (MTs) are a family of cysteine-rich proteins associated with
essential metal homeostasis and heavy metal detoxification.1-5 When fully metalated, the
20 cysteine protein forms two distinct domains, a 9-cysteine N-terminal domain (β) and
an 11-cysteine C-terminal domain (α).6 When fully metalated with seven divalent metals,
the β-domain forms an M3Cys9 cluster and the α-domain forms an M4Cys11 cluster.7
While structures of the fully metalated species are well-known,8 the partially-metalated
and apo-structures are fluxional and hard-to-characterize.9 Thus, the metalation
mechanisms and the factors influencing the metalation pathways of apo-MT1a remain
unclear.10 These mechanisms are essential to our understanding of in vivo metalation
processes that control the homeostatic role1, toxic metal responses11 and the resistance to
metal-based chemotherapeutics associated with cellular metallothioneins.12-15
The well-known description of the clustered domain structure for MT only applies to the
metalated structures after cluster formation but is not accurate in describing the structure
of apo- and partially-metalated MT species.9 To investigate the properties of the

2

A version of this chapter has been published.

Reproduced with permission from: Irvine, Gordon W., and Martin J. Stillman. "Cadmium binding
mechanisms of isolated domains of human MT isoform 1a: Non-cooperative terminal sites and cooperative
cluster sites." Journal of inorganic biochemistry 158 (2016): 115-121.
Copyright 2016 Elsevier
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individual domains of MT, the isolated domain fragments can be used and metalation
studies carried out to determine the behaviour of the individual domains.16 It should be
noted that the isolated domains may have different properties than when joined by the
linker sequence due to the possibility of entropic effects in cluster formation and protein
folding and also due to inter-domain exchange of metals.17-19 However, the underlying
metal binding structures are the same for the full-length protein and the two isolated
domain fragments, namely terminally bound metals at low metal concentrations leading
to clustered domains at saturation. For this reason, examining the isolated domains of MT
allows separation of the domain specific spectral properties which are blurred in the
complete protein.
MT simultaneously functions as a zinc and copper chaperone, a heavy metal chelator and
a redox active agent.20-22 There have been suggestions that different isoforms bind
specific metals and have their own unique functions, despite high sequence similarity.23
Domain specificity of metal binding also remains a controversial topic in the field.24-30
The MT1 and MT2 isoforms are the most widely expressed in human tissues31-32 and
likely most important isoforms for overall metal homeostasis. They have also been
implicated in arsenic induced oxidative stress and cancers33-34 and tumor resistance to
chemotherapeutics.35 Many chemotherapeutics are metal-based so determining the
binding mechanisms operating at all levels of metalation of MT is important for an
overall description of its many functions in vivo.12-13, 15, 36
Electrospray ionization mass spectrometry (ESI-MS) has emerged as one of the most
useful tools for answering questions about MT structure, dynamics and metalation
mechanisms.37-40 This is due to the ability of ESI-MS to distinguish all species in solution
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with different masses (ie. different numbers of metals bound) and to give semiquantitative information on their relative abundances.24 The ionization efficiency of
different metal loadings of the same isoform is essentially the same for MTs and thus the
relative abundances can be relied upon to accurately reflect solution conditions.41-42
In this chapter we have studied metalation of the isolated α- and β-domains of human
MT1a to determine parameters that change the cadmium binding mechanism resulting in
either terminally-coordinated or clustered metal binding sites. It is known that the
mechanism of the metalation of the full protein is pH-dependent24, 43 but little is known
about the individual domain responses to changes in pH. Biologically, MT-1a is
upregulated in response to cadmium intoxication, due to displacement of Zn from ZnMT and this newly synthesized apo-MT can be metalated by cadmium.44-45 We also
reconcile conflicting reports about MT metalation mechanisms and show significant
differences in binding preferences for the individual domains of human MT-1a.

3.2
3.2.1

Methods
Protein preparation

Individual domain fragments of recombinant human metallothionein 1a (β:
MGKAAAACSC ATGGSCTCTG SCKCKECKCN SCKKAAAA, α: MGKAAAAC
CSCCPMSCAK CAQGCVCKGA SEKCSCCKKA AAA) were expressed separately
with an S-tag in BL21 E. coli cells which has been described in detail elsewhere.46 In
brief, cells containing the plasmid were grown on kanamycin containing media from a
stock culture and grown for 16 hours at 37oC. The colonies were then inoculated into
4x1L broth cultures enriched with 50 μL of 1 M cadmium and incubated in a shaker for
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approximately 4 hours until an absorbance of 0.8 at 600 nm was reached. Isopropyl β-D1-thiogalactopyranoside (IPTG) was then added to induce expression of MT and 30
minutes later 150 μL of 1 M cadmium sulfate solution was added to the broth. The cells
were collected 3.5 hours after induction, centrifuged and stored at -80oC.
The recombinant cells were lysed using a cell disruptor (Constant Systems, UK) at
20,000 psi. Then, the cell lysate was centrifuged for 1 h to remove cellular debris. The
supernatant was filtered and loaded on to a GE healthcare SP ion exchange column with a
total volume of 10 mL. The columns were washed with 10 mM Tris(tris-hydroxymethylaminomethane) buffer at pH 7.4 for approximately 2 h to remove loosely bound proteins
and other organic compounds. The MT fragments were eluted using an increasing
gradient of 1 M NaCl + 10 mM Tris buffer at pH 7.4. The eluted MT was concentrated
down to <20 mL and the S-tag cleaved using a Thrombin Clean-Cleave kit as per the
manufacturers’ instructions (Sigma-Aldrich). The mixture was then diluted, desalted and
placed on another SP ion exchange column. The S-tag was eluted at low salt
concentrations with MT eluting at higher concentrations. The isolated MT fragments
were concentrated to approximately 100 µM and stored at -20oC.
To prepare MT for the pH titration experiments, aliquots were first demetalated and
desalted using centrifugal filter tubes with a 3 kDa membrane (Millipore) and a 10 mM
pH 2.8 ammonium formate buffer. The low pH solutions contained 1 mM dithiothreitol
(DTT) to prevent oxidation of the free thiols in MT. The pH was raised by buffer
exchange with argon saturated, pH 7.0 10 mM ammonium formate solutions that did not
contain DTT. The concentrations of the protein solutions were checked by remetalation
of a small aliquot with cadmium using the metal-to-ligand charge transfer band at 250 nm
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(αε250 = 45,000 M-1 cm-1 βε250= 36,000 M-1 cm-1). The solutions were also monitored for
oxidation using UV-visible absorption spectroscopy at 280 nm. MT concentrations used
were 40-90 µM to ensure good signal-to-noise ratios. In addition to demetalating MT in
the presence of DTT, the solutions were vacuum degassed and bubbled with argon to
displace any dissolved oxygen. This was done for the 10 mM Cd2+, 0.5% NH3 and 0.5%
formic acid solutions as well to ensure no oxygen was introduced into the system during
the titration.

3.2.2

ESI-MS pH titrations

Mass spectra were collected on a micrOTOF II electrospray-ionization time-of-flight
mass spectrometer (Bruker Daltonics) in the positive ion mode. NaI was used as the mass
calibrant. The scan conditions for the spectrometer were: end plate offset, −500 V;
capillary, +4200 V; nebulizer, 2.0 bar; dry gas flow, 8.0 L min−1; dry temperature, 30 °C;
capillary exit, 180 V; skimmer 1, 22.0 V; hexapole 1, 22.5 V; hexapole RF, 600 Vpp;
skimmer 2, 22 V; lens 1 transfer, 88 μs; lens 1 pre-pulse storage, 23 μs. The mass range
was 500.0–3000.0 m/z. Spectra were assembled and deconvoluted using the Bruker
Compass data analysis software package.
For the metalation experiment, Cd(II) acetate was added sequentially to the MT solution
and a spectrum recorded for each step. The metalation caused a drop in pH due to the
displacement of H+ from the thiol groups so the pH was monitored and adjusted as
needed throughout the titration. The pH was confirmed using a micro-pH probe
(Accumet).
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In addition to metal titrations, a pH titration was carried out at the mid-point of the metal
titration to monitor the change in metal distribution as a function of pH. Solutions of
oxygen-free 0.5% NH4OH and formic acid were used to adjust the pH. ESI-MS spectra
were recorded for each change in pH. In total, 4 replicate pH titrations were taken for
each fragment. No change in the overall the M2+/MT ratio was observed meaning no
precipitation of Cd(OH)2 occurred. The error associated with these ESI-MS
measurements is estimated to be about ±10% and the error associated with the pH probe
is ±0.1 pH unit.

3.2.3

Circular dichroism pH titrations

For the circular dichroism (CD) spectra 1.5 molar equivalents of cadmium acetate were
added to apo-αMT and apo-βMT in a pH 7.0 10 mM ammonium formate solution. The
CD spectra (Jasco J810, New Jersey) were measured over the range of 200-310 nm at
various pH points. At low pH (<4.0) demetalation occurs and a lowering of signal
intensity can be seen in the βMT CD spectra. Below 220 nm, the CD spectra are skewed
due to the absorbance of the ammonium formate buffer and are not shown. The
significant cadmium-dependent CD spectral bands lie in the 240-280 nm region.10, 47-48
The overall CD envelope was monitored for a signal characteristic of a CdS MT cluster,
with a crossover point near 250 nm.

3.3
3.3.1

Results
The pH dependence of cadmium metalation of the αMT
fragment

The metalation reaction was carried out over a wide pH range and the αMT speciation
recorded via ESI-MS and CD spectroscopy. Of particular importance was detecting the
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presence or absence of the Cd4-αMT cluster in both sets of spectral data. Unlike, the
situation for the full protein βαMT where there are 20 cys, the formation of the Cd3- and
Cd4- species in the -domain fragment must involve bridging cysteinyl thiols due to
stoichiometric limitations. The nature of the Cdx-MT species can be identified from the
CD spectral envelope characteristics. The Cd4-MT cluster species exhibits a characteristic
sigmoidal CD band envelope that arises from exciton splitting of pairs of Cd(II) ions in
the cluster.48
Figure 3-1 shows representative deconvoluted ESI mass spectra of the cadmium
metalation of the αMT fragment. The spectra are separated into three distinct binding
modes, a cluster-dominated, cooperative binding mechanism at low pH (4.5-6.4), a
terminal-thiolate-dominated non-cooperative mechanism at high pH (7.3+) and a mixed
mechanism when close to neutral pH (6.5-7.2). This metalation pH dependence is similar
to that of the full-length protein where the tendency of the α-domain to cluster dominates
the reaction at slightly acidic pH.24 This trend holds true for the isolated domain.
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Figure 3-1: Representative deconvoluted ESI-mass spectra showing the trend in
speciation as a function of pH for 4 steps in the Cd(II) metalation of apo-αMT. The
trend in species formation as the Cd(II) is added in mole eqivalent (eq) aliquots can be
separated into three: a non-cooperative formation of a distribution of species in spectra
(A-D) at the highest pH (7.3 and above: “7.3+”), semi-cooperative formation of both a
distribution of species and the Cd4Cys11 cluster in spectra (E-H) found between pH 6.57.2 and the predominant cooperative formation of M4Cys11 clusters in spectra (I-L) below
pH 6.4. *- acetate adducts at +59 Da, #-Cd5-MT species at +112 Da. Sodium adducts at
+22 Da not indicated but are present in some spectra in small quantities.
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3.3.2

pH dependence of the cadmium metalation of the βMT
fragment

Figure 3-2 shows representative deconvoluted ESI-MS data for the Cd(II) titration of the
isolated β-domain fragment. In contrast to the α-domain, the dominant binding mode is
the formation of terminally bound metals except at very low pH (<5.8). The spectra are
separated into a mixed mechanism at low pH (<5.8) similar to that of the α-domain in
Figure 3-1 at pH 6.5-7.2. Even near pH 4.0, there is no strong tendency for the βfragment to bind the Cd(II) into clusters confirmed by the presence of intermediate
metalation products. The non-cooperative, terminal thiolate-bound mechanism becomes
dominant above pH 6.0 and representative spectra of this mechanism can be seen in
Figure 3-2 E-H.
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Figure 3-2: Representative deconvoluted ESI-MS spectra of the metalation of apoβMT with Cd(II) at various stages in the titration. Representative deconvoluted ESImass spectra showing the trend in speciation as a function of pH for 4 steps in the Cd(II)
metalation of apo-βMT. The trend in species formation as the Cd(II) is added in mole eq
aliquots can be separated into two: a semi-cooperative formation of a mixture of a
distribution of species and the Cd3Cys9 cluster in spectra (A-D) below pH 5.8 and a noncooperative formation of a distribution of species in spectra (E-H) above pH 5.9 (“5.9+”).
*- acetate adducts at +59 Da. Sodium adducts at +22 Da not indicated but are present in
some spectra in small quantities.
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3.3.3

Circular dichroism spectra of the pH titration of partially
metalated α and βMT fragments

Figures 3-3 and 3-4 show the CD spectra of the α- and β-domains of MT under a range of
pH conditions. The partially metalated (1.5 eq. of Cd(II)) domains exhibited a change in
CD envelope morphology in response to the increasing pH. The bimodal CD envelope
with a crossover point near 250 nm and a maximum near 260 nm is characteristic of a
Cd4(SCys)11 cluster.48 The slight blue shift is likely due to the simultaneous presence of
the apo-fragments and clustered fragments at low pH. The changes in the CD spectra
mirror those observed by ESI-MS. This supports the reliability of ESI-MS to report the
solution species distribution correctly as both sets of data match closely.

Figure 3-3: Circular dichroism spectra of Cd1.5-αMT at pH 5.2-7.8. Traces 2-4
(black) were measured at pH 5.2, 5.7 and 6.2 respectively. The red line (pH 6.7) shows a
mixed spectrum where both clustered and terminally bound Cd-MT are present. The light
grey lines 6-7 (pH 7.4 and 7.8) correspond to terminally bound Cd-MT. The apo-αMT
spectra (line 1) is shown in burgundy as a reference.
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The α-domain shows a clear shift from the Cd4(SCys)11 cluster signal at low pH with a
peak centered near 260 nm and a crossover point near 250 nm to a signal with a
maximum near 250 nm and a crossover point closer to 240 nm (Figure 3-3). This new
maximum overlaps with the Cd-S ligand-to-metal charge transfer band and is indicative
of terminally bound Cd(II) lacking symmetrical structure.

Figure 3-4: Circular dichroism spectra of Cd1.5βMT at various pH values. Lines 2
and 3 (pH 4.0 and 4.5, respectively) are likely partially demetalated as the intensity is
only slightly higher than the apo-trace in red labeled line 1. Lines 4-5 (pH 5.0 and 5.5)
and line 6 to a greater extent (pH 7.2) are blue shifted due to cluster collapse and
complete binding of free metal, unlike at the lower pH.
The β-domain shows a more subtle shift in its CD spectrum (Figure 3-4) than the αdomain which matches the trend in the ESI-MS data closely. The ESI-MS shows that the
cluster structure is not dominant even at low pH so terminally-bound intermediates are
present in all CD spectra recorded. The β-fragment spectrum shifts less dramatically from
a maximum near 255 nm at low pH to 250 nm at neutral pH. The maximum at 255 nm is
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a result of a mixture of the apo, partially-metalated terminal intermediates and the
clustered structures. This matches the ESI-MS data in Figure 2 that show a similar
mixture of MT species.

3.3.4

pH titration curves of the partially metalated α and β-domains

Figures 3-5 and 3-6 show the change in ESI mass spectral data as a function of pH of the
partially metalated domains of MT. The fraction of terminally bound Cd(II) was
determined by taking the ratio of intermediates (Cd1-3αMT or Cd1-2βMT) to total CdxMT
species including starting and end products (apo, Cd4αMT or Cd3βMT) over a wide pH
range. All titrations were performed with approximately 1.5-2 eq. of Cd(II) bound to the
individual fragments of MT (see Figures 3-1 and 3-2 for representative spectra). Both
titrations were fit with a sigmoidal curve using a least-squares fitting method. From this
curve it can be seen that the pKa(clustering) of each domain differs greatly with βMT slightly
less than 6.0 and αMT at approximately 7.0.
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Figure 3-5: The pH dependence of the binding mechanism of the αMT fragment. A
sigmoidal fit (red line) was determined by least squares method. The degree of noncooperativity was determined by the normalized ratio of the intermediates to the initial
and end products observed in the ESI mass spectral data. The pH of the 50% mixture was
7.0.
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Figure 3-6: The pH dependence of the binding mechanism of the βMT fragment. A
sigmoidal fit (red line) was determined by least squares method. The degree of noncooperativity was determined by the normalized ratio of the intermediates to the initial
and end products observed in the ESI mass spectral data. The pH of the 50% mixture was
5.8.
Another significant difference between the two titrations is that the fraction of terminally
bound Cd(II) hovers around 0.2 at low pH for β compared to near 0.0 for the α-domain.
This indicates an elevated abundance of terminally-bound intermediates in the β-domain
metalation mechanism. By using these ratios as an indicator of metalation mechanism,
the sensitivity of the binding mode to pH for each domain can be measured. In addition,
the pH ranges at which each mechanism dominates can clearly be seen.
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3.4
3.4.1

Discussion
Historical conflict on the binding mechanism of MTs

There have been conflicting reports on the metal binding mechanisms of MT for over 30
years.20, 39, 49-50 When comparing metals with different electronic properties (ie. Zn(II) vs.
Cu(I) vs. As(III)), it is clear that MT would adopt different conformations and likely the
metalation reactions would vary greatly in mechanistic detail.51-52 However, the
metalation mechanism is controversial because the products of the metalation appear to
vary for each experiment reported even when focusing only on divalent metals like Zn(II)
and Cd(II).39, 53-55 For Cd(II) binding, NMR26, 43, 56 and CD47, 57 spectroscopy have been
employed in an attempt to solve the mystery of the divalent metalation mechanism. In
addition, metalation with Co(II), a paramagnetic species monitored by visible region
absorption and EPR spectroscopy has been used to quantify cluster formation.58-60 With
the development of ESI-MS many groups have probed the metal binding reaction and
come to a range of conclusions.39, 55, 61-64 We have summarized the results of a selection
of studies in Table 3-1. The pH dependence of the metalation mechanism presented here
allows us to reconcile these conflicting reports and characterize the individual domain
binding preferences of Cd(II).
The discrepancy in the mechanisms proposed by the different groups is likely a
combination of many factors including isoform differences, sample preparation
procedures and ESI-MS settings. However, based on the results we describe here we
believe the pH under which the experiments are run is the most important factor in
determining the metalation mechanism. From the ESI-MS and CD spectra shown in
Figures 3-1 to 3-4 it is clear that the distribution of species in the partially metalated
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protein solution is dependent on the solution pH. The exact nature of the species in
solution is dependent on the binding mechanism and from the CD spectra we can obtain
structural information about the species present. The key to our analysis of the binding
mechanism is the presence or absence of intermediate species that involve terminal
coordination. For the α-domain this is Cd1-3-αMT and for the β-domain, Cd1-2-βMT.
Table 3-1: Summary of results from selected groups using a variety of methods and
pH conditions to study the M(II) metalation mechanism of metallothioneins
Metal

MT isoform

Method

pH

Mechanism

Reference

Cd

rabbit MT2

NMR

7.2

cooperative

41

Cd

rabbit MT2

NMR

8.6

non-cooperative

41

Cd

Blue crab MT1 ESI-MS

7

non-cooperative

18

Cd

hMT1a

CD/UV/ESIMS

8

non-cooperative

46

Cd

rabbit MT2

NMR

7.5

cooperative

54

Cd

hMT1a

ESI-MS

8.4

non-cooperative

53

Cd

hMT2a

ESI-MS

7.4

cooperative

37

Cd/Zn

hMT3

ESI-MS

7.5

non-cooperative

60

Cd/Zn

hMT2a

ESI-MS

7

cooperative

18

Zn

hMT1a

ESI-MS

9.2

non-cooperative

52

Zn

hMT2a

Zn-sensor
fluorescence

7.4

non-cooperative

61

Zn

rabbit MT2

ESI-MS

7.5

cooperative

62

Zn

hMT1a

ESI-MS

7

non-cooperative

14
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3.4.2

Bridging the gap between apparent discrepancies

The intermediate species Cd1-2-βMT diminish in intensity at lower pH (<5.7) but do not
disappear to the extent of the Cd1-3-αMT intermediates. This indicates a fundamental
difference in binding mechanism between the two domains. The α-domain mechanism is
dominated by cooperative cluster formation at neutral and slightly acidic pH, whereas
even at very low pH, the β-domain exhibits a preference for terminal coordination
through a mostly non-cooperative mechanism.
We consider the origin of the mechanistic discrepancy between domains to lie in
the relative stabilities of the respective metal-thiolate clusters. This is related to the
stoichiometry of the domain specific clusters for divalent metals: in the α-domain it is
M4(Cys)11 and in the β-domain M3(Cys)9. In the β-domain the Cys-to-M(II) ratio is 3:1
compared to the α-domain where it is 2.75:1. More important is likely the overall charge
and proton accessibility of the basic thiolate ligands. The larger extent of bridging in the
α-domain reduces the charge-to-metal ratio. The M4(Cys)11 cluster of αMT has a charge
of -3 and is a 3D-almost rigid cage whereas the βMT domain M3(Cys)9 cluster structure
also has a charge of -3 but the 9 Cys are much more exposed, and offer much less
stability than the -cluster. The terminally coordinated M(II) in [M(Cys)4]2- would be
more vulnerable to protein attack with a Cys-to-M(II) ratio of 4:1 and an overall charge
of -2 for each metal bound. The ability to coordinate 4 metals with a -3 overall charge
makes the α-cluster more resistant to proton attack than terminally coordinated metals or
the β-cluster.
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3.4.3

Isolated domains give insight into the full-length MT binding
mechanism

It is important to put these results into context with respect to the binding mechanism of
the full protein, βαMT. Our results for the domain fragments and the full protein65 show
that the metalation mechanism, and the intermediates formed before saturation, depend
on pH. From previous work on the full-length protein it was inferred that the alpha
domain was responsible for the cooperativity of Cd(II) binding since Cd4-βαMT-1a was
the dominant intermediate at lower pH.65 We show in this chapter that the α-domain is
solely responsible for the cooperative, cluster-driven pathway as the pH dependence
matches that of the full-length protein and the isolated β-domain mostly follows the noncooperative, terminally-bound pathway. This divergence in cluster pH sensitivity must
have important biological implications.

3.4.4

Biological context of low pH studies

Many sub-cellular compartments that are involved in protein folding are slightly acidic
making the titration curve of the α-domain (Figure 3-5) relevant in a biological context.6667

The switch in binding preference near pH 7.0 means that MT could behave differently

depending on its cellular localization. In acidic compartments any cadmium present
would be bound in a cluster structure in the α-domain, making it less available for
donation to other metalloenzymes. These results also imply that in the metalation of the
full-length protein, it is the α-domain that clusters at acidic pH when binding cadmium, in
agreement with previous work that showed a cooperative binding mechanism for MT1a65 and other isoforms.39, 43 Taken together, this implies that the α-domain plays a more
important role in detoxification, being able to cooperatively bind cadmium in a cluster
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structure, leaving the β-domain available to terminally coordinate metals that can be
donated to nascent metalloenzymes. Previous studies have indicated that the β-domain is
more likely to donate zinc to these newly synthesized proteins because it contains lower
affinity binding sites than the α-domain.16-17
Domain specificity is a topic of interest in the field of metallothionein research
that has similarly drawn controversy. Recently, we have shown that pH plays an
important role in inducing some domain specificity, specifically in zinc displacement by
cadmium.24 At low pH the α-domain shows slight specificity for cadmium but not at
neutral pH.24 Together with the results presented in this chapter, we can conclude that the
specificity seen in the α-domain is likely due to the strong clustering preference at acidic
pH for the α-domain that is not present in the β-domain. The domain specific nature of
cadmium binding may have evolved as a mechanism for cadmium sequestration, leaving
the β-domain more or less metal-free and able to participate more readily in redox
chemistry and the binding of other essential metals like zinc and copper. Indeed, it has
been suggested that the β-domain is the copper-binding domain.20, 28

3.5

Conclusions

We have described the pH dependence of the cadmium metalation reaction for each of
the isolated domains of human MT-1a. This reconciles previous conflicting reports and
demonstrates binding differences between the two domains of MT-1a. We demonstrate
that it is possible for αMT to change binding motifs and metalation mechanism within a
physiologically relevant pH range and this may help to explain how MTs fulfill their
multitude of proposed biological roles. In contrast, the preferred cadmium binding
mechanism of the β-domain is non-cooperative metalation by terminal cysteine ligands.
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Chapter 4

4

Structural changes of MT1a during the arsenic
metalation reaction: folding under typically denaturing
conditions3

4.1 Introduction
Metallothionein (MT) has long been known to be a major player in cellular metal
homeostasis and since its first isolation in 1957, has been shown to affect many cellular
processes 1. It is a uniquely structured protein with cysteine accounting for approximately
30% of its total residues with a mass of approximately 6-10 kDa, depending on the
isoform. The X-ray determined structure of the fully metalated MT resembles that of a
dumbbell with two metal binding domains (α and β), separated by a short linker sequence
2-3

. The formal structure of MT is based almost entirely on the changes induced by metal

coordination and the formation of the metal clusters 4-5. MT binds a wide variety of
metals including Zn2+, Cu+, Cd2+ and the metalloid As3+.6 However, the structure of the
partially metalated protein is unknown, yet is important as an intermediate in vital
cellular metalation chemistries. In this chapter, experimental evidence of As-MT
coordination geometry and stoichiometry as well as partially metalated MT structure will
be examined.
MT is a multi functional protein acting as a source of reducing -SH groups in redox
reactions, detoxifying heavy metals and regulating cellular zinc and copper
concentrations. 7 The importance of MT to cellular metal homeostasis is highlighted by
its ubiquitous nature; nearly all organisms have some type of MT or MT-like protein

3

A version of this chapter has been published:

Reproduced with permission from: Irvine, Gordon W., Kelly L. Summers, and Martin J. Stillman.
"Cysteine accessibility during As3+ metalation of the α-and β-domains of recombinant human MT1a."
Biochemical and biophysical research communications 433.4 (2013): 477-483. and Irvine, Gordon W., and
Martin J. Stillman. "Topographical analysis of As-induced folding of α-MT1a." Biochemical and
biophysical research communications 441.1 (2013): 208-213.
Copyright 2013 Elsevier
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coded for in their genomes.8 In addition to the regular functions of MT, it has emerged
that MT can play a role in cancer progression and drug resistance in tumors. 9-10 With
many cancer treatments relying on metal based drugs that may induce expression of MTs,
it is important to determine the mechanism by which MT metalates and the structure of
the apo- and partially metalated forms of MT that are the predominant species present in
the cellular environment.1 By studying the structure of the metal-free protein and its
partially metalated intermediates, predictions about metalation with a wide variety of
metals and metal complexes can be made. This may prove useful in designing drugs to
combat tumours that have shown resistance to traditional therapies and in determining
how MT carries out its many biological functions.
Partially metalated MT (that is MT with fewer metals bound than its maximum capacity)
is vital to metal-based cellular chemistry because this species is likely to be the dominant
form of cellular MT. It has been considered that apo-MT does not have structure in the
traditional sense but rather it adopts a more randomly coiled and ill-defined conformation
11

. However, more recent studies have suggested that apo-MT may have a loosely

defined, but structurally significant conformation at neutral pH that is only lost under
denaturing conditions 12-13. Metalation of apo-MT can lead to the formation of fully
metalated protein. However, due to the concentrations of metals found in a cell, it would
be expected that partially metalated species would predominate 14. Unfortunately the only
solved structures of MT are fully metalated forms 2-3, 15-16. Significantly, structures of
both the partially metalated MT and apo-MT remain elusive.
In this chapter, we use the differential rate of the modification of the free cysteines in the
-metal-binding fragment to probe the spatial distribution of cysteines not involved in
metal binding as a function of metalation status. We also use this method to quantify free
thiols in MT as well as to assess the relative accessibilities of cysteines in the alpha and
beta domains of MT. The reaction profile of Bq with up to 11 cysteines in α-MT provides
a clear indication of the metal-dependant nature of apo- or partially-metalated MT
folding. This reaction is dependent on the variable accessibility of the unbound cysteines.
We confirm a stoichiometry of As3-αMT and As3-βMT and binding mode of terminal
cysteine coordination with discrete units of As(Cys)3 as opposed to clustered structures.
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Overall, the reaction profile of Bq provides a unique description of the topological
distribution of free cysteine residues, conformations adopted in the partially metalated
protein and confirms predicted binding motifs of Asx-MT.

4.2
4.2.1

Methods
Protein preparation

Methods for expression and purification of the alpha domain fragment have been
previously reported in more detail 17. In brief, the α-domain of recombinant human MT
isoform 1a (α-rhMT 1a) was used having the follow sequence: GSMGKAAAAC
CSCCPMSCAK CAQGCVCKGA SEKCSCCKKA AAA. The expression of the
recombinant protein was carried out in E. coli strain BL21 using the recombinant α-rhMT
1a sequence inserted into a pET29a plasmid. The plasmid also coded for an N-terminal Stag with the sequence MKETAAAKFE RQHMDSPDLG TLVPRGS. The inclusion of an
S-tag into the recombinant protein is done to stabilize the protein during purification
steps and was removed via a Thrombin CleanCleaveTM kit (Sigma).
To limit oxidation of the cysteinyl thiols, all solutions used were saturated with argon and
evacuated before use. In addition, all solutions used in the purification process were
chilled to maintain the integrity of the protein and prevent degradation. Protein solutions
were stored at -20oC in sealed vials that had been thoroughly evacuated.
Demetalation of the protein was achieved by buffer exchange with a 10 mM solution of
ammonium formate, pH adjusted to 2.8. The solutions were buffer-exchanged by
centrifuge in an Amicon Ultra Centrifugal Filter Tube (Millipore) with a 3 kDA MW
filter. This ensured complete demetalation and maintained high concentrations of the
protein.

4.2.2

Solution preparation and titrations

Solutions of 150 mM para-benzoquinone (Bq, Fisher Scientific) were prepared by
dissolution in 100% methanol (Caledon) and diluted to a final concentration of 15 mM in
deionized water. These solutions were prepared just before they were to be used, bubbled
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with argon for at least 20 minutes, evacuated and kept on ice shielded from light until
use. Solutions of 2 mM As3+ were prepared by dissolving As2O3 in conc. HCl and
diluting with deionized water. The final pH of the solution was adjusted to 2.8 using
NH4OH. The solution was then saturated with argon and evacuated before use.
MT concentrations were determined by metalation of 100 µL aliquots of the apo-MT
with Cd2+ and examination of the absorption spectrum, specifically the peak at 250 nm.
The 250 nm peak corresponds to the ligand-to-metal charge transfer transition of the Cdthiolate bond (εα;250 nm = 45,000 M−1 cm−1). Concentrations of α-rhMT 1a ranged from 3060 μM in order to ensure a strong mass spectral signal for all 27 species that are formed
during metalation and modification of apo-α-rhMT 1a, that is the set of AsnBqxα-rhMT
(n=0-2, x=0-11) that will be simultaneously measured.
Titration of MT with As3+ was carried out by adding approximately 0.5 molar equivalents
of As3+ to the protein solution. The reaction of MT with As3+ is much slower than with
metals such as Cd2+ or Zn2+, so the reaction vials were put in an evacuator for 1 hour to
equilibrate. Once the system came to equilibrium, the speciation of the α-MT was
checked by ESI-MS to ensure that it had been partially-metalated and a distribution of
apo-, As1- and As2- α-rhMT existed in solution, Figure 4-1A. Sequential addition of Bq to
the protein solution was performed and mass spectra acquired until all the species had
been fully modified (ie. no free cysteinyl thiols remained in any of the partially metalated
species). Titrations were performed at pH 2.8.
Mass spectra were measured with a microTOF II electrospray ionization time-of-flight
mass spectrometer (Bruker Daltonics, Canada) in the positive ion mode. The settings of
the instrument that were used have been previously described 17. The mass spectra were
analyzed using the Bruker Daltonics analysis software.

4.3
4.3.1

Results
Metalation of α and βMT with As3+

Figure 4-1A shows the ESI-MS data recorded for the metal free, apo-αMT with mass
4,081.8 Da. Figure 4-1B shows the ESI-MS data after 1 hour equilibration following the
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addition of 0.75 molar equivalents of As3+. The data show that there are 3 species of
αMT present: apo-αMT, As1-αMT and As2-αMT (in order of decreasing abundance).
These data confirm the non-cooperativity of the As3+ metalation reaction because very
little As3-MT forms, which is the final product of the metalation reaction. An excess
amount of Bq (40 molar equivalents) was added to the reaction vial to ensure complete
reaction with any available cysteinyl thiols and the ESI mass spectra were recorded. The
number of Bq that reacted was dependant on the number of free cysteines available in
each of the species. Figure 4-1C shows ESI-MS data after the excess addition of Bq to
the solution measured in Figure 4-1B. All 11 cysteine residues of apo- MT were
modified by binding 11 Bq resulting in a mass of 5,258.9 Da. Similarly, As1-MT had 8
cysteines modified for a final mass of 5,008.7 Da, and As2-MT had 5 cysteines
modified for a mass of 4,760.6 Da. There was a very small amount of the As3--rhMT
species present, the two free cysteines were modified by binding 2 Bq resulting in a mass
of 4,513.5 Da. The mass spectral data accounted for all the cysteines in each domain.
In a separate experiment, 2.5 mole equivalents of As3+ were added to apo-αMT and the
solution was equilibrated for 1 h. The spectrum in Figure 4-1D shows that, when
compared with the species in Figure 4-1B, the abundance of the apo-αMT and As1-αMT
species decreased and the proportion of As2-αMT and As3-αMT increased, with As3-αMT
being the most abundant as expected with the increased concentration of As3+. In this
case, a limiting amount of 2 mole equivalents of Bq were added to the solution after the
spectrum in Figure 4-1D was measured to probe the availability and accessibility of the
free cysteines. The data in Figure 4-1E illustrate the distribution of the free cysteines. The
As3-αMT species can be seen without Bq modification and with 1 and 2 Bq molecules
bound. The abundances of the modified species for both As2-αMT and As3-αMT follow
an approximately normal distribution. This indicates equal accessibility of the remaining
cysteines after metalation with 2 or 3 As3+ ions. The mass spectrum for the complete
modification of all free cysteines was achieved by adding a 10-fold excess of Bq, Figure
4-1F. The presence of As3-αMT with 2 Bq and As2-αMT with 5 Bq (4513.4 and
4766.6 Da, respectively) is observed in the mass spectra, as expected for the fully
modified protein species. Taken together, the spectra in Figure 4-1 confirm
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stoichiometric binding for As(Cys)3 for each step in the metalation reaction and the
presence of two free cysteinyl thiols upon saturation with arsenic.

Figure 4-1: ESI mass spectra of αMT1a with increasing As3+ loading and cysteine
modifications to form Asn-αMT (n = 1–3). (A) Metal-free apo-αMT. (B) After 1 h
equilibration with 0.75 mole equivalents of As3+ added. (C) After 40 mole equivalents of
Bq added to the solution in B. (D) After 1 h equilibration with 2.5 mole equivalents As3+
added to the apo-αMT solution. (E) After 2 mole equivalents of Bq added to Asn-αMT
shown in D. (F) After 10 mole equivalents of Bq added to Asn-αMT species shown in D.
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The As3+ metalation and Bq reactions of apo-βMT measured by ESI-MS are shown
in Figure 4-2. The apo-βMT has a mass of 3752.6 Da (Figure 4-2A). Because As3-βMT
has no free cysteines, the metalation reaction was quenched after 1 h by addition of 2
mole equivalents of As3+ (Figure 4-2B) to ensure that As1- and As2-βMT were the
dominant species and probe Cys accessibility. The mass spectrum shows that the most
abundant species were As2-βMT (3896.1 Da) and As1-βMT (3824.1 Da) with no
appreciable amount of apo-βMT or As3-βMT. Addition of 10 mole equivalents of Bq
resulted in the spectrum shown in Figure4- 2C. Unexpectedly, the excess Bq did not react
with all the free cysteines present. Significant fractions of unreacted As1-βMT and As2βMT remained, as well as an approximately normal distribution of 1–3 Bq bound to As2βMT and 1–4 Bq bound to As1-βMT (Figure 4-2B). Even when excess (40 mol eq) Bq
had been added there remained unreacted species (Figure 4-2D). This is likely the result
of oxidation since the mass of the unreacted species is less than predicted and decreases
by 3 Da, indicating internal Cys-Cys crosslinks had been formed. Despite the oxidation,
the Normal distribution pattern can still be deciphered indicating approximately equal
access to the remaining cysteine of As1-2-βMT.
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Figure 4-2: ESI mass spectra of βMT1a showing As3+ binding and cysteine
modification with Bq to form Asn-βMT (n=1–2) using Bq. (A) Metal-free apo-βMT.
(B) After 2 mole equivalents of As3+ added to solution of apo-βMT. (C) After 10 mole
equivalents of Bq added to Asn-βMT species shown in B. (D) After 40 mole equivalents
of Bq added to Asn-βMT species shown in B.
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4.3.2

Cysteine modification of Asn-αMT with Bq

Figure 4-3: Deconvoluted ESI-MS data showing the binding of As3+ to apo-αMT and
the subsequent titration of the protein solution with Bq. (A) Distribution of species
upon reaction of 0.5 mol. eq. of As3+ and inset in the top right is the mass spectrum of the
starting apo- solution The spectra show the Bq titration at approx. 1 (B), 5 (C) and 10 (D)
mol. eq. of Bq reacted with the protein solution.
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The deconvoluted mass spectrum of the apo-αMT is shown in the inset of Figure 4-3A.
The reaction with As3+ resulted in a distribution of species: apo-, As1- and As2-αMT with
apo- being the most abundant, As1 at approximately 65% and As2 at approximately 15%
relative abundance. After As-binding was completed, 1 mol eq of Bq was reacted with
the solution shown in Figure 4-3A to form the spectrum in Figure 4-3B. In this early
stage of the Bq titration, both modified and unmodified species are clearly present in
solution. When further mol eqs of Bq are added, a more complicated mass spectrum is
recorded, Figure 4-3C, with 27 individual species (more clearly delineated in Figure 4-4).
This is the midpoint in the reaction, with the mass spectral data complicated by the
presence of both metalated and apo species each having varying degrees of cysteine
modification. The identification of all 27 species is shown in Figure 4-4. This spectrum
beautifully illustrates the power of ESI-MS in providing exquisite detail for the progress
of complicated, multifaceted reactions. Finally, the addition of excess Bq results in all
free cysteinyl thiols being modified, greatly simplifying the spectrum (Figure 4-3D).
Now just three species are observed: the apo-Bq11-MT, singly metalated As1-Bq8-MT and
the doubly metalated As2-Bq5-MT. Thus, Figure 4-3D shows the completed reaction with
all the starting species' cysteines being fully modified by Bq.
This complete modification rules out oxidation as a cause of the unusual patterns seen in
Figure 4-3C. When MT is oxidized, Cys-Cys bridges are formed and, therefore, are
unreactive towards Bq. If there was oxidation in the protein solution the endpoint in the
Bq titration would be changed for some proportion of the protein that had been oxidized.
For example, instead of Bq11-αMT being an endpoint for the titration of the apo-protein,
there would be a distribution of endpoints with Bq11, Bq9 and Bq7-αMT being present
depending on the extent of protein oxidation. In addition the recorded masses would
differ from the expected masses by 2 Da per mole of Cys-Cys oxidation. No such
distribution is observed so it can be concluded that the free thiols were not cross-linked
but all forms covalent bonds with Bq.
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Figure 4-4: Deconvoluted ESI-MS data showing the 27 individual species of
intermediate and fully modified MT (A). Peaks are isolated by parent species (ie. apo,
As1 or As2) and shown on separate axes for clarity. Shown are the reaction profiles for
the As1 (B), As2 (C) and apo-αMT species (D).
Figure 4-4A shows the ESI-mass spectrum at the midpoint of the titration (taken from
Figure 4-3C). This is mass spectral data that include a combination of the spectra of the
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apo-, As1- and As2-species variably modified by Bq. Figures 4-4B, C and D separate out
the three key species, namely As2-αMT, As1-αMT, apo-αMT and their respective
cysteine-modified intermediates. We note that insufficient Bq has been added at this
stage to fully modify all cysteines in the protein (that saturation point is shown in Figure
4-3D). In all, there are 27 individual MT species shown in this single mass spectrum.
This kind of accuracy and resolution of spectral lines is unique to ESI-MS as other
spectroscopic techniques would not be able to distinguish with the same detail the
abundance of species present in solution. To simplify the data analysis, the spectra of the
separately metalated species, along with their intermediate and final products, are isolated
and are shown in Figure 4-4B (As2-α-MT + up to 5 Bq), C (As1-α-MT + up to 8 Bq) and
D (apo-α-MT + up to 11 Bq). Key in this series of spectra is that the As3+ can react in
single steps from 1 to 3 and that it uses 3 cysteine thiols to bind. So from the 11
cysteines of apo-αMT, there are 8 left free for As1-, 5 left free for As2-, and 2 left free in
As3-αMT. When saturated with Bq, all of these free cysteines are modified (Figure 4-3D)
but when insufficient Bq is added the reaction stops mid-flight providing a snapshot of
the relative accessibility of the free cysteines because the reaction progress is governed
by the kinetics of the modification.
In the experiment carried out here the dynamic structure of the protein is controlled by
the metalation status (0, 1, 2, or 3 As3+). The distribution profile of the Bq-modified
cysteines depends on the relative accessibility between all 4 protein species (i.e. apo-,
Asn, n=1-3).
The profile for Bq reacting with the five free cysteines in As2-αMT is complicated.
Although the Bq modification pattern reported for the apo-αMT, namely a Normal
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distribution at low pH 13 is expected to be disrupted by the metalation there are no
previous data to suggest what the effect of the metalation will be. Metal-induced folding
has been discussed for MT for many years 18-20 and it is to be expected that with 2 As3+
bound that the peptide will fold and the cysteines could then be buried. The model of
As2-αMT in Figure 4-5C shows this possibility. The data in Figure 4-4B suggest that the
five free cysteines in the As1 species have different steric hindrance with respect to
reaction with the incoming Bq. The profiles in Figure 4-4 does not exhibit a Normal
distribution rather the profile indicates that some cysteine residues are buried even under
denaturing conditions upon metalation with As3+.
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4.3.3

Modeling the As-MT metalation reaction

Figure 4-5: Scigress models (MM3/MMD) of the structure of Apo-αMT (A), As1–
αMT (B), As2–αMT(C) and As3–αMT (D) using space filling models to visualize the
extent of folding in each species. The MD calculations were carried out at 500 K for
500 ps. The As3+ ions are shown in purple.
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4.4

Discussion

Metal-induced folding is a well studied process in the field of bioinorganic chemistry and
particularly important for metals that play a structural role for metalloproteins.21-23 MT
does not fit nicely into traditional categorization of a catalytic or structural
metalloprotein, but instead coordinates metals in a flexible manner as a
metallochaperone. The ability to accommodate a large number of metal ions per peptide
in a functional homeostatic role makes investigations of metal-induced folding of MT
difficult. In addition, the lack of structural features in the random coil, apo-MT further
complicates structural investigations. Thus, a new technique of cysteine modification to
probe the global reactivity of cysteine-rich MT was used to probe the metal-induced
folding and metalation properties of Asx-MTs under denaturing conditions.
The reaction profile for the reaction of Bq with all 11 free cysteines of the apo-αMT is
unlike that expected based on the low pH conditions. Based on our previous studies 13, it
was expected that MT would not have a defined structure capable of interfering with the
Bq cysteine modification reaction. At pH 2.8, where these titrations were carried out, it
was expected that the MT would exist in a denatured form, as a random, loosely defined
structure, as depicted by the model in Figure 4-5A. As such, all cysteine residues would
be expected to exhibit a similar degree of steric hindrance. This would result in a Normal
distribution of the modifications with an increasing manifold maximum from apo- to the
fully modified Bq11 species (see Figure 1-5A for an example of a Normal distribution
pattern) 13. This was clearly not the case in the reaction profile of the apo- and As1-2-αMT
species studied here. The presence of As3+ changed the reaction mechanism for each
species and gave non-Normal reaction profiles.
For the As1-2-αMT species, the metal-induced folding likely creates an environment
where cysteines not directly involved in metal coordination are shielded by backbone
which is now anchored by the metal coordination. For partially-metalated species, the
metals are still labile, unable to produce sharp signals in NMR spectra.24 The lability of
the metals may bring other so-called "free" cysteines into transient associated with the
metal ions, shielding them from reaction with Bq at the exterior of the protein surface.
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While the reaction profiles for As1-αMT and As2-αMT are relatively straightforward to
explain, the reaction profile of the apo-species in the presence of the As-bound protein is
much more difficult to interpret. At pH 2.8 it is unlikely that the apo-αMT adopts a
compact conformation that should interfere or modify the accessibilities of the free
cysteinyl thiols of the protein. All other studies which modified apo-MTs in isolation at
low pH resulted in a Normal distribution of modified species.25-27 In previous metalation
studies, fully metalated As-MT species have been shown to transfer As3+ to apo-species
through protein-protein interactions.28 Many other studies have demonstrated MT
donating metals such as Zn and Cu to other metalloenzymes through direct interaction
with each other.29
The pattern is not likely a result of Bq aggregation or some other property of the cysteineBq reaction because the pattern is not replicated in the absence of a bound metal. In
solutions only containing apo-MT this phenomenon is not seen .13 The presence of metal
induced structure at pH 2.8 indicates that H-bonding may not be an important factor in
determining As-MT structure. The pattern shown in Figure 4-4D is very similar to the
one in 4-4C. It is likely the interaction and transfer from the As1- species to the apospecies is causing the altered reaction profile of Bq.
The models were calculated using MM3/MD techniques at a nominal MD temperature of
500 K temperature to simulate a low pH environment with the H-bonds disrupted. The
models suggest that the apo- species is indeed the most open conformation of the protein
and that when bound to arsenic, the protein adopts a more compact, globular structure. As
described previously, even though apo-MT may have an open conformation at low pH,
protein-protein interaction with partially metalated species may account for the Bq
reaction profile resembling that of a more compact conformer. We suggest that the
metalated species and apo-species interact with each other shielding the cysteine residues
that are on the surface of both species. The transfer of arsenic most likely occurs by a
process of coordination of the As3+ by exposed cysteinyl thiols on the surface of an apoprotein.28 This would explain the drastic change in reaction profile, since under metalfree conditions those most exposed residues would be the ones most likely to react with
an incoming Bq molecule. The inter-protein exchange maintains a pool of apo- and
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minimally-modified species by shielding the residues that, under metal-free low pH
conditions, would be the first to be modified. It should be noted that the most exposed
residues at such a low pH would likely be closer to the ends of the peptide and have less
shielding from the backbone on one side when compared to the cysteine residues in the
middle of the sequence.
In additional to information gained about the conformations adopted by the MT species
in solution, the stoichiometry was successfully confirmed. Discrete units of As(Cys)3
form until all cysteine residues are occupied in the β-domain and all but two are involved
in coordinated in the α-domain. Unlike for the apo- and As1-2- species the remaining free
cysteine residues As2/3-species were equally accessible, giving rise to a Normal
distribution of modified species (Figures 4-1 and 4-2). This is likely the result of
significant compaction of the protein structure as more metals are coordinated. For Cd2+
metalation it was shown through IM-MS that the number of conformers converged as
metalation proceeded and resulted in a more rigid and compact structure.30 It is likely that
arsenic metalation mirrors this process, although it is surprising that the convergence on a
narrower set of compact conformers is possible even under typically denaturing
conditions.

4.5

Conclusions

In this chapter we have demonstrated the multifaceted usefulness of our cysteine
modification approach. We were able to confirm the stoichiometry of arsenic binding
predicted through first principles of inorganic chemistry and that the binding mode is the
same for all levels of arsenic saturation of MT. In addition, information pertaining to
protein conformation and possible protein-protein interactions was obtained through the
analysis of modification profiles. The deviance from Normal distribution under
denaturing conditions is surprising and highlights the importance of metal coordination to
the folding of MTs.
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Chapter 5

5

Selective cysteine modification of metal-free human
metallothionein 1a and its isolated domain fragments:
Solution structural properties revealed via ESI-MS4

5.1 Introduction
Since their discovery in 19571, metallothioneins (MTs) have been of interest due to their
many unique structural and metal binding properties. These special properties include
binding of up to 7 Zn2+ and Cd2+, forming two metal-thiolate clustered domains (the α
and β-domains) that are joined by a short linker sequence.2-3 While the biological
function(s) of this family of proteins are still debated, it is generally agreed that their
functions are connected with zinc and copper homeostasis4-7, redox signalling8-10 and
toxic metal sequestration.11-15 Despite these many proposed functions, and their capacity
to bind so many metals,16-17 MTs are surprisingly small, flexible proteins that lack typical
optically active structural features. This lack of formal secondary and tertiary structure in
the absence of bound metal ions precludes traditional structural analysis via spectroscopic
methods.18-19 In addition, the dynamic nature of the coordinated metals in the metalbinding sites makes characterization even more difficult for metalation states other than
the fully saturated protein.2, 20
The structures of metallated metallothioneins have been probed with a wide range of
methods, including fluorescent resonance energy transfer (FRET)21, ion-mobility massspectrometry (IMS)22 and, following cysteine modification, electrospray ionization mass
spectrometry (ESI-MS) analysis.23-25 Traditional ESI-MS studies have resulted in a large
number of mass spectrometric data being reported that clearly distinguish between

4
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cysteine modification of metal‐ free human metallothionein 1a and its isolated domain fragments: solution
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metalation states present in solution. Through the semi-quantitative properties of ESIMS, the distribution of those species can be analyzed.26 In addition to the extent of metalsaturation, ESI-mass spectral data can also determine the relative concentrations of the
many differentially modified protein species simultaneously.24 The abundance of easily
modifiable cysteine residues (20 in human MTs) offers an opportunity to exploit this
reactivity to obtain information on the solution structure of MTs based on the relative
reactivity of individual cysteinyl thiols.25, 27-28 This experiment is similar to the use of
H/D exchange in identifying regions of proteins that are more or less exposed to the
solvent.29-30 Analysis of charge state distributions31 and ion drift in IMS gives additional
information about the overall folded state of the protein.32
ESI-mass spectral data have been used to determine structural properties of apo-MT25 and
MT partially metalated with As3+24 and Cd2+28, 33. ESI-MS data can also be used to
determine quantitative biochemical parameters as recently demonstrated in the
determination of arsenic metalation kinetics34, cadmium and zinc equilibrium and kinetic
constants28, 35-36 and copper binding affinity.37 The key to these semi-quantitative data is
the assumption that apo-MTs and those with different numbers of metals coordinated
exhibit very similar ionization efficiencies; this assumption has been supported by the
literature, especially for metalation of metallothioneins.38 While it is true that the
different MT-isoforms will have slightly varying ionization efficiencies,39 when
analyzing modifications of the same isoform, the behavior of all species in solution has
been demonstrated to be predictable and the metal-binding parameters determined align
closely with those determined by other methods.36, 40-41
Previous studies using cysteine modification agents to probe the solution structure and
metal binding properties of MTs have focused on one modifier at a time, leading us to
question whether there was a bias based on the size and relative solvation properties of
the modifying molecule.
In this chapter, we use three cysteine modification agents of varying size and
hydrophobicity, p-benzoquinone (Bq), N-ethylmalemide (NEM) and iodoacetamide
(IAM), to probe MT solution structure as a function of the accessibility of its cysteine
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residues. We carried out the reactions of the full-length human MT1a and its isolated αand β-domains under native and denaturing conditions. By analyzing the characteristic
modification profiles of folded and unfolded MTs (obtained at neutral and low pH) as
well as changes in charge state distribution, we describe the modification properties of
the folded, globular apo-metallothionein structure under native conditions and compare it
under denaturing conditions. The ESI-mass spectral data provide modification profiles
and charge state distributions that we use to determine the relative accessibility of the
cysteinyl thiols to the modifiers, which leads to conclusions about the overall
compactness of the proteins.

5.2
5.2.1

Methods
Protein preparation

Recombinant human metallothionein 1a (βα: MGKAAAACSC ATGGSCTCTG
SCKCKECKCN SCKKCC SCCPMSCAKC AQGCVCKGAS EKCSCCK KA, α:
GSMGKCCSC CPMSCAKCAQGCVC KGASEKCSCCKKAAAA, β: GSMGKAAAA
CSCATGGSCTCTGSC KCKECKCNSCKKAAAA) was expressed with an S-tag in
BL21 E. coli cells which has been described in detail elsewhere.42 In brief, cells
containing the plasmid constructs for the full protein (βα-MT1a) and for the isolated
domains (β-MT1a and α-MT1a) were plated on to growth media containing kanamycin
from a stock culture stored at -80oC and grown for 16 hours at 37oC. The cells were then
transferred into 1L broth cultures enriched with 50 μL of 1 M cadmium and incubated in
a shaker for 4 hours until OD 600 absorbance was between 0.6-0.8. Isopropyl β-D-1thiogalactopyranoside (IPTG) was then added to induce expression of MT and 30
minutes later 150 uL of 1 M cadmium sulfate was added. The cells were collected 3.5
hours after induction, centrifuged and stored at -80oC.
The recombinant cells were lysed using a cell disruptor (Constant Systems, UK) at 20K
psi. The cell lysate was centrifuged for 1h to remove cellular debris. The supernatant was
filtered and loaded on to an SP ion exchange column (GE Healthcare) with a total volume
of 10 mL. The columns were washed with pH 7.4 10 mM Tris (trishydroxymethylaminomethane) buffer for approximately 2h to remove loosely bound
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proteins and other organic materials. MT was eluted using an increasing gradient of 1 M
NaCl + 10 mM Tris buffer at pH 7.4. The eluted MT was concentrated down to <20 mL
and the S-tag cleaved using a Thrombin Clean-Cleave kit as per the manufacturers’
instructions (Sigma-Aldrich). The S-tag was separated using an ion-exchange column
since the S-tag does not bind as strongly as MT and thus elutes at lower salt
concentrations. The eluted, cut Cd-MT was concentrated to approximately 120 µM and
stored at -20oC. In this chapter, we refer to the recombinant human liver MT1a isoform as
“MT”, but all other isoforms are referred to with their complete isoform and subisoform
descriptors.
To prepare MT for the modification experiments, aliquots were first demetalated and
desalted using centrifugal filter tubes with a 3 kDa membrane (Millipore) and a 10 mM
pH 2.8 ammonium formate buffer. The low pH solutions contained 1 mM dithiothreitol
(DTT) to prevent oxidation of the free thiols in MT. The pH was raised by buffer
exchange with argon saturated, pH 7.0 10 mM ammonium formate solutions that did not
contain reductant. The final concentration of the protein solutions were determined by
remetalation of a small aliquot with cadmium using the metal-to-ligand charge transfer
band at 250 nm (ε250 = 89,000 Lmol-1 cm-1). The solutions were also monitored for
oxidation using UV-visible absorption spectroscopy to monitor absorption corresponding
to 280 nm from oxidized disulfide. Once demetalated and desalted, the MT concentration
was determined, all concentrations were between 40-90 µM to ensure good signal to
noise ratios In the ESI-MS experiment.
In addition to demetalating MT in the presence of DTT, the solutions were vacuum
degassed and bubbled with Argon to displace any dissolved oxygen. This was also
carried out for the 10 mM 1,4-benzoquinone (Bq), N-ethylmalemide (NEM) and
iodoacetamide (IAM) solutions and the 0.5% NH4OH and 0.5% formic acid solutions as
well to ensure no oxygen was introduced into the system during the modification reaction
or pH adjustment. Great care was taken to reduce the possibility of oxidation of the
protein especially at neutral pH. All modification agents were obtained from SigmaAlrich (USA).
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5.2.2

ESI-mass spectra collection

Mass spectra were measured with a micrOTOF II electrospray-ionization time-of-flight
mass spectrometer (Bruker Daltonics) in the positive ion mode. NaI was used as the mass
calibrant. The scan conditions for the spectrometer were: end plate offset, −500 V;
capillary, +4200 V; nebulizer, 2.0 bar; dry gas flow, 8.0 L min−1; dry temperature, 30 °C;
capillary exit, 180 V; skimmer 1, 22.0 V; hexapole 1, 22.5 V; hexapole RF, 600 Vpp;
skimmer 2, 22 V; lens 1 transfer, 88 μs; lens 1 pre-pulse storage, 23 μs. The mass range
was 500.0–3000.0 m/z. Spectra were assembled and deconvoluted using the Bruker
Compass data analysis software package. ESI-mass spectrometry was used to monitor all
stages of the modification reaction. Approximately 1 molar equivalent of the modifying
agent (Bq, NEM or IAM) was added stepwise and a spectrum recorded after each
addition. The ESI-mass spectra were recorded and averaged over 2 minutes.

5.2.3

Molecular models

MM3/MD calculations were carried out using Scigress Software (Fujitsu, Poland) and
parametrized using the modified force field described by Chan et al.42 with the dielectric
constant of 78 for water to obtain energy minimized structures of the Cu-bound protein.
The original apo-MT1a structure was obtained from Rigby et al.19 A cycle of MM3
minimizations followed by MD calculations gave energy-minimized apo-MT structures
reported here. The structures were first energy minimized using the MM3 calculation
followed by an MD simulation at 500 K for 10 ps and then another MD simulation at the
same temperature for 1000 ps. Structures with closed, intermediate and open
configurations were selected from energy minima as representations of the multiple
conformations apo-MT adopts in solution.

5.3
5.3.1

Results
Modification of the isolated α- and β-domain fragments of
metallothionein

The isolated α- and β-domain fragments of MT were reacted with each of the three
cysteine modifying agents to probe the compactness of their structures at neutral (native
conditions) and low pH (denaturing conditions). The fragments were studied separately
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from the full-length protein to test whether cysteinyl thiols would be buried to a different
extent within the smaller volumes of the individual fragments, especially the small βdomain. Figure 5-1 shows the reaction profile of the β-domain fragment (N-terminus
fragment) with p-benzoquinone (Bq). The data show the distinct cysteine access
differences between the unfolded state of the fragment at low pH, and the folded, native
state at pH 6.8. At low pH the modifications follow a systematic and stochastic trend as
the number of equivalents of Bq molecules added increases. At pH 6.8, the pattern is very
different, with both the unmodified (0 Bq) apo-fragment and the fully modified (9 Bq)
fragment coexisting. While some adducts are present in the low pH spectra, they did not
add to the shielding and a Normal distribution of modifications is seen.

Figure 5-1: Representative deconvoluted ESI-MS spectra from the modification of
the β-domain fragment of MT1a with p-benzoqinone (Bq). The reaction at pH 2.8 (left
panel) and 6.7 (right panel) gave markedly different reaction products labelled with
vertical lines for the 1, 3, 5, and 9 Bq bound masses. Note that the apo-fragment is not
indicated, its mass lies to the left of the “1” line. The fully modified fragment is indicated
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by the “9” line.. The number of molar equivalents of Bq added in the stepwise titration is
listed to the right of each panel up to 8.8.
In the second test, the more hydrophobic and slightly larger modifier, NEM, was used.
The reaction profile of the β-domain fragment with NEM is shown in Figure 5-2 under
native and denaturing conditions. At low pH, the data show the incremental increase in
modification as the mol. eq. of NEM are increased. At pH 7.4 NEM modified fragments
from apo-(0) to fully modified (9) are present until the end; a stark departure from the
pattern than observed at low pH and remarkably similar to the Bq modification pattern.
At all points during the reaction either apo- or Bq9-βMT are the most abundant species.

Figure 5-2: Representative deconvoluted ESI-MS spectra from the stepwise
modification of the βMT fragment by NEM. The extent of the modification in terms of
number of covalent NEM modifications on the MT is shown by the vertical lines for the
1, 3, 5, and 9 NEM bound masses. Note that the apo-fragment is not indicated, its mass
lies to the left of the “1” line. The fully modified fragment is indicated by the “9” line..
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The number of molar equivalents of NEM added in the stepwise titration is listed to the
right of each panel up to 8.8. The NEM was added stepwise with the mol eq as shown to
the right of each panel at pH 2.8 (left panel) and pH 7.4 (right panel).
The reaction profiles for the NEM and Bq modification reactions of the β-domain
fragment of MT1a (Figs 1 and 2) are strikingly similar at low pH. Both exhibit a
stochastic, Normal distribution of intermediate species under these denaturing conditions.
Under more native conditions for both modifiers the starting apo-βMT and end product,
Mod9βMT are the two dominant species in solution with minor abundance of
intermediate species. It appears that the modification of the β-domain fragment leads to
the protein unfolding, promoting subsequent modification reactions due to the disruption
of native structure and exposure of previously buried Cys residues to the solvent. The
series of spectra show that throughout the stepwise addition, the native and the fully
modified “9” species are the most abundant. The extent of the modifications is seen
clearly near the 4.0 NEM mol. eq. point where the differences between neutral and low
pH spectra are most dramatic. To further understand the properties of this metal-free,
native, folded state of MT under these conditions, the charge state distributions were
analyzed.
The charge states of the isolated domain fragments were similar following complete
modification with both Bq and NEM. The charge state distributions for the NEM
modifications of the β-domain fragment are shown in Figure 5-2. In each of the 6 panels,
the charge state average shifts higher following the Cys modification reaction, indicating
an increase in surface area. The weighted average charge state shifts only slightly for the
apo-proteins between native and denaturing conditions before modification reactions. For
βαMT the native condition average charge state is 5.2 and increases marginally to 5.5
when the pH is lowered (Left spectra 3A and B). There is a more dramatic shift in charge
states upon modification in all cases. The largest differences in average charge state
occurs under native conditions in the βα- and α-MT modification reactions (3A and E).
While the appearance of new charge states indicates unfolding, the effect in the small
MT-protein and the even smaller fragments is more subtle than in classic studies, such as
that for myoglobin unfolding. Thus it is difficult to make conclusions about the folded
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state of MT from charge states alone. However, when combined with the ESI-MS data
for the modification reaction patterns the conformational picture of MT becomes clearer.

Figure 5-3: Representative ESI-MS charge state manifolds measured during
cysteine modification of βαMT1a and its isolated fragments. Spectra at approx. 1.6
mol. eq. of NEM added are shown on the left side of each panel and those near the end of
the titration on the right side. The weighted average charged state is shown above each
spectrum in italics.
The α-domain fragment reacted in a very similar manner when modified with both Bq
and NEM. The data for the reaction of the α-domain fragment of MT1a with Bq has been
published previously,25. The stepwise NEM modification reaction of the α-domain
fragment under native and denaturing conditions is shown in Figure 5-4.
The reaction at pH 2.8 follows the trend for the β-domain fragment and also the
previously reported modification of the α-domain fragment by Bq.25 Under denaturing
conditions, where the peptide is expected to be unfolded, modification follows a
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stochastic, Normal distribution of modified intermediates. As above for the β-domain
fragment, at neutral pH it can be seen that the α-domain fragment modification by NEM
results in very low abundance of the partially-modified intermediates (NEM1-10αMT)
when compared with the β-domain reaction. The series of spectra in Figure 5-4 (right)
indicate that the initial modification of the apo-fragment is initially sterically unfavorable
compared with the low pH reactions. However, once modification has begun, those
peptides unfold allowing the subsequent modification to proceed rapidly, culminating in
the growing presence of the fully modified NEM11α-fragment. The throttling effect of the
initial steric hindrance to modification by NEM results in the very low abundances of the
partial modified fragment. The implication is that for the α-domain fragment under native
conditions, the folded native peptide is resistant to modification.
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Figure 5-4: Representative deconvoluted ESI-MS spectra of the modification of
αMT fragment with NEM. The extent of the covalent NEM modification (0 -11) is
shown by vertical lines (apo (0), 2, 4, 6, 8, and 11). NEM was added stepwise, with the
molar equivalents added shown to the right of each panel, at ph 7.4 (left panel) and 2.8
(right panel). *-+60 Da adduct, #-unknown contaminant at 5183 Da not corresponding to
MT or any modified species.
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5.3.2

Modification of the full-length protein (βαMT)

The full length protein, βαMT, consists of the two isolated domain fragments discussed in
the previous sections, joined by a short linker sequence. The protein is much larger with
20 cys in the sequence. Much like the isolated domain fragments, the full protein exhibits
a stochastic, Normal distribution of modification intermediates (NEM/Bq1-19 βαMT)
under denaturing conditions as can be seen in Figure 5-5. Both NEM and Bq modifiers
exhibit nearly identical patterns and this is consistent across all three peptides studied.
Despite the differences in size and hydrophobicity, both NEM and Bq reactions cause
similar changes to the structure of the proteins under native conditions.
The results of the modification reactions at pH 7.4 are substantially different when
compared with the isolated domains fragments. In particular, the charge state distribution
significantly changes during the modification reaction at pH 7.4, which can be seen in
Figure 5-3 (left panel). Two new charge states (+9 and +8) emerge for the fully modified
protein (NEM20βαMT) compared with only a slight shift in charge state abundance for
the modified isolated α- and β-domain fragments. This can be explained by a larger
number of covalent modifications, resulting in a much larger peptide that also has a very
different electrostatic surface and by the more drastic surface area difference between the
folded and unfolded states.
Despite having different properties, it is clear that in the case of the full MT protein at
denaturing pH (2.8), cysteine modification with Bq and NEM follows a similar pathway,
resulting in largely the same type of reaction profile. In order to contrast the reactions of
these hydrophobic molecules, we also used iodoacetamide (IAM) to covalently modify
the cysteine residues of the full MT protein. The full length protein was chosen for IAM
modification because of the more dramatic changes in charge state and reaction pattern
expected. IAM is much smaller, more hydrophilic and reacts via a different mechanism
than the NEM and Bq cysteine modifiers described above.
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Figure 5-5: Deconvoluted mass spectra of NEM modifications of βαMT under native
(pH 7.4, right) and denaturing (pH 2.8, left) conditions. The masses and numbers of
the covalent modifications are shown by the vertical lines 0 (apo)-20. The mol. eq. of
NEM reacted are shown to the right of each spectrum. *-indicates the presence of
partially oxidized MT species #-+60 Da adduct.
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Figure 5-6 shows the results of the IAM modification experiment. Under both denaturing
(7, left panel) and native (7, right panel) conditions, IAM results in a Normal distribution
of modified MT species, although the distribution is wider under the native, pH 7.4
conditions. At low pH, the modification reaction is much slower than for the other two
modifiers tested and excess IAM was reacted with the apo-MT solution overnight.
However, even with a large excess of IAM, after 24 h only 5.8 molar equivalents of IAM
had reacted but the general pattern of modification is apparent and matches that of the
other modifiers. It is also similar to the neutral pH reaction in terms of modification
profile and distribution of modified species, although a smaller range of modified species
are present at any given time. The IAM modification did not result in the cooperative
modification patterns indicative of structure disruption in the full length protein.
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Figure 5-6: Deconvoluted mass spectra of the βαMT modification with IAM under
denaturing conditions at pH 3.0 (A) and native conditions at pH 7.4 (B). At low pH,
the kinetics of the reaction is very slow so only the spectrum at 1 h (top) and the
incompletely modified spectrum at 24 h (bottom) are shown in (A).
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5.4

Discussion

The challenges of investigating the structure of apo-metallothioneins are numerous. The
fluxional nature of a disorganized peptide and the lack of good chromophores make
traditional methods of structure determination difficult or impossible. Proton NMR
showed a disordered structure for apo-human, horse and bovine MT2a, however, the
chemical shifts were similar to the zinc and cadmium analogues.43 FRET studies have
shown that the overall volumes of the full protein, as well as its isolated domains, are
largely unchanged between the metal-free and metal-saturated states.21, 44-45 Ion-mobility
mass-spectrometry has confirmed the presence of a range of conformations in the apoprotein and the fluxionality inherent before metal binding occurs.22 In previous reports,
we have begun to probe the structure via global reactivity towards cysteine modifying
agents.24-25, 27, 31 Other groups have also probed the reactivity of the fully metalated
protein towards NEM to investigate properties of demetalation and stability of cadmiumMT clusters.33
In this study we sought to probe the metal-free solution structures of βαMT and its
isolated domain fragments using three different commonly used cysteine modifiers and
analyze the reaction profiles using ESI-MS. Our report here includes the reaction profiles
for modification of the isolated domain fragments and contrasts those differential
modification data with the reactivity of the full length protein. The isolated domains
being smaller, having less overall volume and a smaller surface area than the full protein
were predicted to exhibit a smaller change in average charge state and this is observed in
Figure 5-3. Although the charge states only changed slightly in the isolated domain
fragments (α increased 1.0 and 0.6 and β 0.4 and 0.9 at high and low pH respectively),
reaction profiles for NEM and Bq followed a cooperative pathway under native
conditions at neutral pH (Figures 5-1, 5-2 and 5-4).
We have previously described the cooperative pattern arising from unequal solvent
access of the cysteines in apo-MTs.25 The modification proceeds rapidly once the
compact conformation initially proposed many years ago from early molecular dynamics
calculations19 is unfolded by the initial modifications. This indicates that both isolated
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fragments are capable of adopting a more folded conformation to shield cysteine residues
from the solvent despite their small size (3.7 and 4.08 kDa).
In Figures 5-1, 5-2 and 5-4, it is clear that during the reaction of both apo-α and apo-β,
the unmodified apo-fragments coexist with the fully modified protein during the stepwise addition of the modifier. This is counter-intuitive for a protein with 9 or 11 cysteinyl
thiols that remain unreacted while other individual MT molecules, with only a few free
cysteines, react to become fully modified. This can be explained by the compact
conformers adopted by the full length protein at neutral pH (6.8 – 7.4) making the
cysteines sterically inaccessible. Conceptually, it can be understood that modifiers of any
size or of hydrophobicity should be at least somewhat hindered in their reaction. The data
we have measured are essentially “snapshots” of the reaction, the progress reports that
would be observed if excess modifier were added and ultra-high speed spectra recorded.
Instead we use a step-wise addition where we run out of modifier and the distribution of
modified species is recorded at each point. The modification status is governed by the
relative kinetics of the reaction to modify each cysteine. The reaction kinetics are
governed by two major factors: the intrinsic rate of the chemical modification of the
cysteine and the inhibition effect of the steric hindrance of the surrounding protein
structure. Since the reactions are irreversible, the reverse equilibrium reaction has no
effect on the distribution of the products.
Under denaturing conditions at low pH, all three modifiers (NEM, Bq and IAM) followed
pathways that resulted in a stochastic, Normal distribution of species that summed to the
mol. eq. of modifier added. Under these conditions the protein adopts a more extended
conformation and it is reasonable to conclude that all cysteines are essentially equally
exposed to the solvent and incoming modifier molecules. This results in a purely
statistical reaction pathway where individual MT molecules with more unreacted
cysteinyl thiols are more likely to be modified than those with more modifications
already present.
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Figure 5-7: Comparison of the reaction profiles shown by the relative abundances of
each modified βαMT-species at approximately the half way point, for the three
cysteine modifiers used. (A) Relative abundances under denaturing conditions at pH
2.8-3.0 and (B) relative abundances under native conditions at pH 6.8-7.4. The relative
abundances shown in this Figure were extracted from raw deconvoluted ESI-MS data at
approximately 10 mol. eq. of each modifier.
A very different picture emerges during modification under native conditions at neutral
pH. The larger, more hydrophobic modifiers (NEM and Bq) give rise to a cooperativelike pattern. Under native conditions, the more compact conformations shield most of the
cysteinyl thiols, allowing only a fraction of the apo-protein to react, becoming
increasingly unfolded as modifications proceed. Russell and co-workers showed a small
fraction of apo-MT2a exists as a more disordered and open conformer, at least in the gas
phase for the +5 charge state.22 These conformers are likely more accessible for
modification and are the ones that fully react, leaving the more compact conformers of
apo-MT with unmodified thiols. To visualize the equilibrium between apo-MT
conformers, molecular dynamics simulations were used to generate a range of possible
structures (Figure 5-8). Because the reaction with the modifiers is controlled by access to
the cysteinyl thiols, the thiols in the more compact conformers remain less reactive than
those species whose structure has been disrupted by modification. This results in a large
fraction of unreacted apo-MT, small amounts of partially modified protein and the
accumulation of the fully modified protein as seen in Fig 8B for NEM and Bq
modifications.
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Figure 5-8: Molecular dynamics simulated structures of apoMT under native
conditions. The "closed" structure is one where the Cys residues are more buried within
the interior of a bundled protein, "intermediate" where there is more access to the Cys
residues and "open" where there is the most unhindered access.
It is interesting that this cooperative-like pattern is not observed in the mass spectral data
from the reaction of the smaller and more hydrophilic IAM modifier. Instead, a wider
stochastic distribution is observed and the width of the distribution of the IAM reaction
profile is compared in Figure 5-9C. The wider distribution is likely due to the unequal
solvent accessibility of the cysteinyl thiols in the folded configuration. IAM is less
disruptive to the compact conformers of MT than the larger and more hydrophobic Bq
and NEM modifiers. This has implications for the choice of modifier when examining
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properties of cysteine-rich proteins like MTs. IAM may be more suitable if native
structure needs to remain largely intact, whereas Bq and NEM are better in producing a
more dramatic change in reaction profile depending on the protein conformation. In
addition, NEM is able to be used over a wide range of pH, 2.8-7.4 tested here, where
IAM is unreliable at low pH (<4) and Bq unreliable at basic pH (>7) ranges.
Figure 5-9 compares the reaction profiles at the halfway point (10 mol. eq.) under native
(neutral pH) and denaturing (acidic pH) conditions. The Bq and NEM reaction profiles
show how the reactivity of apo-MT has been dramatically changed by the switch between
compact and extended conformers at neutral and low pH respectively. However, these
profiles are contrasted by the reaction profile of the IAM species, Fig 10C, where the
profiles follow stochastic distributions under both denaturing and native conditions,
although the low pH distribution is much narrower. This may be a function of slow
kinetics of the reaction under these conditions or may speak toward the equal
accessibility of the cysteines and even less interference by the surrounding peptide due to
the small size of the IAM molecule.
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Figure 5-9: Extracted ESI-MS reaction profiles for all three cysteine modifiers used.
In this Figure, the relative abundances of each of the βαMT-species are compared after 10
mol. eq. of each modifier has been reacted under native (neutral pH) and denaturing (low
pH) conditions. (A) Comparison of the BQ, (B) NEM and (C) IAM reaction at low (grey
bars) and neutral pH (black bars).

123

Our systematic approach in probing the structures of βαMT and its isolated domains have
provided further evidence for the adoption of a bundled or compact structure by the
metal-free protein. These data summarized in Table 5-1, indicate that even the smaller,
isolated fragments behave in the same fashion. To completely understand the metalation
mechanisms of MT, a starting point must be established which up until recently was a
poorly defined apo-structure.
The biological significance of apo-metallothioneins remains a source of controversy
within the community. Some have indicated that apo-MT comprises a significant portion
of the cellular MT pool46. Regardless, upon ribosomal translation the nascent MT will be
in its apo-form and it remains a mystery how specificity and quantity of MT metalation
occurs. The redox properties of MT have also been a source of controversy. While it is
clear gluathione is the major source of reducing thiols in the cell,47-48 it is unclear to what
extent MTs also play a role.49-51 The "hidden" nature of most of the thiols in MT
demonstrated in this chapter may cast doubt on how integral a role MT1a plays in cellular
redox chemistry.
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Table 5-1: Summary of reaction profiles following reaction of three cysteine
modifiers with the full protein and the two isolated fragments under native and
denaturing conditions
Protein construct

Modifier

Native reaction

Denatured reaction profile

profile
βαMT1a

NEM

Cooperative

Non-cooperative, stochastic

Bq31

Cooperative

Non-cooperative, stochastic

IAM

Non-cooperative,

Non-cooperative, stochastic,

stochastic, wide

narrow distribution

distribution
αMT1a

NEM

Cooperative

Non-cooperative, stochastic

Bq25

Cooperative

Non-cooperative, stochastic

IAM

Non-cooperative,

Non-cooperative stochastic

stochastic
βMT1a

NEM

Cooperative

Non-cooperative, stochastic

Bq

Cooperative

Non-cooperative, stochastic

IAM

Non-cooperative,

Non-cooperative, stochastic

stochastic
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5.5

Conclusion

In this chapter we describe the cysteine modification reactions of metallothionein and its
isolated domain fragments with well known modification reagents (Table 5-1). All three
peptides (α- and β-domain as well as the full βαMT) gave similar reaction profiles under
native and denaturing conditions, indicating all three fold into a tightly wrapped structure,
buring selective cysteine residues. The larger modifiers, Bq and NEM, showed the most
drastic difference between conditions, going from a stochastic non-cooperative pattern
when denatured to a cooperative one under native conditions. The smaller IAM only
showed a broader distribution of modified cysteine residues under native conditions but
the overall pattern was similar to the denatured conditions. The larger modifiers were
better able to probe the ill-defined structure of apo-MT as they caused larger disruptions
to the native fold. This highlights a new way probe intrinsically disordered, or "less
ordered", protein structure by monitoring residue modification by ESI-MS.
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Chapter 6

6

Metalation kinetics of the human α-metallothionein 1a
Fragment is dependent on the fluxional structure of the
apo-protein5
6.1

Introduction

One-third of all proteins require a metal cofactor in a functional or structural capacity to
perform their respective function.52 These cofactors are commonly d-block metal ions
such as Fe, Cu, Zn or Mo, termed essential metals, which have been selected
evolutionarily for their physicochemical properties and environmental availability53.
Despite this efficient use of metal ions by biological machinery, other metal ions present
in the surrounding environment can be highly toxic, even at very low levels of
exposure.54-56 These toxic metals, which include As, Cd, Hg, and Pb, often replace
essential metals in key metalloproteins, resulting in inactivation of enzymatic function
and inhibition of critical cellular processes.57 Fortunately, the cell has natural defences to
protect against inevitable toxic metal exposure by sustaining significant quantities of
biological ligands that act to sequester the metal ions.58-59 Examples of these molecules
include the tri-peptide glutathione and the small, two-domain protein, metallothionein.6061

Metallothionein (MT) is a small, cysteine-rich, metal-binding protein. The mammalian
forms adopt a two-domain structure when saturated with divalent metals62. In the fully
metalated, two-domain protein, metal binding is organized into two metal-thiolate
clusters with stoichiometries of: M4S11 ( domain) and M3S9 ( domain) where these
divalent, d10 metals are tetrahedrally coordinated by a combination of terminal and

5

A version of this chapter has been published

Reproduced with permission from: Irvine, Gordon W., et al. "Metalation Kinetics of the Human
α‐ Metallothionein 1a Fragment Is Dependent on the Fluxional Structure of the apo‐ Protein." Chemistry–
A European Journal 21.3 (2015): 1269-1279.
Copyright Wiley 2014
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bridging thiolate ligands of the 20 cysteines.63 Under normal cellular conditions, in the
absence of toxic metal exposure, MT coordinates Zn2+ and Cu+ ions 64. In this state, MT
is considered to act as a metallochaperone or storage protein, able to shuttle essential
metals to apometalloenzymes65-67. This homeostatic or metal buffering role is a critical
role for metallothioneins, especially for Zn2+ and Cu+ 68-69, however, following exposure
to toxic metals, such as Cd2+, MT adopts a more protective role by actively sequestering
these metal ions63,

70

. Because of the central role of MT in cellular metal regulation,

dysfunction in gene coding for metallothioneins or modifications to their native structures
can lead to serious disease and increased toxic metal sensitivity71-75. Previous studies
have shown that de novo transcription of MT mRNA can be induced by both Cd2+ and
Zn2+76-78. Consequently, two potential mechanisms are possible by which MT can act to
sequester the toxic Cd2+ ions: (1) metal substitution in which Cd2+ replaces Zn2+ in preexisting Zn-MT, or (2) coordination of Cd2+ to de novo-synthesized apo-MT.
While MT is ubiquitous across all kingdoms and in all organs in mammals, the actual
metalation mechanism of the apo-MT is poorly understood. The mechanism leads to
selectivity between different metals in the metal-saturated proteins

79-80

. Although many

studies have investigated metal substitution reactions of Zn-MT with Cd2+ or exchange
between Zn-MT and Cd-MT81-88, few studies have investigated the details of the
metalation reaction of the metal-free or apo-MT. This is due to the technical difficulties
working with a sulfhydryl-rich protein that is highly sensitive to oxidation, lacks a formal
20 or 30 structure which precludes CD spectroscopic analysis, and is chromophorically
silent due to the d10 metals typically bound in vivo. The structure of a metal-free protein
can usually be used to provide detailed information about metalation pathways from the
changes that take place as metalation proceeds89. But for metallothioneins, it has been
generally considered that apo-MT has no formal structure90 and only after metalation
does MT gain a more organized structure79, 90-92. The topology of the partially-metalatedAsx-MT species have recently been probed experimentally24, 27 and it was shown that the
differential rate of the covalent modification of cysteine residues on MT is an effective
probe of solution structures.
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The question then arises whether these conformations, which can be identified by
modification with Bq, influence the metalation mechanism. Biologically, this is important
because tumors are known to have a much lower pH (5.8≤) than normal cells as a result
of the anoxic environment in which they are found93. In this context, apo-MT may adopt
an altered conformation and, therefore, might interact with metal-based drugs differently
due to the structural changes induced by the lower pH.

Thus, understanding the

conformational dependence of metalation of apo-MT is of great importance in
determining the poorly known but vitally important mechanistic details of metalation.
The lack of an intrinsic probe in apo-MT makes it difficult to monitor structural changes
due to metalation or change in environment. Previous studies have overcome this
limitation using FRET-labeled-MT to monitor changes in overall dimensions of the
protein94. These studies have shown that FRET emissions only change slightly when MT
was demetalated, suggesting that the apo-MT fragment dimensions remains somewhat
compact94-95. This retention of compact dimensions in the α- and β-domains may indicate
that despite the lack of formal structural features, the globular structure of the apo-MT
may be important to its metal binding properties.
In this study, we investigated the dependence of the rate of the metalation reaction with
Cd2+ on the extremes of the folded state of apo-MT1a. To reduce the complexity of the
two-domain, 7-metal binding protein we chose to study the  fragment that contains only
the four-metal  domain.
Figure 6-1 shows the -fragment's four-metal-binding domain structure of the Cd4MT1a and the arrangement of the metals both within the peptide folded structure and
with the thiolates of the Cd4-S(Cys)11 cluster96. Since high concentrations of denaturant
are not compatible with ESI-MS studies, we used low pH to model the denaturing effects
of the guanadinium hydrochloride denaturant and used the modification reaction profiles
of the 11 cysteines by benzoquinone as a way of probing the solution structure of the apoMT under two extremes of conformation: folded and unfolded. Our objective was to
determine whether the conformation of the apo-MT affected the metalation reaction.
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Figure 6-1: The structure of the α-fragment of hMT1a. (Left) The Cd4SCYS-11 cluster
structure showing the wrapping of the peptide chain. (Right) The connectivity between
the 11 Cys and the 4 Cd2+ in the -binding domain showing the mixture of terminal and
bridging S from the 11 Cys. Structures adapted from the model of Chan et al.24 . The
NMR structure of Cd4-MT2 was originally reported by Messerle et al.97 The sequence of
α-rhMT1a is provided in the Experimental Procedures section.
The molecular probe chosen was benzoquinone (Bq) due to its reactivity towards cysteine
residues. Previously, MT cysteines have been modified by iodoacetamide to determine
the extent of free cysteine and the extent of disulfide bridge formation98. Bq is a larger
molecule than modifiers like iodoacetamide and, therefore, is likely more affected by
steric hindrance in the vicinity of the thiol reaction site. This provides a more sensitive
marker of the steric hindrance of the cysteines introduced by the conformational changes
introduced by folding. Therefore, the differential accessibility of each of the cysteinyl
thiols is a probe of the extent of shielding of the cysteines. Bq also reacts more quickly
than alkylating reagents at the pH range used in this study99. The chemistry of Bq with
respect to thiols is attractive because the reaction with quinones is fast and quantitative at
pH below 7.5100.
Our results clearly show that there are structural differences in the conformational
families of apo-MT under native and denaturing conditions and that there is a significant
metalation rate dependence on those conformations.
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6.2
6.2.1
The

Methods
Metallothionein preparation
recombinant



domain

of

human

metallothionein

1a

(MGKAAAACCSCCPMSCAKCA QGCVCKGASE KCSCCKKAAA) was produced by
over-expression in E. coli BL21(DE3) cells as described in detail elsewhere101. Briefly,
the cells were grown in the presence of CdSO4 and the Cd-containing -domain was
isolated and purified as an S-tag fusion protein using an SP ion exchange column and
superfine G-25 Sephadex size exclusion column equilibrated with 10 mM Tris-HCl (pH
7.4).

The N-terminal S-tag (MKETAAAKFE RQHMDSPDLG TLVPRGS) was

subsequently cleaved from the concentrated protein fraction using a Thrombin
CleanCleaveTM Kit (Sigma) as per the manufacturer’s instructions.
Metal-free or apo-MT was prepared by eluting the thrombin-cleaved Cd-bound protein
from a G-25 size exclusion column equilibrated with 10 mM Tris-HCl pH 2.7. Elution of
the protein with a low pH eluent effectively removes the metal ions from the protein,
which separate from the protein band on the G25 size-exclusion column. Since MT is
devoid of aromatic amino acids, the metal-free protein fractions were detected by the UV
absorption at 220 nm, which corresponds to the electronic transitions generated by the
polypeptide backbone. Protein concentrations were determined by remetalation with
Cd2+ and examination of the UV absorption spectrum at 250 nm, which corresponds to
the ligand-to-metal charge transfer transition generated by the metal-thiolate bond (εα250=
45,000 M-1cm-1;)102. For ESI-MS studies the pH of the protein solutions was adjusted
using NH4OH (Caledon Laboratory Chemicals) and HCOOH (Caledon Laboratory
Chemicals).
Solutions of 500 mM parabenzoquinone (Bq; Fisher Scientific) were prepared in 100%
methanol (Caledon Laboratory Chemicals) and diluted to 50 mM in >16 MΩ·cm
deionized water (Barnstead Nanopure Infinity). Bq solutions were bubbled extensively
with argon. The reaction of benzoquinone with thiols has been previously described103.
Reactions were carried out in 10 mM ammonium formate buffer at pH 2.8 and 6.7 with
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MT concentrations ranging between 20-40 μM. The neutral pH data set was collected at
pH 6.7 and the low pH data set at pH 2.8.

6.2.2

ESI-MS of proteins with modified cysteines

Mass spectra were collected on a micrOTOF II electrospray-ionization time-of-flight
mass spectrometer (Bruker Daltonics, Toronto, Ontario, Canada) in the positive ion
mode. NaI was used as the mass calibrant. The scan conditions for the spectrometer
were: end plate offset, -500V; capillary, +4200 V; nebulizer, 2.0 bar; dry gas flow, 8.0
L/min; dry temperature, 30oC; capillary exit, 180 V; skimmer 1, 22.0 V; hexapole 1, 22.5
V; hexapole RF, 600 Vpp; skimmer 2, 22 V; lens 1 transfer, 88 µs; lens 1 pre puls storage
23µs. The mass range was 500.0–3000.0 m/z. Spectra were constructed and
deconvoluted using the Bruker Compass DataAnalysis software package.

6.2.3

ESI-MS data analysis and reaction modeling

The relative rate constant values (kn) of each of the 11 reactions of apo-α-MT with Bq
were estimated using ReactLab software (Jplus Consulting Pty Ltd, Australia) and those
values were used in the simulation program HYSS (Hyperquad, UK). The set of 11 kn’s
were slightly modified in HYSS to fit the mass spectral data points measured for
reactions at both neutral and low pH (6.7 and 2.8). The relative rate constants were
determined using an integrated second-order bimolecular reaction expression:
ln[Bt/At]=ln[B0/A0]+k[B0-A0]t
Where B is in excess relative to A, ie in this equation B would represent Bq and A the
MT species. It is solved as a series of 11 consecutive reactions where the k is the rate
constant and the reactions are coupled to each other. HYSS allows coupling of multiple
expressions in a single model and tuning of the k-values to minimize the difference
between model and experimental results. In this way 11 k-values were obtained.

6.2.4

Molecular modeling of apo-αMT and cysteine modifications

Molecular modeling calculations for Figure 6-6 were carried out using Scigress Version
3.0.0 (Fujitsu Poland Ltd.). The calculations for Figure 6-1 was carried out using Cache
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Version 6.1 (Fujitsu, America). Allinger's MM3 Force Field augmented for metals was
used with the modified force field from Chan et al.96. Modeling parameters and sequence
information have been previously described by Rigby and Stillman19.

6.2.5

Kinetic measurements of cadmium binding to αMT

Separate solutions of apo-α-rhMT 1a at pH 2.0 were prepared for the kinetic study
containing 237.5 mM KCl and 2.0, 3.0, 4.0, 5.0, 6.0, or 7.0 M guanidinium chloride
(GdmCl). The concentrations of the apo-αMT 1a ranged from 9.5-17.2 μM. Cadmium
solutions were prepared as the sulfate salt at a concentration of 52 mM in 10 mM
Tris/HCl buffer (pH 7.4) with 200 mM KCl. The metalation kinetics of apo-α-MT1a in
the presence of GdmCl were measured under stoichiometric Cd2+ conditions equating to
4.0 molar equivalents of Cd2+ per mole of apo-αMT 1a. The metalation reaction was
carried out at 10°C using a BioLogic SFM-300 stopped-flow instrument (BioLogic
Science Instruments, Claix, France) powered by a MPS-52 unit (BioLogic) and coupled
to a MOS-250 light source (BioLogic). The low pH protein solution of apo-αMT1a was
neutralized by mixing with 1% NH4OH in the mixing chamber of the stopped-flow
instrument immediately prior to mixing with Cd2+.

Metalation was monitored by

detecting the change in UV absorbance at 250 nm corresponding to Cd-thiolate bond
formation. The dead time for this mixing sequence was 2 ms. Data points were collected
every 2 ms for 8 s, every 1 ms for 6 s, or every 500 s for 0.5 s followed by every 2 ms
for 7 s depending on the rate of the reaction. The reported kinetic data are an average of
at least four independent kinetic traces. The kinetic traces of the metalation reaction of
MT with Cd2+ were fit using the Gepasi v. 3.0 (Virginia Polytechnic Institute,
Blacksburg, VA (6-7)) simulation program as a single bimolecular reaction such as that
shown in Equation 4, Scheme 1.
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Scheme 6-1: The four, sequential, bimolecular reaction steps that lead to complete
metalation of the apo-αMT1a
To check that the reaction rate was not dependent on the increasing viscosity of the
solution, apo-αMT1a was prepared with 237.5 mM KCl and 0.34 M sucrose. The
sucrose was prepared by adding 0.582 g of sucrose to 5 mL of protein in 10 mM Tris-HCl
pH 7.4. A solution of Cd4-αMT1a in the presence of 5 M Cl- was also prepared. The
kinetic analyses (not shown) were then carried out in the presence of high sucrose and
high salt concentrations. In neither case were the kinetic results were changed.

6.3
6.3.1

Results
Metallothionein cysteine modification using p-benzoquinone
(Bq)

We have previously described the reaction of Bq with the cysteines of apo-MT and the
successful use of this method to probe for changes in surface topography as a function of
As3+ metalation27.

We further demonstrated that a single Bq molecule reacts

stoichiometrically with each cysteine residue in MT for a total of 11 Bq reacting with the
11 cysteine residues in -rhMT1a104. In the current study, aliquots of the Bq solution
were added to the solution of apo-αMT. ESI-MS was used to determine the extent of Bq
modification of cysteine side chain residues upon sequential addition of Bq to the MT
solution (Figure 6-2). The reactivity of Bq towards free cysteine residues is determined
by two main factors: (1) the intrinsic nature of the chemistry of covalent bond formation
between Bq and the thiol and (2) the steric hindrance of the access to the cysteinyl thiol
introduced by the folding of the protein structure surrounding the thiol

27, 104

. Therefore,

the differential rate of the reaction between the 11 cysteines of the apo-MT1a is will
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depend of the relative accessibility of the thiol and presence or absence of surrounding
structure.

Figure 6-2: ESI mass spectral data recorded for the stepwise modification of the 11
Cys in apo-αMT1a with para-benzoquinone (Bq). The number of Bq bound to the
protein is shown by the vertical lines from 0 to 11. The Bq was added stepwise with mol
eq as shown.
Figure 6-2 shows a partial set of the experimental ESI mass spectral data for titrations of
apo-MT under denaturing (i) and native(ii) conditions: (i) at pH 2.8 and (ii) at pH 6.7.
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Many more steps were recorded than shown here. Of importance in these two data sets is
the difference in the distribution of the Bq modified species. The denatured or unfolded
(pH 2.8) peptide was modified in the expected manner; that is, a Normal distribution of
modifications was observed as a function of the mol eqs of Bq added. The maxima of the
Normal distribution progresses in an approximately linear fashion as a function of
increasing Bq addition.
Under native or folded conditions (at pH 6.7) the data show an important and significant
change to this trend: the additions of Bq do not result in a linear and progressive increase
in the Normal distribution maximum. Rather the relative abundance of modified species
lags behind the profile of the low pH traces and exhibits a tailing pattern that dips
significantly, then the relative abundance sharply increases for the fully modified species,
Bq11 (Figure 6-2, right). The reaction profile at pH 6.7 becomes so irregular that a
significant fraction of the completely modified apo-MT, with 11 Bq, is clearly present
even with just 3.6 eq Bq added, in complete contrast to the profile of the reaction carried
out at pH 2.8. By the 7.4-Bq-added point, the 11-Bq species dominates. This nonlinear
behaviour contrasts sharply the stochastic pattern of the low pH reaction.
The variance in range of modified species is due to residues in the unfolded protein
having similar accessibilities. In the folded protein the accessibilities vary and broaden
the range of species present at any given point. The presence of a folded apo-MT under
native conditions also introduces another process: the unfolding of the native structure
due to Bq modification, further explored in the Discussion section.

6.3.2

Determination of relative rate constants

The key to the interpretation of the difference in the reaction profiles of the Bq
modification reactions at low and neutral pH is found in the differences in the 11 relative
rate constants for the two conditions. The 11 kn’s of the reaction of Bq with each of the
cysteines at both neutral and low pH were determined by modeling the 11 sequential
bimolecular reactions using the computer program HYSS. HYSS allows for the tuning of
each of the 11 separate kn’s involved in the complete modification reaction of apo-αMT.
As a result of the large number of sequential reactions involved in the complete
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modification of the cysteines in apo-MT it is unlikely that selection of a series of
incorrect kn values could give a reaction profile that fits the observed ESI mass spectral
data as closely as here. In Figure 6-3A, the reaction profile of all 11 species at low pH is
plotted with insets that show the predicted mass spectral relative abundance data at two
stages in the reaction: namely at 3 and 7 equivalents of Bq reacted. The distribution of
modified species closely matches the experimental ESI mass spectral data shown in
Figure 6-2 at the same point in the Bq additions (Figure 5).
Figure 6-3B shows the modeled reaction profile for the Bq titration at neutral pH. This
profile clearly differs from that in Figure 6-3A in that the MT(Bq10) and MT(Bq11)
species appear much earlier in the titration at pH 6.7. The green line in Figure 6-3B
(which represents the relative abundance of MT(Bq11) is the most prominent of the 11
species by the 6-Bq point compared with only dominating at the 10-Bq point at pH 2.8.
The insets show the relative abundance of MT species at the stages where 3 and 7
equivalents of Bq have reacted with the apo-MT illustrating the same tailing pattern at the
beginning of the titration as seen in the ESI mass spectral data. At 7 Bq equivalents the
MT(Bq11) species is the most abundant in solution which mirrors the experimental mass
spectral data, Figure 6-2. The modeled data show that the differences in the experimental
plots are due largely to the differential kn values of each of the 11 separate MT-Bq
reactions.
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Figure 6-3: Simulations of the protein speciation when 11 mol eq Bq react over time
with apo-αMT at (A) pH 2.8 and (B) pH 6.7. Each species of (Bq)n-αMT (n=0-11) is
shown as it forms then is replaced by the n+1 Bq modified species: apo (black), Bq1
(red), Bq2 (green), Bq3 (blue), Bq4 (teal), Bq5 (pink), Bq6 (orange), Bq7 (purple), Bq8
(dark blue), Bq9 (fuchsia), Bq10 (brown) and Bq11 (dark green). In both simulations, the
relative abundance of each species, as would be observed in ESI-MS data, is shown at 3
and 7 molar equivalents of Bq reacted in bar graph format. The insets model the ESI-MS
data actually measured and shown in detail in Figure 6-2. The * indicates where the
abundance of particular species differs between conformations. kn's used: pH 2.8: 3.76,
3.59, 3.46, 3.40, 3.38, 3.37, 3.29, 3.26, 3.13, 3.01, 2.87 and for the neutral pH: 4.14, 4.04,
3.98, 3.92, 3.89, 3.85, 3.84, 3.79, 3.80, 3.78, 3.99. It is estimated that the error in these
values is ±10% the same as from the original ESI-MS data.
Figure 6-4 assembles the experimental data (black) and simulated data (red) as a function
of the relative abundance of the Bq-modified species for the titrations carried out at pH
2.8 (left) and 6.7 (right). The simulated ESI-MS relative abundance data were obtained
by extracting slices at each Bq-addition point based on the 11 kn values used in Figure 63. This Figure provides a direct comparison between the experimental data and the
model with its simulated spectra. The model matches the experimental data remarkably
well, particularly reproducing all the specific features of the experimental data at both
low and neutral pH closely.
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Figure 6-4: Comparison between the experimental data (black) and the simulated
model data (red) for stepwise modification of apo-αMT by Bq at low pH (Left) and
neutral pH (Right). The black bars show the experimental ESI-MS spectra recorded at
the specified Bq addition point. The simulated model data at each pH are taken from a
single calculation that requires all 11 kn's to be used.
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6.3.3

Comparison of the kn Values Used in Generating the Model
Reaction Profile

The values of the 22 kn’s (11 for each pH) were compared by normalizing the kn’s of the
first 10 reactions to the final reaction kn (MT(Bq10) + Bq  MT(Bq11)) for both data sets.
Our argument for this approach is that it is likely that once 10 cysteine residues have been
modified by Bq, any specific structure present prior to the reaction will have been
disrupted. Because we consider that the MT(Bq10) structure is similar under both
conditions, we consider that the reaction rates of this final modification step,
MT(Bq10)+BqMT(Bq11), at both neutral and low pH will be similar. In Figure 6-5 it
can be readily seen that the normalized ratios of each kn are much higher in the low pH
data set (black) than the neutral pH data set (red); also, the range of the values are very
different, ~5% variance at neutral pH versus ~33% variance at low pH.

Figure 6-5: Normalized relative rate constants (kn) for each of the 11 cysteine
modification reactions at each pH (2.8 and 6.7). The ratios for the low pH kns are
shown in black and the high pH kn ratios are shown in red. The kn were determined
through simulation of the data in the program HYSS. The kns are normalized to the kn for
the last modification reaction: apo‐ αMT(Bq)10 + Bq  apo‐ αMT(Bq)11.
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The accuracy of the simulation using the HYSS-determined kn values can be seen in
Figure 6-4 where the simulation and the actual data points from the ESI-MS are plotted
on adjacent axes. It can be seen that the simulation tracks the data points remarkably
closely. The errors in the ESI-MS data are estimated to be 10%105. The simulation
models 11 separate reactions in one calculation; any error in an individual kn value will
affect the distribution of all species in the simulation.

The close alignment of the

simulation and the experimental data for the 11 simultaneous bimolecular reactions is
challenging and the fact that the alignment is so close points to the reasonableness of the
analytical approach.

6.3.4

Molecular dynamics models

Molecular dynamics calculations were used to obtain representative structures of the apoMT and the cysteine modified apo-MT for the native and denatured protein (Figure 66). To mimic the effects of denaturation, the temperature setting was increased from 200
K to 500 K, a nominal temperature, that results in a much more open structre in the MD
calculaitons. In Figure 6-6A, the native protein model, results in a structure that is
globular making it possible for the cysteine residues to be shielded from the solvent in the
interior of the globular structure.

This structure closely resembles that reported

previously by Rigby, et al.19. The denatured model, in Figure 6-6C, shows a structure
that is much more string-like where the cysteine residues are not shielded and, therefore,
will be far more accessible to both the solvent and the incoming Bq molecules. The
native and denatured models of apo-αMT agree with previous experiments by Liu et al.106
that showed a decrease in effective diameter of the protein when folding. The effects of
the Bq modification of all 11 cysteine residues on the native and denatured structures are
shown in Figure 6-6B and D. The Bq modifications have the effect of disrupting the
globular structure in the native model opening the structure so that it resembles the
denatured structure. This provides some support for our proposal that the effect of the
protein structure on the MT(Bq10) + Bq MT(Bq11) reaction is practically the same at
high and low pH.
This is the origin of the reaction profile of the native structure. The modification provides
a continuum of increasingly unfolded structures when starting with a folded protein.
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When the initial structure is already unfolded, there is no such continuum and the tailing
reaction profile is not observed, but rather a profile that exhibits a stochastic pattern
mirroring a Normal distribution.

Figure 6-6: Molecular dynamics (MM3/MD) calculated structures at the energy
minima for each of the key structures. Representations of (A) native apo‐ αMT at
neutral pH with H‐ bonding properties intact and (C) denatured apo‐ αMT. The
structure of apo-αMT with 11 Bq modified cysteine residues in native conditions (B) and
under denaturing conditions (D).

6.3.5

Cadmium metalation kinetics of αMT in the presence of a
chemical denaturant

The ESI-MS Bq modification data indicated the presence of two families of conformers:
open at low pH and closed or folded at neutral pH. However, while metalation at neutral
pH is possible with both Zn2+ and Cd2+ it is not possible to use low pH to study the
metalation of the unfolded structure. To obtain the unfolded conformers we used an
increasing concentration of a protein denaturant.

Specifically, guanidinium chloride

(GdmCl) was used as the chemical denaturant as it disrupts hydrogen bonds that may be
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stabilizing the protein backbone as predicted from the previous modeling studies19. The
binding of four divalent metals to the α-domain has been proposed to occur as four
sequential bimolecular reactions107 corresponding to the addition of each of the four
metal ions to the protein to form the fully metallated Cd4 species in much the same way
as the three As3+ ions bind sequentially to apo-MT108.
CD spectra were recorded at increasing GdmCl concentrations to ensure that the presence
of GdmCl did not interfere directly with the metalation reaction causing the product of
the reaction to be altered. Figure 6-7A shows that the effect of increasing [GdmCl] added
to already folded Cd4- αMT is a slight blue shift of approximately 1-2 nm. This is likely a
solvent effect to due with the interaction of increasing amounts of GdmCl with the
exterior of the protein, it did not effect the overall envelope shape. From this we can
conclude that the metal core remains intact because we still see the exciton effect from
the Cd4S11 cluster. The UV-Vis spectrum remained essentially unchanged (S. Fig 13). To
ensure the GdmCl did not directly interfere with the metal-induced folding in the
presence of 6M GdmCl, Cd4-αMT. was demetalated by reduction of pH and remetalated
by bringing the pH back to 7. The demetalation causes a loss of CD intensity in the S to
Cd2+ charge transfer region (Figure 6-7B, blue line), which is regained when the pH is
returned to neutral (Figure 6-7B, green line). The spectra of Cd4-αMT metalated in the
presence of GdmCl matched that of the already folded Cd4-αMT.
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Figure 6-7: Circular dichroism spectra of Cd4α-MT in 10mM ammonium formate
(black lines). (A) Effect on the CD spectrum of the presence of increasing GdmCl
concentrations. (B) Effect on the CD spectrum of demetalation, followed by remetalation in the presence of increasing GdmCl concentrations. (B) Effect on the CD
spectrum of demetalation, followed by re-metalation in the presence of 6M GdmCl.
Figure 6-8 shows representative kinetic traces (in black) obtained for the metalation
reaction in the presence of 2.0, 4.0 and 7.0 M GdmCl at 10 0C. A slowing of the
metalation kinetics is apparent by visual inspection of the kinetic traces where the time
required to reach an absorption plateau, thus signaling the end of the metalation reaction,
increases from less than 0.2 s in the presences of 2 M GdmCl to greater than 4 s in the
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presence of 7 M GdmCl. The kinetic data were fit using the Gepasi simulation program
as a single bimolecular reaction (red traces) to obtain the observed rate constants (kobs).
A single bimolecular reaction was used because it resulted in the best fit of the kinetic
data suggesting that the final bimolecular reaction in the series of four bimolecular
reactions (one for each addition of the four metal ions) is the rate-limiting step and thus
the only observable reaction at 250 nm. This final reaction results in formation of the
cluster structure and is, therefore, expected to be the slowest step of the 4-step reaction.
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Figure 6-8: Time dependence of the metalation reaction of apo‐ αMT with Cd2+ as a
function of an increasing concentration of GdmCl. The red line indicates the fit
generated by the program Gepasi. Each trace has a different X‐ axis range for (A) 0 ‐
0.8 s; (B) 0 ‐ ‐ 2.0 s; (C) 0 ‐ 7.0 s). A line marks 0.5 s in each trace to illustrate the
reduction in the rate as a function of increased GdmCl concentration. The absorbance was
monitored at 250 nm.
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The observed k values plotted in Figure 6-9 were fit with a sigmoidal curve emphasizing
the significant reduction in the second-order rate constant over the narrow range of 3 – 5
M GdmCl. From these data, it can be reported that > 4 M GdmCl results in complete
denaturation of the metal-free protein and no further rate reduction is observed. The
noise varies in the plots shown due to the faster reactions being completed close to the
dead time of the stopped flow mixer, requiring a much shorter integration time. The final
concentrations of protein differ from the initial due to dilution when mixing with the Cd2+
and basic buffer solution but the rate constants have been normalized for concentration.

Figure 6-9: The observed rate constant (kobs) for the metalation of apo‐ α-MT with
Cd2+ as a function of GdmCl concentration. kobs sharply decreases between 3 and 5 M
GdmCl as a result of loss of protein structure. The error in the measurement is higher
with higher kobs due to the limitations of the stopped flow device and dead time. The
mean kobs values are: 60.4±10.3, 57.8±10.1, 50.7±9.8, 39.7±4.8, 27.0±5.3, 3.80±2.9,
3.74±1.8, 3.32±1.9 106 M-1 s-1.

6.4

Discussion

The metal-saturated structure of mammalian metallothioneins is dominated by cysteinemetal bond formation. These structures have been studied extensively by NMR, EXAFS
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and XANES methods96,

101, 109-112

. Despite this extensive literature, the details of the

stepwise metalation mechanism by which the 7 Zn2+ or Cd2+ ions bind to the apo-MT is
very poorly understood. However, it is clear that the metalation reaction follows a
distinct pathway because in the case of both Cu+

64, 113

and As3+105, 108 kinetic data have

been reported that are metal-status dependent. By this we mean that the time dependent
data recorded during these metalation reactions are sensitive to the metal loading between
0 metals bound and being fully saturated.
So, stepping back from the structures of the fully metalated MT previously reported,
takes us to the question of the dependence of metalation on the structure or conformation
of the metal-free, apo-MT. There are few techniques that can give information about this
hard-to-characterize protein. Particularly, the conformation of the metal-free, apo-MT,
because of its fluxional nature110 has not been described extensively. FRET experiments
provided evidence that at neutral pH both α and βMT fragments retained their compact
structure upon demetalation94-95 and molecular models114 and ESI-MS data115 support this
conclusion. However, it is important to understand the dependence of metalation on the
conformation of the apo-MT in order to determine metalation mechanism and the
directors for metal specificity. Moving forward through the metalation process brings us
to the important role of the partially metalated protein. This role is directly related to the
buffering or homeostatic role of MTs. In that role, the bound metals will shuttle in and
out of the MT's binding sites. The conformation of the partially metalated protein then
becomes the launching point for delivery of a metal to a metal-dependent enzyme or the
receiving point for uptake of metals from metal-chaperones. This process has been
recently discussed for Zn-MT116¸

The structural determinants for this process are

unknown. However, elucidation of the metalation and folding mechanisms is critical for
characterizing the functional role or roles of MT in vivo.

The challenge is in

understanding the conformational dependences of the stepwise metalation of apo-MT.
The metal-induced folding of apo-MT is driven by the stepwise formation of the metalthiolate cluster within the core of the domain117. To study the structural properties of the
apo-MT starting point we used cysteine modification with Bq, and exploited the
observed differential reaction rate of the Bq with the cysteinyl thiols to provide
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information on the ease of the modification of the cysteine thiols and, therefore, the
relative exposure of the thiols to the reactive Bq.
The Bq reaction profiles with apo-MT are interpreted as being due to random binding at
low pH giving a Normal distribution of Bq modifications with an increasing manifold
maximum. At neutral pH a highly selective modification profile was observed and can be
explained by the differential shielding of the cysteinyl thiols by the globular structure. It
is the reaction profile showing all 11 modification reactions that is the key result of this
experiment: at neutral pH, the MT(Bq11) species is observed after the reaction of only 2-3
equivalents of Bq. If the reaction were solely due to probability of the 11 free thiols of
the apo-MT reacting with the Bq then only a relatively narrow band of cysteine
modifications should be present at any given point in the reaction. The observation of the
MT(Bq11) species with only a small amount of Bq reacted indicates very unusual reaction
properties that are uniquely present at neutral pH but not at low pH (Figure 6-2). This
unusual reactivity at neutral pH can be explained by the cysteinyl thiols in apo-MT
being shielded by the compact, folded structure of the apoprotein.

However, as

increasing numbers of Bq molecules react with the cysteine residues in the protein, the
protein becomes more and more unfolded, exposing the remaining free thiols to the
solvent and to the incoming Bq. In other words, as the protein is modified, it adopts more
open sets of conformations which promote Cys-Bq reactivity.
In Figure 6-5, at neutral pH, we can understand the trend in kn's as a function of Bq added
is a composite of two opposing trends: (i) the kn's decline as in the low pH reaction and in
keeping with the statistical loss of reaction sites as a function of increasing Bq and (ii) the
kn's increase as the peptide unfolds due to structural changes induced by Bq modification,
exposing remaining free thiols to the solvent. The starting kn is depressed significantly
due to the effects of steric shielding, so the span in k1 to k11 is essentially zero. The claim
that the protein is being unwound by cysteine modifications is supported by molecular
dynamics models where the native protein under the same conditions but having been
modified by Bq appears as a string-like structure instead of having a globular structure
(Figure 6-6).
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In contrast, during the low pH reaction, there is no structure to shield the cysteinyl thiols
and this unusual reaction pattern does not occur. At low pH the first kn is much higher
than in the final reaction because there are 11 thiols that are all equally accessible. These
kn values follow the trend reported by Ngu et al.105 for the rate constants for 6 As3+
binding to apo--MT in which the rate constants diminished linearly as a function of
remaining sites for the As3+ to bind to the apoprotein. However, even at low pH we
observe a pause in the reduction of kn that we interpret as being due to an unfolding of
any residual structure as a result of the Bq loading at the 5-Bq point. So, the values of the
kn for Bq 5, 6 and 7 do not diminish, but then the statistical dependence of the remaining
Cys dominates the kn value to the last reaction that forms apo-αMT(Bq11)

6.4.1

Metalation of the α-domain with Cd2+: Testing the Two
Conformational Classes

Only one report has been published on the kinetics of the metal binding reaction of metalfree MT with Cd2+. This report showed that the metalation of the two-domain rabbit liver
MT2a proceeded at a rate that was immeasurable by stopped-flow techniques at room
temperature in that the reaction was complete within the 4 ms dead time of the
instrument.91 Indeed, that report was somewhat surprising in that the reaction was found
to proceed at a rate much faster than what might be predicted but this fast rate is
confirmed in this present study.
A more recent study on the metalation of the individual domains of human MT1a with
As3+ showed a metalation reaction that proceeded several orders of magnitude slower
than that observed for Cd2+, with observed rate constants in the range of 0.8 –6.3 M-1s1 108

.

The slow metal binding kinetics permitted the use of selective mass spectrometric

techniques to monitor the relative formation of the individual domain intermediates in the
metalation pathway. This report showed that the metal binding mechanism of As3+ to
MT followed a series of sequential bimolecular reactions, in which the observed secondorder rate constants decreased for the successive steps in the reaction scheme. This is
consistent with a non-cooperative mechanism of metal binding to the each of the domains
of human MT1a. 107 In the experiments described here, the Bq modification data
pointed to the presence of different conformational families, a native form at neutral pH
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and a denatured form at low pH.

This terminology is not really useful for

metallothioneins because the conformation of the metal-free, apo-MT does not appear to
be rigid at either pH; rather at neutral pH the structure is more globular and bundled
whereas at low pH it is more linear. It is the metalation of the protein that introduces the
rigid structure117-118. However, it is clear from the experimental and computational data
that the neutral pH apo-MT structure is more folded and certainly the data described here
show that it exists in a form that shields the cysteines far more than the conformations
adopted at low pH do.
The metalation experiment could not use acidity to change the conformation because that
would alter the metalation reaction itself, rather we used a reversible chemical denaturant
added in increasing concentrations to the metal-free protein solution to provide a
gradually unfolded structure. A significant result of this work is that the more compact,
globular conformation metalated significantly faster than the denatured protein. The fit
of the data to a single bimolecular reaction suggests that the rate-limiting step is the final
addition of the 4th Cd2+ to form the metal-thiolate cluster. This folding step requires the
rearrangement of the partially metalated Cd3-αMT peptide backbone to allow for
formation of the Cd4-αMT cluster. This rearrangement of the coordinating cysteinyl
thiols involves the movement of the bridging and terminal cysteine ligands to the correct
orientation (Figure 6-1). It is likely that in the globular conformation, the cysteine
residues are pre-arranged to have to the correct orientation for cluster formation and
therefore, this final rearrangement step is fast. The denatured protein may be able to bind
the first two metals more quickly in a bead-like structure previously reported116, but once
bridging cysteines are required for the cluster structure, the necessary structural
rearrangement is much slower.

Although one might expect the open, string-like

conformation to metalate more rapidly due to the increased accessibility of cysteine
residues compared to the globular state, the results of the metalation experiment with
Cd2+ show unambiguously that the opposite is true. These data suggest that the cluster
formation must be the rate limiting step and that the globular structure of apo-α-MT
allows for a more rapid formation of this clustered core.
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The presence of the two-conformational families as descriptions of the structure of apo-αMT accounts for both the metalation kinetics and the Bq reactivity data. A templatestructured apo-αMT retains a globular structure upon demetalation and this globular
structure accounts for the increased rate of metalation when compared to the unfolded
protein. The randomly structured protein is thought to resemble the nascent apo-α-MT at
a post-translational state prior to initial metalation. This structure, although present for
only a short period of time in the cell, may play a relevant role in the redox status,
signalling and metal homeostasis of the cellular environment119. Our final consideration
concerns the metalation mechanism of apo-MT for Zn2+, Cd2+ and Cu+.

The

conformation of the apo-MT is pH dependent and the pH of the cellular environment
would be able to confer structural effectors that may favour binding of a specific metal
species or change the way in which MT interacts with other metal chaperones and
metalloenzymes.

6.5

Conclusions

The conformation of apo-MT has been shown to have a direct bearing on the
rate of the metalation reaction with Cd2+. The cysteine modifier benzoquinone was used
to probe the surface structure of the apo-MT in globular (neutral pH) and unwound (low
pH) conformations. The rate constants of the metalation reactions were directly related to
the folded state of the apo-MT. The conformation of the protein was assessed by using
low pH conditions to unfold the protein and then by comparing the modification reaction
profiles as up to 11 Bq molecules modified the cysteinyl thiols.

The significant

difference in reaction profiles for the modification of the 11 cysteines at neutral and low
pH was interpreted in terms of a globular conformation with restricted access to the thiols
at neutral pH compared with a much more open structure with essentially unimpeded
access to the thiols at low pH. Molecular modeling provided structures that illustrated
the two extremes. The arrangement of coordinating cysteine residues is a main driver of
the metalation kinetic rates and the close proximity of the cysteines in the folded, or
native conformation allows for rapid formation of the Cd-thiol core. This may be
important in mechanisms of MT-mediated metal detoxification by de novo synthesized
MT and displacement of other bound metals.
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Chapter 7

7

A Simple Metallothionein-Based Biosensor for
Enhanced Detection of Arsenic and Mercury6
7.1

Introduction

Many toxic metals are found naturally in the earth's crust at a very wide range of
concentrations and are present in many environments. The inherent toxicity of these
metals and their bioavailability influence the extent to which they pose problems for
human health as well as to plant and animal life. Two species with significant effects on
human health are As3+ and Hg2+.1-2 Mercury contamination, which has been well
documented in Japan, as well as in other countries including Canada, has caused
thousands of cases of Minamata disease.3 Clearly, contamination from industry,
agriculture and natural deposition must be monitored in a cost-effective and rapid method
to prevent future cases.4 Hg2+ is the most common speciation of mercury in aquatic
systems owing to its solubility and interaction with organic species.5 MT has been shown
to bind Hg with a high affinity and form stable complexes with a variety of Hg species.6-9
However, MT does not bind specifically to any one metal due to its fluxional nature and
lack of defined binding sites that would discriminate against certain metal co-factors.10-11
Arsenic, in particular As3+, is present at chronic as well as acute levels in drinking water
in many parts of the world but is not evenly distributed among sources.12 Therefore
detection and quantification of arsenic in potable water and even water used for irrigation
that can bioaccumulate in crops, is vital in assessing the safety of various water sources.
13-14

6
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Areas that are affected by significant arsenic contamination tend to be poor and have
limited access to expensive and centrally located testing facilities.15-16 A cheap, portable,
reliable and easy-to-use method to detect arsenic would help in monitoring contamination
levels in poor, rural areas of South and Southeast Asia. The method must have a low
detection limit due to the high toxicity of arsenic and mercury. Even small concentrations
(<50ppb) of arsenic can have serious chronic effects.17-18 Biosensors are a broad category
of sensors based on biological materials that may meet these criteria.
Biosensors containing DNA, enzymes and metal-binding proteins offer promising tools
with which to obtain real-time, in-situ data for heavy metal contamination.19-20
Metallothioneins (MTs) are a family of cysteine-rich, metal-binding proteins that bind
soft metals like mercury with particularly high affinity.21-23 Hg2+ has been shown to have
higher affinity for MTs than other Hg-species.24-25
At low pH, MTs are able to bind strongly to As3+ although the reaction is slower than
with native metals (zinc or copper) at neutral pH.7, 26-27 Cd and ZnMT demetalate below
pH 3.528 leaving the metal-free apo-MT available for the coordination of arsenic
species.29 The unique properties of MT make it an excellent candidate for increasing the
sensitivity of electrochemical sensor and efforts have been made to create MT-modified
electrodes for metal sensing.30-33 The success of many of these devices is limited due to
the time consuming preparation and expense required for other essential components,
such as MT-specific antibodies34 or reducing agents.35 In this study our goal was to
develop a low-cost, environmentally friendly biosensor using MT adsorbed onto paper
discs and placed on screen printed carbon electrodes (SPCEs) for the detection of arsenic
and mercury.

7.2
7.2.1

Methods
Reagents and instrumentation

All reagents used were of analytical grade. Electrochemical characterizations and
measurements were performed using a four-channel system (eDAQ QuadStat, e-Corder 8
and Echem software, eDAQ Europe, Warsaw, Poland). SPCEs (DRP-110) and the boxed
connector for SPEs (DRP-DSC) were purchased from DropSens (Asturias, Spain). The
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working electrode was carbon while the reference and counter electrodes were Ag/AgCl
and a carbon ring, respectively. Circular paper discs were cut from Grade 1 filter paper
(Whatman Asia Pacific Pte Ltd., Singapore, Singapore). Standard solutions of 1000 ppm
As3+ and Hg2+ were diluted with 18 MΩ ultrapure water obtained from a Millipore
Alpha-Q water system (Bedford, MA, USA) to final concentrations ranging from 1 ppm
to 5 ppb. Data were plotted on Microsoft Excel and refined using ORIGIN
(Northhampton, MA, USA).

7.2.2

Recombinant protein preparation

Recombinant human metallothionein 1a (MGKAAAACSC ATGGSCTCTG
SCKCKECKCN SCKKCC SCCPMSCAKC AQGCVCKGAS EKCSCCK KAA AA)
was expressed with an S-tag in BL21 E. coli cells, as described in detail elsewhere [36].
In brief, cells containing the plasmid for the full protein (βα-MT1a) were plated on to
growth media containing kanamycin from a stock culture stored at −80 °C and grown for
16 h at 37 °C. The grown cells were then inoculated into 4 × 1 L broth cultures enriched
with 50 μL of 1 M cadmium sulfate and incubated in a shaker for 4 h until the OD600
absorbance was 0.8. Isopropyl β-D-1-thiogalactopyranoside (IPTG) was then added to
induce expression of MT and 30 min later 150 μL of 1 M cadmium sulfate solution was
added to the broth. The cells were collected 3.5 h after induction, centrifuged and stored
at −80 °C.
The recombinant cells were lysed using a cell disruptor (Constant Systems,Daventry,
UK) shot at 20 k psi. From there, the cell lysate was centrifuged for 1 h to pellet out
cellular debris. The supernatant was filtered and loaded on to a GE healthcare SP ion
exchange column with a total volume of 10 mL. The columns were washed with pH 7.4
10 mM Tris(tris-hydroxymethyl-aminomethane) buffer for approximately 2 h to remove
loosely bound proteins and other organic compounds. MT was eluted using an increasing
gradient of 1 M NaCl + 10 mM Tris buffer at pH 7.4. The eluted MT was concentrated
down to <20 mL and the S-tag cleaved using a Thrombin Clean-Cleave kit as per the
manufacturers’ instructions (Sigma-Aldrich). The mixture was then diluted, desalted and
placed on another SP ion exchange column. The S-tag does not bind as strongly as MT
and thus elutes at low salt concentrations. The protein and S-tag were separated in this
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fashion. The eluted MT was concentrated to a total volume of 10 mL and lyophilized for
storage and transport.
The lyophilized MT was reconstituted in 10 mM ammonium formate buffer and buffer
exchanged to remove excess salt. The MT solution was checked for oxidation using UVVis spectroscopy and ESI mass spectrometry to ensure the lyophilisation process did not
cause oxidation of the MT thiols or loss of bound metals.

7.2.3

Disc preparation and electrochemical measurements

Filter paper was cut into discs of approximately 8 mm using a hole puncher and 20 μL of
40 μM reconstituted MT solution was added to the discs. The discs were kept in the
fridge and allowed to dry under nitrogen to prevent oxidation. Once dry, the discs were
placed on a DropSens electrode. The integration of the protein laden disc and SPCE has
been described in detail elsewhere.36 For the Hg2+ experiments measurements were taken
with an incubation time of 2 minutes to allow for equilibration.
For the As3+ experiments, HCl was added to the metal solutions to adjust the pH to 2.0.
This was done to remove and Zn2+ or Cd2+ still bound to MT adsorbed onto the paper
disc. The equilibration time was longer, up to 30 minutes to allow for complete reaction
as the kinetics of As3+-MT binding is known to be slow at room temperature.26
Anodic stripping voltammetry (ASV) measurement parameters for both metal detection
experiments were as follows: deposition potential -350 mV; deposition time 150 s;
scanning range between -0.2 and +0.3 V; scanning rate 100 mV/s; step W 20 ms; step H
2 mV; eChem stripping linear mode.

7.3
7.3.1

Results
Biosensor preparation

The quality of the MT protein adsorbed on to the paper discs was checked first by ESIMS prior to and after lyophilization to ensure purity. The protein was examined again
prior to disc preparation by far UV absorption spectroscopy to monitor for oxidation of
the thiols. UV spectroscopy is a fast, non-destructive technique for determining MT
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quality and concentration. The ligand-to-metal charge transfer (LMCT) absorption at 250
nm was used to calculate protein concentration. For use in the biosensor, it was crucial
that there was little (<0.15 abs) absorbance at 280 nm which would indicate the presence
of oxidized thiols (Figure 7-1).
In the preparation of the MT-loaded discs, it was determined that solutions of 40 μM
gave the best signal response (Figure 7-2). Adsorption of additional aliquots of MT
solution did not increase the signal response significantly, nor did the addition of higher
concentrations of MT. This addition of 40 μM concentration of MT to the paper discs
results in approximately 8 μg of protein being loaded in total. It should be noted that MT
contains 20 cysteiene residues and is stored bound to Cd2+ so the thiol and Cd2+
concentration loaded on to the disc is 20 and 7 times larger, respectively.

Figure 7-1: Far UV spectra of metallothionein (MT) used to monitor oxidation of
thiols. Apo-MT (solid black line), Cd-MT (dashed black line) are both fully reduced with
no thiol oxidation. Aerated MT solutions are shown to illustrate the oxidation: minimal
oxidation (dashed pink line) and significant oxidation (dotted red line). The ligand-tometal charge transfer (LMCT) band and the oxidized thiol absorbance are highlighted
with arrows.
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Figure 7-2: Influence of paper disc MT-loading on the peak heights of the SCys
responses at +0.22 V in the electrochemical scans. The MT concentrations of each of
the 20 μL aliquots added to the paper discs are plotted on the x-axis (n= 3).
The blanks discs on the SPCEs did not show any signals in the scans performed. The
MT-adsorbed discs gave signals slightly above +200mV in both ASV and CV scans,
likely due to the presence of free thiols in the protein. There was also a reduction peak
around -50mV in the CV scan which corresponds to the cysteinyl thiols in MT. The
heights of the peaks are relatively small and this is due to the presence of Zn/Cd2+ in the
isolated, lyophilized protein masking the thiol signal. The presence of these bound
metals is essential to the stability of the protein for longer periods of storage, as apo-MT
degrades more rapidly and is prone to oxidation.37 Compared to apo-MT, Cd/Zn-MT can
be stored as a frozen solution or lyophilized and reconstituted after 2-4 years of storage
without significant degradation.
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Figure 7-3: Representative electrochemical measurements of MT-loaded and blankpaper discs on SPCEs with 25 μL of deionized water added. (A) Cyclic voltammetry
(CV) scan of MT-adsorbed disc; (B) anodic stripping voltammetry (ASV) scan on MTadsorbed disc; and (C) ASV scan of blank paper disc. The ASV and CV scans of the
blank paper disc were similar and showed no distinct peaks.

7.3.2

Arsenic detection using anodic stripping voltammetry (ASV)

The paper discs on the SPCE connected to the DropSens device, coupled with the eChem
software was able to detect As3+ reasonably well in the control experiments, achieving a
strong signal down to a concentration of 100 ppb. The limit of detection (LOD) (3S/N)
calculated for the control paper disc on the SPCE was 69 ppb. For reference, the WHO
recommended limit for arsenic in drinking water is 10 ppb. When the MT was physically
adsorbed on to the paper discs placed over the SPCEs, the sensitivity was increased and
the signal intensity amplified greatly. This can be seen in Figures 7-4 and 7-5, where the
MT disc achieved a three-fold signal enhancement, which results in a detection limit
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below 20 ppb As3+. LOD (3S/N) was calculated to be 13 ppb for the MT-adsorbed discs
on the SPCEs.

Figure 7-4: Typical ASV scans using blank paper discs on screen-printed carbon
electrodes (SPCEs) with 25 μL of arsenic solutions of varying concentration added.
The arsenic concentrations are indicated above their respective trace. Inset in the top left
is the linear response curve for the blank disc set-up.
While this is still higher than the recommended limit for drinking water, it is low enough
to potentially be useful in screening for arsenic contamination in high risk areas. For
example, the Cambodian recommended limit is 50 ppb with some wells having
concentrations as high as 3.5 ppm (to emphasize the danger, 3500 ppb).38 In Bangladesh,
43% of wells have concentrations exceeding 50 ppb.17 The incorporation of the cysteinerich metallothionein pushed the LOD to concentrations below that typically found in
areas of concern.

168

In addition to an increase in signal intensity, the interactions between the arsenic and
MT-disc shifted the peak intensity to a more negative potential. The control disc with no
MT adsorbed showed As(III)-dependent peaks at approximately +160 mV (Figure 7-3)
which is very similar to that reported in the literature with more sensitive electrodes.39-41
The potential of As3+-stripping in the MT-modified disc scans was shifted to
approximately -60 mV and this type of shift is consistent with coordination by thiol42 and
protein modified electrodes.43

Figure 7-5: Representative ASV scans of MT-adsorbed paper discs with 25 μL
droplets of varying arsenic concentrations added. The concentrations are labeled
above their respective traces. Inset in the top right is the linear response curve for the
MT-disc set-up.

7.3.3

Mercury detection using ASV

In addition to As3+ which selectively binds to MT at low pH, we sought to leverage the
higher affinity that MT generally has for Hg2+ over Zn2+ and Cd2+, as similar strategies
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have been previously tested for MT-based metal detection

44

. Since the affinity for Hg2+

is higher than that of the native metals bound to MT, Hg2+ will displace these metals

45

.

In addition, both zinc and cadmium require more negative plating potentials than were
applied during this experiment, limiting their interference in this device. Upon lowering
the pH for arsenic detection or the displacement by mercury, the interferent (Cd/Zn)
concentration is approximately 280 μM.

Figure 7-6: Representative ASV scans of blank paper discs on SPCEs with 25 μL
aliquots of Hg2+ solutions of concentrations 20, 50 and 200 ppb. The concentration
corresponding to each trace is labeled near the peaks at +0.1 V. Inset in the top left corner
is the linear fit of the control data (n=3).
Below 20 ppb detection of Hg2+ became impossible even with the enhancement from the
MT-adsorbed discs. A comparison of Figures 7-6 and 7-7 show the approximately threefold enhancement of the peak current achieved by the MT-disc. The WHO guideline
upper limit for mercury in drinking water is six parts per billion, meaning the device is
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not achieving the sensitivity required to detect such low concentrations, especially in
more natural samples with organic interferents. However, it may be more useful in
monitoring area suspected of contamination which typically have higher concentrations
that the recommended limit 46. The LOD (3S/N) for the MT-modified paper disc was 45
ppb and 120 ppb for the blank paper disc.
The peak current for the Hg2+ signals was shifted to a more negative potential (Figure 77) similar to the shift in the As3+ signal seen in Figures 7-4 and 7-5. The peak seen
around +200 mV in the experimental trace is from the thiols in the protein and was also
observed in the control tests where deionized water was added to the MT-discs (Figure 73).

Figure 7-7: Representative ASV scans for MT-loaded discs with 25 μL drops of
diluted Hg2+ standards with concentrations of 20, 50 and 200 ppb. The concentration
is indicated on the graph near the Hg2+ peaks around −0.02 V. The peaks near +0.2 V
correspond to the thiols of metallothionein. Inset in the top right corner is the linear fit of
the data (n = 3).
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The linearity over the range of mercury concentrations typically found in water
contaminated by industry is adequate since even polluted waters have concentrations up
to 200 ppb

46-48

. While the sensitivity of the device is not ideal for sensing lower

concentrations of Hg2+ typical of non-industrially polluted waters, we have demonstrated
the versatility in our approach in incorporating a protein known to interact with many soft
metals and metalloids that cause environmental health problems. MT is able to enhance
the signal of both metals tested due to its promiscuity of metal binding and lack of
discriminatory metal binding sites.

7.4
7.4.1

Discussion
MT biosensors

The potential of MT-incorporated devices for sensing a wide range of metals is
summarized in Table 2, which lists examples of various metallothioneins being used to
enhance detection methods. The advantage of this strategy is that MT can enhance
methods with specific advantages such as specificity, low detection limit, portability or
low-cost. In our paper disc/SPCE sensor, we enhance a ‘green’ paper matrix with MT to
produce a more sensitive As3+/Hg2+ sensor. The low-cost and environmentally friendly
design of the sensor is greatly enhanced with the protein modification because the
detection limit pre-MT adsorption is much higher than what would be considered
acceptable.
By modifying the conditions under which the ASV scans are run, we can use MT as an
effective and selective pre-concentration agent for both As3+ and Hg2+. Thus, the same
device could be used for different assays depending on the type of contamination
suspected in the given area. Table 2 shows a summary of the different metals sensed by a
number of MT-based biosensors. It is likely a simple MT biosensor would be able to
measure all the metals listed in Table 2, but slightly different strategies or configurations
might have to be used. By using different MT isoforms 49 or a rational design approach 5051

to increase the binding affinity for certain metals, a device could be customized for any

soft metal.

172

Table 7-1: Summary of MT incorporated biosensors

Metal

Cd, Zn,
Ni

Method/Electrode

Modifiers and Extra

Detection

Refer

Type

Components

Limit

ence

MT on carboxymethlyated

1–2.25

chips

ppm

TCEP

5.6 ppb

[41]

50 ppb

[36]

SPR

Cd, Zn

HDME

Cd

Fluorescence

Pt

Zn-Chelex resin, Rh-labelled
MT

[21]

HDME

TCEP

10 ppb

[23]

Ag

Carbon paste

anti MT-antibodies

0.05 ppb

[25]

Pd

HDME

TCEP

10 ppb

[42]

As

Paper disc/SPCE

MT-adsorption

13 ppb

Hg

Paper disc/SPCE

MT-adsorption

45 ppb

Hg, Cu,

Modified gold

Coupling agents, bacterial MT,

1 × 10−15

Zn, Cd

electrode

continuous flow set-up

M

(cisplatin)

This
work
This
work

[43]

Another strategy would be to incorporate apo-MT to eliminate the need for the sensed
metal to have a much higher affinity than the endogenous metals (Cd/Zn). This would
pose additional engineering constraints due to the high oxygen sensitivity of metal-free
metallothionein and would require more extensive sample preparation to remove
dissolved oxygen 52-54.
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7.5

Conclusions

Adsorbing the cysteine-rich protein metallothionein on to paper discs provided a simple,
specific, sensitive and inexpensive sensor for the toxic metals As3+ and Hg2+.
Metallothionein incorporation allowed the SPCE/paper disc system to sense As3+ at low
enough concentrations to be potentially useful in environmental monitoring. This signal
enhancement is likely due to pre-concentration effects of the MT-metal coordination. Our
work shows that even simple physical adsorption of the protein onto an inexpensive
SPCE/paper disc can dramatically increase the signal associated with a metal of interest
without the need for costly coupling reagents or expensive and complicated set-ups.
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Chapter 8

8

Conclusion7

8.1

Metal binding mechanisms of MT

Metallothioneins (MTs) were initially isolated through repeated enrichment of cadmiumcontaining fractions of horse kidney cortex.1 As a result the main function of MTs was
originally thought to be heavy metal detoxification. While this remains true, a number of
other functions have since been proposed for MTs including maintenance of zinc and
copper homeostasis and significant contribution to cellular redox chemistry due to its
abundance thiols which are easily oxidized.2 The capacity to bind up to 7 zinc or
cadmium ions and up to 20 monovalent metals, such as copper and silver has confounded
the determination of the metalation mechanisms. The number of structural conformations,
coordination modes and isoforms of MTs has prevented agreement on an overarching
binding mechanism. This diversity of metalated structures and coordination geometries
does not even begin to include the ambiguities introduced by mixed metal species.
There has been considerable debate surrounding the nature of the zinc and cadmium
binding mechanism of MT, specifically the long studied cadmium mechanism. Cadmium
was historically used as a proxy for the more biologically relevant zinc due to its
amenability to investigation by absorption and CD spectroscopy, as well as 111,113Cd
NMR.3-6 With the advent of ESI-MS, more detailed metalation studies could be
performed but conflicting results only appeared to add to the confusion surrounding the
true mechanism.7-9

7

A version of this chapter has been published:

Irvine, G.W. and Stillman, M.J. (2017) Residue modification and mass spectrometry for the investigation
of structural and metalation properties of metallothionein and cysteine-rich proteins. Int. J. Mol.
Sci. 2017, 18(5), 913 doi:10.3390/ijms18050913
Copyright 2017 MDPI
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One of the main focuses of this thesis was to investigate the binding mechanisms of zinc,
cadmium and arsenic using ESI-MS techniques to determine the binding mechanisms
associated with their coordination and more importantly establish the binding constants
that govern the reaction.

8.1.1

A non-cooperative mechanism?

The non-cooperative mechanism for Cd2+ determined via ESI-MS was first reported in
200710 and then confirmed by Sutherland and coworkers one year later for MT1a.7 but
subsequent studies using the same method with MT2a showed a more cooperative
binding mechanism.9 Although the authors described the mechanism as cooperative,
significant amounts of intermediate species were formed making this description only
partially accurate. The mechanism for MT2a clearly favoured the formation of Cd4- and
Cd7-MT clusters which could be accurately described as a mixed mechanism. These
studies highlighted potential isoform specific differences in binding mechanism.
A single NMR study from 1988 indicated a pH dependence in the cadmium cluster
formation of rabbit liver metallothionein.11 The stability of the cluster allowed for sharp
NMR signals from the α-domain below neutral pH, whereas a broad indistinguishable
signal was observed at higher pH.11 While cluster formation refers more to the structure
formed by MT and not the mechanism, the two are inexorably linked and this was
demonstrated in Chapters 2 and 3. The data presented in these two Chapters show that
both cooperative and non-cooperative binding mechanisms are possible for MT1a
binding of zinc and cadmium. This is likely true for all mammalian isoforms as their
sequence and binding properties are very similar.
Chapter 2 highlighted the differences between cadmium and zinc binding, while both
were pH dependent, zinc binding was only semi-cooperative at low pH around 5.0
whereas cadmium binding was fully cooperative at that pH and remained at least semicooperative until neutral pH. We were able to specifically measure the pH at which the
binding mechanism changed, and this switch occurred rapidly.
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The lack of information with regard to location of the metals within the protein was a
limitation of the experiments chronicled in Chapter 2. In Chapter 3, the isolated domains
were investigated for pH dependence of cadmium binding and it was found that the αdomain followed the pH dependence of the full-length protein closely although the
binding mechanism of the isolated β-domain was also pH dependent. The specific
crossover point which we termed the "pKcluster" was 7.0 for the α-domain and 5.8 for the
β-domain. Chapters 2 and 3 were able to reconcile years of conflicting reports on the
binding mechanism and showed that both can be correct depending on pH conditions.

Figure 8-1: Potential metalation pathways and subsequent deconvoluted mass
spectra.
Significant progress had been made in determining the arsenic binding mechanism prior
to the work reported in this thesis, with the establishment of kinetic and thermodynamic
parameters associated with As3+ binding to MT.12 New information regarding the binding
mechanism was presented in Chapter 4 which reinforced the strong evidence of only non-
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cooperative binding modes for As3+ binding. We are not aware of any reports indicating
the opposite. More specifically, at all points in the step-wise metalation 3 cysteine
residues are involved in the coordination of each arsenic ion, allowing the
accommodation of 3 As3+ per domain. In the α-domain 2 cysteine residues are not
involved in As3+ coordination and remain free under arsenic saturation conditions.

8.2

Cysteine alkylation

In Chapter 4 we introduced the method of cysteine modification through reaction with the
alkylating reagent p-benzoquinone (Bq) for structural studies of MTs. First investigated
for the ability to "count cysteines", this method proved to be useful for more than just
detecting the presence of uncoordinated, free thiols.
First of all any oxidation of the thiols in MT can be detected upon complete reaction
since the end point of the reaction will be 2 modifiers less or more depending on the
extent of the oxidation. Extent of Cys-Cys bridges formed in the peptides in solution can
be measured directly. More interesting is the reaction profiles of cysteine modifiers that
can inform on the solution structure of MTs due to reaction differences between
conformers. Both of these applications are explored in Chapter 4, with surprising results
concerning the non-Normal distribution of modified species under denaturing conditions.
As3+ is able to bind to MT under low pH conditions and causes considerable metalinduced folding, indicating metal binding anchors the structure of partially metalated
MTs and is a more important factor than H-bonding.
Due to concerns over these patterns being specific to the Bq modifier, other cysteine
alkylating reagents were tested in Chapter 5, N-ethylmalemide (NEM) and iodoacetamide
(IAM). These three modifiers have different sizes, hydrophobicities and reaction
mechanisms that are well characterized.13-15
From these tests it was clear that larger and more hydrophobic modifiers like Bq and
NEM resulted in cooperative-like modification profiles, whereas the smaller, more
hydrophilic IAM resulted in Normal distributions of varying width. This is explained by
the more disturbing nature of Bq and NEM to the compact, native conformers of apo-
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MTs. These studies underscore the importance in choice of alkylating reagent depending
on the experiment. To probe structure, a noticeable change must occur and for these
studies larger modifiers are more suited. For studies where protein conformations must be
preserved, IAM is more suited, provided the studies are being done within the effective
pH range of the reagent. The pH ranges were also reported, with NEM being the most
robust, effective over the entire range tested (2.8-7.4) whereas IAM binding kinetics were
prohibitively slow below a pH of 5 and Bq ineffective above neutral pH.

Figure 8-2: Cysteine alkylating reagent accessibility to the compact and open
conformers of apo-MT

8.3

Importance of the structure of apo-MT

The conformation adopted by MT is one that is fluxional and ill-defined but we have
shown in Chapter 6 it is essential for metalation kinetics. This is somewhat counter-
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intuitive, since a more open conformer where the cysteine residues are most exposed to
the solvent and incoming metal ions might be expected to metalate faster. However, key
to the metalation mechanism of MTs, especially when binding cadmium, is the formation
of cadmium-thiolate clusters which involve both bridging and terminal cysteine residues.5
The more compact conformer(s) found under native conditions, while it may not
represent all conformers found under these conditions,16 likely orients the cysteine
residues in a way that is "primed" for metal binding and cluster formation. That is, the
cysteine residues are aligned so that the bridging cysteines are in, or close to, the optimal
position to form a bridging bond between two cadmium ions. Once formed, the
cadmium-thiolate cluster is known for its stability and amenability to determination by
113

Cd NMR and other methods.4, 17-19

To better understand the origin of these differential modification patterns, the reaction
was modeled using a series of sequential, bi-molecular reactions which gave simulated
mass spectral data that included species abundances at different points in the reaction.
When the modeled Ks of the reaction reproduce the experimental mass spectra to a high
degree of similarity, the relative values of the Ks can be compared and conclusions
drawn. In the data presented in Chapter 6, the Ks revealed a series of declining values
under denaturing conditions which is expected as the loss of binding sites as the reaction
proceeds results in the statistical decrease of binding constants. Under native conditions,
the relative constants do not decrease but increase slightly. This can be explained by the
opening or denaturation of the compact conformers by the modification of cysteinyl
thiols by the bulky Bq molecule. There are two major factors in addition to the intrinsic
chemical nature of the reaction that govern the rate at which cysteine residues are
modified:
(1) The statistical availability of free thiols
During the early stages of the modification of a peptide, the abundance of free thiols
makes a reaction more likely since there are more "binding sites" for the modification
reagents. Since there are more places on the protein that are capable of reaction, a
successful collision between a free cysteine and a alkylation reagent is more likely. As
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the cysteine residues are modified, the likelihood of a successful collision decreases due
to the increasingly rare potential reaction sites on the protein.
(2) The steric accessibility of free thiols
It is well-know that the semi-hydrophobic nature of cysteine allows for marked
differences in solvent accessibility depending on the folded state of the protein.20-23 The
more solvent accessible of these residues react at a much faster rate.20 During the
modification reaction of MTs, the compact conformer extends, exposing previously
buried residues and increasing their solvent accessibility and therefore, the rate of
modification. This is likely the origin of the semi-cooperative nature of the modification
reaction of MTs under native conditions.

8.4

Insight into potential metal sensing applications

The intimate knowledge of the arsenic binding properties of MT allowed us to design a
simple, "green", electrochemical MT-biosensor. The adsorption onto paper discs
provided a simple and "green" platform for electrochemical detection using anodic
stripping voltammetry and carbon paste electrodes. This was achieved without the need
for complicated and expensive coupling reagents or electrodes.
The set-up leveraged the unique binding properties of both arsenic and mercury to MT.
As3+ is one of only a few ions that can strongly bind to MT at low pH (<4) so by adding
HCl to the sample, the device was rendered selective for As3+ and removed interference
from Cd2+/Zn2+ that the MT is co-purified with. Mercury has a much higher binding
affinity to MT than most other metals and is able to displace bound Cd2+/Zn2+.
Signal enhancement of arsenic and mercury was 3-fold for each metal and was likely due
to the preconcentration effects of MT. This signal amplification allowed the limit of
detection to be pushed down to a level where the simple device could potentially be used
for arsenic contamination monitoring. We also demonstrated that with slight changes in
protocol the MT-based biosensor was able to detect and amplify the signal of multiple
metals of concern. This application could likely be extended to other metals that have
been successfully tested with other, more complicated MT-biosensors.24

183

Figure 8-3: Schematic of the MT-biosensor preparation

8.5

Biological relevance of MT structure and metalation

With the data presented in the preceding Chapters, it is worthwhile to put all of it into
context. How do these findings impact our understanding of MT's role in a biological
context?
With respect to the pH dependence of the metal binding mechanism, it is clear that zinc
binding is a non-cooperative process in a biological environment. This makes sense in the
context of MT's role as a homeostatic zinc buffer, requiring constant metal coordination
and release. Also the propensity to form terminally coordinated structures as opposed to
metal-thiolate clusters allows for more precise control of metal release with the lability of
individual metal ions disconnected from the others coordinated within the protein.
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For cadmium binding, only slightly acidic conditions are required for cluster formation
and these are found in many sub-cellular compartments, including those involved in
facilitating protein folding and the breakdown of wastes and toxic products.25 It is also
known that clustered Cd-MTs are resistant to degradation and MTs partially-metalated
with cadmium will be digested until the metals are shuffled into one domain and form a
resistant cluster. The high toxicity of Cd-MTs in the renal proximal tubules is a major
problem in kidney disease and these species are very long lived.26-27 Cells in the renal
proximal tubules are known to vary widely and but have intracellular pH well below 7.4
due to the constant transport oh HCO3-/H+.28-29 Clustering in the α-domain of Cd-MTs
may be the source of the longevity of these toxic species.
Accessibility of cysteinyl thiols is also biologically relevant due to the major role MT is
thought to play in cellular redox chemistry.2, 30-31 The potential shielding of these thiols
may lessen the potential impact that apo-MTs have on the redox chemistry of the cell,
especially when in competition with smaller reducing agents such as glutathione.

8.6

Final remarks

The data presented in this thesis provide reconciliation of previously conflicting reports
on the metal binding mechanisms of MT. Both cooperative and non-cooperative
mechanisms can accurately describe the binding of cadmium to MTs, depending on pH
conditions. This is also true for zinc binding, but in a biologically relevant range above
pH 5.5, the most truthful description is that of a non-cooperative mechanism. The power
of ESI-MS for resolving a multitude of species in solution was essential in the
determination of the true binding mechanism and in the insights gained into apo- and
partially metalated MT structure.
The novel method of covalent modification of cysteine residues applied to MTs proved to
be useful in probing many aspects of the structure/function of the protein. Not only were
we able to "count" the free cysteines to propose an unambiguous binding mechanism for
As3+ but also we were able to visualize conformational preferences and protein-protein
interactions through the reaction profiles of the cysteine modifiers. The lack of
description of apo-MT structure over the many years of study of this protein emphasizes
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the difficultly and lack of techniques with which to probe the structures of hard-tocharacterize proteins. The powerful resolution of ESI-MS coupled with the lower
resolution cysteine probe allowed a reasonable description of conformational preferences
of apo-MT and highlighted the necessity of even loosely defined structure in the kinetics
of metal binding. The work in this thesis highlights the need for multi-method analysis in
the description and characterization of disordered proteins.

8.7
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